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Abstract 
Embryonic stem (ES) cells are able to differentiate in vitro into endodermal, 
mesodermal and ectodermal cell types. ES cells and their close counterparts, 
embryonic carcinoma (EC) cells, are a useful model system for studying the 
mechanisms  governing  neuronal  differentiation.  Since  High  Mobility  Group-
nucleosome  binding  (HMGN)  genes  are  regulated  in  a  developmental-stage 
specific  manner  during  mouse  embryogenesis  and  cellular  differentiation, 
their roles in undifferentiated and neural differentiating P19 EC cells were 
examined. Work presented in this thesis firstly optimises the  Retinoic Acid 
(RA)  -induced neural differentiation  protocol  of  P19  EC  cells  based  on  key 
neuronal and glia markers.  Two crucial steps of RA concentration and cell 
plating  density  were  shown  to  increase  the  efficiency  of  neuronal 
differentiation.  Analysis  of  HMGN  proteins  showed  they  were  ubiquitously 
expressed in undifferentiated and neural differentiating P19 cells. HMGN2 and 
HMGN3  were  up-regulated  while  HMGN1  remained  unchanged  upon  neural 
commitment. Unusually, HMGN3 protein was localised in the cytoplasm of P19 
cells. To study the possible role of HMGN proteins, HMGN1 and HMGN2 were 
knocked  down  using  siRNAs.  HMGN1  and  HMGN2  knockdown  in 
undifferentiated  P19  EC  cells  dramatically  down-regulated  the  key 
pluripotency regulator genes Oct4, Nanog and Sox2. Furthermore, HMGN1 and 
HMGN2  knockdown  in  neural  differentiating  cells  affected  seven  neuron-
specific  genes.  These  data  suggest  that  HMGN  proteins  may  play  roles  in 
regulating genes that are involved in maintaining pluripotency and regulating 
neural differentiation in P19 cells. 3 
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Chapter 1 
Introduction 
1.1 Mouse embryo development and stem cells  
The development of a mouse embryo starts with the fertilization of an ovum, 
resulting in the formation of a zygote. The zygote reaches the morula stage 
(4-16  cells)  and  goes  on  to  form  the  blastocyst  (40-150  cells)  before 
implantation.  The  first  definitive  differentiation  decisions  are  made at the 
blastocyst  stage,  which  is  composed  of  three  distinct  cell  types: 
trophectoderm (TE), primitive endoderm, and epiblast (primitive ectoderm). 
All three cell lineages, the TE, primitive endoderm, and epiblast give rise to 
stem cell populations. TE potentially gives rise to trophoblast stem (TS) cells, 
primitive endoderm gives rise to extraembryonic endoderm stem (XEN) cells, 
while  epiblast  forms  embryonic  stem  (ES)  cells.  The  next  stage  is  called 
gastrulation and involves the differentiation of pluripotent epiblast cells into 
three embryonic germ layers known as endoderm, mesoderm and ectoderm. 
Primordial germ cells (PGCs) originate from a small population of mesodermal 
cells from the epiblast and give rise to embryonic germ (EG) cells. 
Mouse ES cell lines were first described in the early 1980s and were derived 
from  the  Inner  cell  mass  (ICM)  of the  pre-implantation embryo  (Evans  and 
Kaufman, 1981; Martin, 1981). Similar to the ICM of the early epiblast stage, 
ES cells are pluripotent cells that have the capabilities both  in vivo and in 
vitro to differentiate into all cell types of the adult organism. ES cells have 
been  shown  to  differentiate  into  neurogenic,  hematopoietic,  cardiogenic, 
myogenic,  epithelial,  endothelial  and  vascular  smooth  cells  (Wobus  et  al., 
2001; Wobus and Boheler 1999; Wobus and Guan 1998).  
EG cell lines were previously established from PGCs embryonic day 8.5 (E8.5) 
and E11 (Matsui et al., 1992). EG cells are pluripotent cells and can contribute 
to all three embryonic germ layers (Labosky et al., 1994). EG cells are shown 
to have similar morphology as ES cells in culture (Mclaren and Durcova-Hillis, 
2001).  Chapter 1    15 
TS cells are isolated from the TE of pre-implantation embryos. However, TS 
cells show limited ability to differentiate compared to ES cells. TS cells can 
form giant cells in vitro (Yan et al., 2001; Tanaka et al., 1998) and contribute 
to the differentiation of trophectodermal cell lineages in vivo. Although ES 
cells can be induced to become TS cells, the induced TS cells do not retain 
the differentiation potential of ES cells (Niwa et al., 2000).  
 
1.2 Embryonal carcinoma cells  
Embryonal carcinoma (EC) cells are known as the malignant counterpart of ES 
cells.  EC  cells  are  derived  from  teratocarcinomas,  a  subset  of  germline 
tumours. These malignant tumours arise in the testes of mice and human, and 
contain a variety of differentiated tissue and a population of undifferentiated 
stem cells. These undifferentiated stem cells are pluripotent and are known 
as EC cells. EC cells from teratocarcinomas are responsible for the malignant 
component  as  opposed  to  the  differentiated  tissue  present  in  the  tumor 
(Kleinsmith  and  Pierce,  1964).  This  was  shown  through  a  study  where 
transplantation of a single EC cell into a new host mouse was adequate to 
regenerate a new tumour (Kleinsmith and Pierce, 1964). In a separate study, 
the  grafting  of  mouse  egg  cylinders  into  the  kidney  capsules  also  formed 
teratomas containing both undifferentiated and differentiated cells (Solter et 
al., 1970).    
Mouse EC  cells was first derived and cultured  in vitro without losing their 
pluripotency in 1967 (Finch and Ephrussi, 1967).  Like mouse ES cells, EC cells 
express  pluripotent  markers  Oct4  and  surface  antigen  SSEA-1  (Niwa  et  al., 
2000; Andrew et al., 1996). Two mouse EC cell lines that have been used in 
stem cell research are F9 EC cells (Verheijen et al., 1999a; Verheijen et al., 
1999b; Lehtonen et al., 1998; Alonso et al., 1991) and P19 EC cells (McBurney, 
1993).  
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1.3 Embryonic Stem cells and Pluripotency 
Pluripotency  is  defined  by  the capability  of  a  cell  to  differentiate into  all 
types of cell that make up an organism (Solter, 2006). ES cells possess the 
ability  to  replicate  indefinitely  in  culture  and  differentiate  into  a  host  of 
functionally  distinct  cell  types.  Because  of  this,  ES  cells  have  become  a 
unique tool to study the early molecular and cellular processes that regulate 
normal  development.  The  mechanisms  by  which  ES  cells  choose  between 
pluripotency  and  differentiation  are  thought  to  be  orchestrated  by  several 
factors.  The  progression  of  pluripotent  or  undifferentiated  ES  cells  to  a 
differentiated  phenotype  is  regulated  by  changes  in  gene  expression,  in 
which, genes that are responsible for self-renewal are down-regulated while 
lineage-specific genes are up-regulated.  
The regulatory mechanisms that control the pluripotency and self-renewal in 
ES cells are not yet fully understood. Nonetheless several factors have been 
identified as crucial in maintaining the pluripotency of ES cells: among them 
are  extracellular  signalling,  transcription  factor  networks  and  epigenetic 
factors.  
1.3.1 Extracellular signalling in pluripotency and self-renewal 
Several  key  extracellular  signalling  pathways  have  been  identified  to  be 
crucial in maintenance of pluripotency and self-renewal of ES cells. Leukemia 
inhibitory  factor  (LIF),  a  member  of  the  IL6  family,  binds  to  leukemia 
inhibitory factor receptor (LIFR) and acts via gp130 receptor resulting in the 
activation of Jak kinases and Stat3 (Burdon et al., 2002). Activated STAT3 
protein is then translocated into the nucleus and activates the transcription of 
several key genes that are involved in pluripotency such c-Myc and Klf4 (Niwa 
et al., 2009; Cartwright et al., 2005). When Stat3 is inhibited, ES cells start to 
differentiate,  whereas  the  over-expression  of  Stat3  maintains  ES  cell 
pluripotency in the absence of LIF (Matsuda et al., 1999; Niwa et al., 1998). 
Binding of LIFR to gp130 also activates the PI(3)K/AKT pathway through which 
T-box3 (Tbx3) is activated. Over expression of Tbx3 inhibits differentiation in 
the absence of Lif by maintaining Nanog expression, whereas the knockdown Chapter 1    17 
of Tbx results in differentiation (Niwa et al., 2009; Ivanova et al., 2006; Paling 
et  al.,  2004).  The  LIFR-  gp130  signalling  also  leads  to  the  activation  of 
Ras/mitogen-activated  protein  kinase  (MAPK)/extracellular  signal-regulated 
kinase (ERK) pathway. Activated forms of ERKs translocate their targets into 
the nucleas which then regulates the activities of key transcription factors 
such as Myc and Elk. The inhibition of ERK siganalling in ES cells has shown to 
facililate  self-renewal  rather  than  activate  differentiation  (Burdon  et  al., 
1999).   
Wnt signalling is also known to play a role in ES cell maintenance through 
glycogen  synthase  kinase  3  (GSK3)  and  adenomatosis  polyposis  coli  (Apc), 
inducing  the  translocation  of  -catenin  into  the  nucleus  forming  -catenin 
/TcF3 (Transcription factor 3)  (Wray et al., 2011;  Willert et al., 2006).  -
catenin/Tcf  activates  the  transcription  of  downstream  targets  that  are 
responsible  for  pluripotency  maintenance.  Over-expression  of  Wnt  protein 
members contributes to the maintenance of pluripotency (Hao et al., 2006; 
Ogawa et al., 2006; Kielman et al., 2002).  
There are other signalling cascades involved in ES cells that are not discussed 
above  such  as  Fibroblast  growth  factor  4  (Fgf4)  signalling  (Kunath  et  al., 
2007),  Bone  morphogenic  protein  (BMP)  signalling  (Ying  et  al.,  2003), 
ACTH/SAF  activation  (Ogawa  et  al.,  2004),  GABA  and  BNP  signalling 
(Abdelalim  and  Tooyama,  2009).  The  extracellular  signalling  cascades  are 
known  to  regulate  ES  cell  pluripotency  via  two  different  mechanisms: 
targeting  core  pluripotency  transcription  factors  and  targeting  cell  cycle 
progression - related genes. Lif-Stat, Lif- PI(3) Kinase, TGF-, Wnt and Fgf4 
signalling  all  target  core  transcription  factors  that  are  responsible  for 
pluripotency,  while    ACTH/SAF  activation,  GABA  and  BNP  signalling  target 
genes that are involved in cell cycle progression.  
1.3.2 Transcriptional network to maintain pluripotency 
A  network  of  inter-related  transcription  factors  (TF)  is  central  to  the 
maintenance of ES cell pluripotency (Ema et al., 2008; Chambers et al., 2007; 
Masui et al., 2007; Niwa et al., 2005; Chambers et al., 2003;  Niwa et al., Chapter 1    18 
2000).  Indeed,  a  large  scale  RNAi  mediated  knockdown  study  identified  8 
genes that are crucial for maintaining the undifferentiated state of ES cells, 
of which 7 are transcription factors or chromatin associated proteins: Oct4, 
Nanog, Sox2, Tbx3, Esrrb, Tcl1 and Dppa4 (Ivanova et al., 2006). Among the 
core members of this pluripotency associated TF network are Oct4, Sox2 and 
Nanog (Chambers et al., 2007; Masui et al., 2007; Niwa et al., 2000). During 
mouse  development,  the  pluripotent  state  requires  the  expression  of  Oct4 
(Nichols et al., 1998) and Nanog (Mitsui et al., 2003) but not Sox2 (Avilion et 
al., 2003), and it has been proposed that this is due to the presence of long-
lived maternal Sox2 protein (Avilion et al., 2003).  
Genome  wide  studies  using  chromatin  immunoprecipitation  (ChIP)  -  based 
techniques  have  revealed  co-binding  of  Oct4,  Nanog  and  Sox2  in  ES  cells, 
suggesting a probable TF circuit that might direct ES cell identity  (Loh et al., 
2006; Boyer et al., 2005). Studies conducted by Loh et al and Boyer et al 
mapped  the  transcriptional  regulatory  network  and  demonstrate  that  Oct4 
and Nanog co-occupy and share a cohort of their target genes. In mouse ES 
cells, Nanog co-occupies 44.5% (345) of Oct4-bound genes, while 353 target 
genes are co-bound by Oct4, Nanog and Sox2 in human ES cells (Loh et al., 
2006; Boyer et al., 2005). These studies revealed that Oct4, Nanog and Sox2 
maintain  pluripotency  by  promoting  the  expression  of  downstream  self-
renewal  genes  while  simultaneously  repressing  the  transcription  of 
differentiation linked-genes.  
Subsequent  genome-wide  ChiP  based  studies  mapped  the  binding  sites  of 
additional TF and their co-regulators in mouse ES cells (Chen et al., 2008; Kim 
et al., 2008). These studies grouped the pluripotent associated TF into “Oct4-
related” and “Myc-related” modules. The Oct4-related module includes Oct4, 
Sox2, Nanog, Smad1, Stat3 and Tcf3 (Chen et al., 2008; Cole et al., 2008). 
Smad, Stat3 and Tcf3 are known downstream effectors for signalling pathways 
regulated by BMP, LIF and Wnt, providing a mechanistic basis for the role of 
these signals in maintaining ES cell pluripotency. Other TFs involved in the 
Oct4-related module are Dax1, Nac1, Zfp281, Esrrb, Nr5a2 and Klf4 (Heng et 
al.,  2010;  Dejosez  et  al.,  2010;  Feng  et  al.,  2009;  Kim  et  al.,  2008).  The 
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Esrrb analysed using ChIPs, providing evidence that Oct4 acts a mediator in 
the assembly and maintenance of these multi-protein complexes on DNA (van 
den Berg et al., 2010; Chen et al., 2008).  
The Myc-related TF module includes the transcription factors c-Myc, n-Myc, 
E2f1, Zfx, Rex1 and Ronin (Dejosez et al., 2010; Chen et al., 2008; Kim et al., 
2008).  The  key  difference  between  the  Oct4-related  and  c-Myc-related 
modules is that the latter involves TFs that occupy sites close to transcription 
start  sites  (TSS)  in  the  genome,  while  the  former  involves  TFs  that  bind 
further away from TSS. The TFs in Oct4-related module have been proposed 
to  act  as  enhancers  (Dejosez  et  al.,  2010;  Kim  et  al.,  2008).  The  c-Myc- 
related module mostly targets genes associated with protein metabolism and 
cancer related genes (Kim et al., 2010). 
Another  vital  dimension  to  the  pluripotency-associated  TF  network  is  the 
ability of many of these TFs to self-regulate their own expression, including 
Oct4,  Sox2,  Nanog,  Esrrb,  Sall4,  Dax1,  Klf2,  Klf4,  Klf5,  Stat3  and  Tcf3 
expression (Feng et al., 2009; Chen et al., 2008; Kim et al., 2008; Cole et al., 
2008; Lim et al., 2008; Jiang et al., 2008; Boyer et al., 2005; Loh et al., 2006; 
Chew et al., 2005). The accurate regulation of these TFs is crucial, as their 
over and/or under-expression would affect ES cell identity and differentiation 
state (Mitsui et al., 2003; Niwa et al., 2000).   
Amongst all pluripotent associated TFs, Oct4, Sox2 and Nanog appear to be 
involved in a feed- forward self activating gene regulation circuit that plays a 
key role in maintaining the core pluripotency TF network, maintaining ES cell 
self-renewal and determining cell fate.  
1.3.2.1  Oct4 
Oct3/4, also known as Pou5f1, was first described as either Oct3 or Oct4 in 
three different studies (Rosner et al., 1990; Scholer et al., 1990; Okamoto et 
al., 1990). Throughout this thesis,  Oct3/4 will  simply be referred as Oct4. 
Oct4  consists  of  a  DNA  binding  domain  called  the  POU  domain  and  two 
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pluripotent  cell  lineages  such  as  the  ICM  and  germ  cells  in  vivo  and 
undifferentiated ES cells in vitro (Rosner et al., 1990; Scholer et al., 1990; 
Okamoto et al., 1990;  Nichols et al., 1998;  Palmieri et al., 1994). Oct4 is 
known to regulate a broad spectrum of target genes, and from an embryonic 
developmental  perspective,  the  main  target  of  Oct4  is  Cdx2.  Depletion  of 
Oct4  in  ES  cells  leads  to  differentiation  into  trophectoderm  via  the  up-
regulation of Cdx2 (Niwa et al., 2005).  
1.3.2.2  Sox2 
The protein structure of Sox2 consists of a DNA-binding HMG domain and a 
transactivation domain that can be divided into three subdomains (Ambrosetti 
et al., 2000). Sox2 was initially identified as an Oct-Sox enhancer element 
binding protein on the regulatory region of the Fgf4 gene (Yuan et al., 1995). 
Later,  Sox2  was  shown  to  occupy  the  regulatory  regions  of  genes  that are 
specifically expressed in pluripotent stem cells (Rodda et al., 2005; Kuroda et 
al.,  2005;  Tokuzawa  et  al.,  2003;  Tomioka  et  al.,  2002;  Nishimoto  et  al., 
1999). The loss of Sox2 in vivo is embryonic lethal due to the improper ICM 
growth, indicating that Sox2 is essential for pluripotent stem cell maintenance 
(Avilion et al., 2003).  
1.3.2.3  Nanog  
The  Nanog  protein  structure  consists  of  three  domains:  a  DNA-binding 
homeodomain and two C/N terminal flanking transactivating domains (Wang 
et al., 2008; Pan et al., 2003). Nanog was identified from a functional screen 
based on the capability to maintain ES cell pluripotency in the absence of Lif 
(Chambers  et  al.,  2003).  The  repression  of  Nanog  in  vivo  results  in  early 
embryonic lethality (Mitsui et al., 2003). However, ES cells depleted of Nanog 
still  maintain  pluripotency,  although  with  increasing  inclination  to 
differentiate, suggesting that Nanog is not a critical factor in the pluripotent 
transcriptional network of ES cells (Chambers et al., 2007). In contrast, over-
expression of Nanog in ES cells under differentiation conditions increased the 
tendency towards the undifferentiated state, suggesting that Nanog may play 
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1.4 ES/EC cells and neuronal differentiation in vitro  
1.4.1 Neural development  
Neuronal differentiation is a process that involves the generation of various 
neuronal subtypes from progenitor cells. The development of the CNS begins 
during prenatal development, following the induction of neuroectoderm. The 
neuroectoderm  forms  a  thickened  region  on  the  dorsal  side  of  the  early 
embryo called neural plate. The neural plate is then converted to the neural 
tube that will later form the brain and spinal cord. 
The  molecular  mechanisms  that  trigger  the  neuroectoderm  induction  were 
elucidated  mainly  from  studies  conducted  using  Xenopus,  chick  and  other 
lower  vertebrates.  These  studies  identified  multiple  pathways  that  include 
the activation of Fibroblast growth factor (Fgf) and Notch, inhibiton of bone 
morphogenetic  protein  (BMP)  and  inactivation  of  Wnt  signalling  in 
orchestrating  the  induction  of  neuroectoderm  (Stern,  2006;  Stern,  2005; 
Wilson  and  Edlund,  2001).  Likewise,  mouse  ES  cell  models  show  the 
involvement  of  FGF,  BMP  antagonists  and  Wnt  inactivation  in  neuron 
differentiation, mimicking early neuroectoderm development in vivo (Ying et 
al., 2003; Aubert et al., 2002; Tropepe et al., 2001). 
FGF signalling is one of the  initial known mechanisms implicated in neural 
induction and  specification.  It  is  activated  prior to  and  also  synergistically 
with BMP inhibition and Notch activation (Stern, 2006; Lowell et al., 2006). 
The FGF signalling acts through the activation of extracellular signal-regulated 
kinase  (ERK1/2)  pathway  promoting  transcription  of  target  genes.  In  the 
mouse ES system, inhibition of FGF signalling eliminates the neuroectodermal 
induction from undifferentiated cells (Ying et al., 2003). In embryogenesis, 
BMP signalling blocks neuroectoderm formation and favours the activation of 
other lineage choices. BMP acts through a SMAD-dependent pathway resulting 
in the transcriptional activation of genes involved in other lineages. For the 
induction of neuroectoderm, BMP antagonists Noggin, Chordin and Follistatin 
are produced by mesodermal cells to inhibit BMP signalling. The role of Wnt 
signalling in neuroectoderm development is complex.  In a study conducted Chapter 1    22 
using Xenopus model, neuroectoderm induction requires the activation of Wnt 
(-Catenin)  as  this  pathway represses  BMP  expression  (Baker et  al.,  1999). 
However, the Wnt signalling must be antagonised in the later stages to allow 
neural specification (Stern, 2006). Studies conducted in the chick model show 
that  Wnt  inactivation  together  with  FGF  signalling  is  required  for 
neuroectoderm  induction  (Wilson  and  Edlund,  2001;  Wilson  et  al.,  2001). 
Finally, the evidence that neuroectoderm induction requires Notch signalling 
was shown in chick and Drosophila models, and later corroborated in mouse 
and human ES cells (Lowell et al., 2006; Akai et al., 2005; Gaiano and Fishell 
2002). In chick and fly, it has been shown that Notch ligand Delta 1 signalling 
together with FGF activation induced neural specification (Akai et al., 2005; 
Gaiano and Fishell 2002).  
1.4.1.1  Retinoic acid signalling and neural development 
Retinoic  acid  (RA)  plays  crucial  roles  in  the  nervous  system  including 
regulating  neural  differentiation,  axon  outgrowth  and  neural  patterning 
(Maden, 2007; Li et al., 2005). The concentration of RA is found to be higher 
in the posterior hindbrain and spinal cord compared to the anterior region in a 
developing embryo. The lack of RA signalling leads to the abnormal formation 
of the posterior hindbrain and spinal cord suggesting the crucial role of RA 
during  neural  development  (Maden,  2007).  During  neuronal  and  glial 
differentiation, RA promotes the activation of several genes that include TFs 
and  cell  signalling  molecules  (the  role  of  RA  in  neuronal  differentiation  is 
further discussed in section 1.4.3.1). Additionally, studies from Jacobs et al 
uncovered  the  effect  of  RA  deficiency  on  granule  cell  differentiation, 
suggesting that RA is required for neuronal differentiation of isolated adult 
brain NSCs (Jacobs et al., 2006).  
1.4.2 In vitro neuronal differentiation of ES/EC cells 
ES/EC cells are pluripotent because they can self-renew and have the ability 
to differentiate into cell types of all three germ layers (Labosky et al., 1994; 
McBurney  1993).  Specifically,  they  have  the  ability  to  differentiate  into 
neurons and glia, and can maintain a population of neural stem cells in vitro Chapter 1    23 
(Schmidt  et  al.,  2001;  Strübing  et  al.,  1995;  McBurney  1993;  Evans  and 
Kaufman, 1981; Martin, 1981). 
The specification of neurons and glia arising from neuroectoderm is a crucial 
process  in  early  CNS  development,  as  the  time  and  position  where  each 
neuron is born determines the ultimate location and role that the cell will 
perform.  Each  neuron  expresses  a  distinct  set  of  neurotransmitters  and 
receptors, enabling it to perform a highly specialised function. Accordingly, in 
vitro ES/EC neuronal differentiation involves the induction of neuroectoderm 
or neural stem cells (NSC) (also sometimes referred as neural progenitor cells, 
NPC or often used intechangeably), which give rise to various neuron subtypes 
depending  on  the  morphogens  used  in  the  differentiation  culture  (Zhang, 
2006). The same morphogen added into ES/EC cultures at different times or 
different  concentrations  can  give  rise  to  different  populations  of  neuron 
subtypes  (Guan  et  al.,  2001).  Hence,  achieving  directed  neuronal 
differentiation from ES/EC cells is a major challenge. 
Multiple protocols have been established for neuroectodermal induction and 
the  generation  of  NSC  from  ES  cells.  These  protocols  are  based  on  the 
mechanisms  underlying  both  neural  induction  during  embryogenesis  and 
neurogenesis in the adult CNS. NSCs of the embryonic CNS are known as radial 
glial cells, whereas adult brain NSCs are astrocyte-like stem cells (Doetsch, 
2003). ES cell-derived NSCs are shown to have similar properties to embryonic 
radial  glial  cells,  and  have  the  ability  to  self-renew  and  differentiate  into 
neurons, astrocytes and oligodendrocytes (Nat et al., 2007; Liour et al., 2006; 
Plachta et al., 2004; Liour and Yu, 2003). Some studies have compared  ES 
cell-derived  NSCs  to  NSC  from  adult  brain  and  found  that  the  former 
proliferate readily and prefer adherent cultures compared to brain NSC that 
proliferate better as clusters of cells floating freely in the medium (Colombo 
et  al.,  2006).  Transcriptional  profiling  demonstrated  close  similarities 
between NSCs from both origins, although ES cell-derived NSC showed a wider 
range of neuronal subtype markers such as rostral spinal cord-specific markers 
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Meanwhile,  studies  conducted  by  several  groups  show  ES  cell-derived 
neurogenesis  mimics  embryogenic  neurogenesis  through  the  expression  of 
lineage-specific TF such as Sox2, Sox3, Otx2 and Pax6 (Barberi et al., 2003; 
Wilson and Edlund 2001). These results suggest that ES cell-derived neuronal 
differentiation mimics neural development during embryogenesis and in the 
adult brain, establishing it as a good model system for studying the molecular 
events governing neural differentiation. 
Protocols established for directed neuronal differentiation in vitro from ES 
cells are based on two approaches. The first protocol uses embryoid body (EB) 
formation to mimic the environment that leads to neuroectoderm induction in 
the embryo, thus providing appropriate cell-to-cell interactions and adding a 
morphogen such as retinoic acid to imitate signalling molecules. The second 
protocol involves growing ES cells in serum free media, in a feeder cell- free 
culture, or at a low cell density, thus removing the signalling molecules that 
inhibit neural commitment and evoking a default mechanism for generating 
NSC. Although current protocols are based around these two approaches, the 
individual  steps  can  vary  between  research  laboratories.  Furthermore,  the 
end product is heterogeneous in terms of the neuronal subtypes generated. 
Consequently,  in  vitro  neuronal  differentiation  from  ES/EC  cells  requires 
optimisation  of  culture  conditions  to  achieve  directed  differentiation,  and 
extensive characterisation of the neurons produced. 
1.4.3 Embryoid Body formation in generating neuroectoderm 
and neuronal differentiation in vitro  
Early studies on neuronal differentiation from mouse EC cells were based upon 
neuroectoderm induction through the formation of EBs (Martin et al., 1981; 
Pierce and Dixon, 1959; Stevens, 1959). EC cell-derived EBs show a similar 
pattern of neuronal differentiation when compared to isolated inner cell mass 
cells cultured in vitro (Martin et al., 1977). Similarly, mouse ES cells grown in 
suspension without LIF form aggregates within 2-4 days and have the ability to 
generate cells from all three germ layers (Maye et al., 2004; Rathjen et al., 
2002). From day 6 onwards, EBs form an inner epithelial layer which consists 
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Fgf5,  Otx2,  Sox1  and  Six3  (Maye  et  al.,  2004;  Rathjen  et  al.,  2002; 
Coucouvanis and Martin, 1995). Two protocols for the generation of neurons 
and glia through EBs from mouse ES/EC cells using RA and conditioned media 
have been established, and are discussed below. 
1.4.3.1  Retinoic acid protocol to produce neurons from ES/EC cells 
The outcome of neuronal differentiation from ES cells through the formation 
of EBs can be significantly increased by the addition of retinoic acid (RA), 
(Gotlieb  et  al.,  2002;  Guan  et  al.,  2001).  RA  promotes  the  induction  of 
neuroectoderm  through  the  formation  of  EBs  and  neuronal  differentiation 
from EC (Bain and Gotlieb, 1994; Jones-Villeneuve et al., 1983).  
Mouse ES cells are treated with RA in a protocol known as the RA (4-/4+), 
where the cells are allowed to form aggregates in suspension for 4 days and 
treated with RA for another 4 days, before transferring single cells from the 
EBs  to  adherent  culture  to  generate  neurons  and  glia.  The  extent  of 
differentiation was then determined based upon cell morphology, expression 
of cell-type specific markers and electrophysiological measurement (Bain et 
al., 1995). For EC cells, the protocol utilises RA (2+/2-), where the cells are 
allowed to form aggregates in suspension for 2 days in the presence of RA and 
then  for  2  additional  days  without  RA,  before  transferring  single  cells  to 
adherent  cultures  to  form  neurons  and  glia  cells  (McBurney  1993;  Jones-
Villeneuve et al., 1983).  
The addition of RA was shown to significantly induce neuronal differentiation 
from  ES/EC  cells  as  shown  by  the  production  of  neuroectodermal  cells 
(Strübing et al., 1995; Fraichard et al., 1995; Bain et al., 1995; Wobus et al., 
1994).  RA-induced  neuronal  cells  at  the  initial  stages  of  differentiation 
expressed  neuron-specific  markers  such  as  Neurofilament  (NFL)  protein  68 
kDa, NFL 160 kDa and the synaptic vesicle protein synaptophysin (Strübing et 
al., 1995; Fraichard et al., 1995; Bain et al., 1995; Rohwedel et al., 1998). 
Further differentiation leads to the expression of markers such Microtubule-
associated proteins MAP2, MAP5, B-III Tubulin, NF 200 kDa and NCAM (Finley 
et al., 1996; Strübing et al., 1995; Fraichard et al., 1995; Bain et al., 1995). Chapter 1    26 
The mechanism of RA in inducing neural commitment from stem cells in vitro 
was  investigated  by  Berg  and  McBurney,  where  they  revealed  RA  can  be 
present  for  as  short  as  2-4  hours  and  still  be  effective  in  inducing  the 
irreversible  neuronal  differentiation  of  P19  EC  cells  (Berg  and  McBurney, 
1990). However, the mechanisms whereby RA induces neural differentiation of 
ES/EC cells are not fully understood. The possible mechanism of RA action 
involves  a  group  of  nuclear  retinoic  acid  receptors  (RARs)  that  are  known 
ligand-dependent  TFs  (Umesono  et  al.,  1988).  It  is  hypothesised  that  RA-
responsive genes may play a role in activating a cascade of reaction leading to 
transcriptional  activation  of  genes  involved  in  neural  specification.  RARs 
interact with RA-response elements (RARE) and activate the transcription of 
genes  involved  in  developmental  regulation  such  as  Pax6,  Mash1,  sonic 
hedgehog,  NeuroD  in  neuronal  differentiating  mouse  ES  cells  (Guan  et  al., 
2001).  
1.4.3.2  Conditioned medium in inducing neural differentiation 
Neural induction using conditioned medium during EB formation from ES cells 
was  introduced  by  Rathjen  and  co-workers.  They  demonstrated  that 
conditioned medium from the human hepatocellular carcinoma cell line, Hep-
G2,  promotes  homogeneous  differentiation  of  primitive  ectoderm-like  cells 
from mouse ES cells (Rathjen et al., 1999). Cells from EBs formed through this 
method express specific NSC markers such Sox1 and Nestin (Rathjen, 2002; 
Rathjen et al., 1999). These NSCs can go on to generate functional neurons 
and glia when exposed to appropriate signalling molecules (Rathjen et al., 
2002). However, the molecules in Hep-G2 that trigger neuronal differentiation 
have not been indentified and this protocol has not been applied to human ES 
cells.  
1.4.4 Default mechanism in directing neuronal differentiation 
from ES cells 
The  default  mechanism  protocols  are  based  on  studies  conducted  using 
Xenopus and chick, which proposed that in the absence of specific signalling 
molecules,  pluripotent  cells  become  committed  to  neural  specification 
(Hemmati-Brivalou and Melton, 1997). The model suggests that the inhibition Chapter 1    27 
of BMP signalling could promote neural specification (Fainsod et al., 1997; 
Piccolo et al., 1996; Sasai et al., 1995; Smith et al., 1992; Hemmati-Brivalou 
and  Melton,  1994).  Recent  work,  however,  has  demonstrated  that  the 
mechanism of inducing neural commitment not only requires the inhibition of 
certain signalling molecules but also requires positive factors for the survival 
of these committed cells (Stern, 2005). Based on the evidence for a default 
pathway  in  triggering  neural  induction,  several  protocols  were  derived  for 
obtaining neurons and glia from ES cells. These included the use of serum-free 
medium,  culturing  cells  at  low  density,  feeder-independent  culture  and 
stromal cell co-culture, discussed below. 
1.4.4.1  Serum free medium in promoting neural differentiation from ES 
cells 
Culturing ES cells in serum-free medium or nutrient-poor neurobasal medium 
successfully promotes the commitment and enrichment of NSCs (Okabe et al., 
1996). These media conditions were originally used for culturing NSCs derived 
from  embryonic  or  adult  brain  regions  (Reynolds  and  Weiss,  1996).  The 
principle of culturing in serum-free media is based on the observation that 
serum  contains  a  neural  differentiation  inhibitor,  most  likely  to  be  BMP 
derivatives (Sasai et al., 1995). Current protocols involve culturing ES cells in 
serum-free  medium  coupled  with  other  conditions  such  as  feeder-
independence or low cell density to obtain neural induction.  
1.4.4.2  Low density culture in directed neural differentiation 
Several studies have shown that ES cells can be induced to form NSC in low 
clonal densities (1-20 cells/well) under feeder-free and serum free conditions 
(Tropepe et al., 2001). It was shown that a single neural stem cell isolated 
from  the  neural  tube  when  cultured  with  EGF  or  FGF2  could  proliferate 
forming  floating  clonal  spheres  of  undifferentiated  neural  precursor  cells 
(Reynolds and Weiss, 1996). This low density culture protocol generates NSCs, 
neurons,  astrocytes  and  oligodendrocytes  albeit  at  lower  success  rate 
(Tropepe et al., 2001). The production of NSCs from ES cells using this method 
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defined  medium.  This  result  suggests  that  this  method  is  not  an  efficient 
system for generating neuronal differentiation from ES cells. 
1.4.4.3  Feeder-independent ES cells cultured as monolayer at moderate 
densities promotes neural induction 
Neural  commitment  from  ES  cells  can  be  achieved  under  serum-free 
conditions  at  moderate  densities,  but  is  most  effective  when  cells  are 
cultured in adherent monolayer cultures under feeder-independent conditions 
(Ying et al., 2003). This protocol was established using mouse ES cells that 
express green fluorescent protein (GFP) driven by the Sox1 promoter. Sox1 is 
a  NSC  marker,  so  the  GFP  provides  an  accurate  readout  for  NSC  in  live 
cultures. These mouse ES cells cultured using this protocol produced 75% GFP 
positive cells by 5 days and could be selected to further differentiate into 
neurons,  astrocytes  and  oligodendrocytes.  The  advantages  of  this  protocol 
include  the  ability  to  generate  NSC  culture  from  ES  cells  within  a  short 
induction time (4-6 days) and the ability to isolate NSCs using Fluorescence 
Activated Cell Sorting (FACS) method.  
1.4.4.4  Stromal cell co-culture of ES cells in neuronal differentiation 
This  protocol  is  based  on  the  successful  survival,  proliferation  and 
differentiation of hematopoietic stem cells with bone marrow stromal cells 
(Kaushansky,  2006).  ES  cells  plated  with  a  variety  of  stromal  cell  lines  in 
serum free medium (or serum replacement) have the ability to direct neural 
induction  (Barberi  et  al.,  2003;  Kawasaki  et  al.,  2000).  This  protocol 
generates NSCs from mouse ES cells characterised by markers such as Nestin 
and  neural  cell  adhesion  molecule  (NCAM)  by  day  6  before  further 
differentiating  into  neuron  and  glia  (Barberi  et  al.,  2003;  Kawasaki  et  al., 
2000).  
Advantages  of  this  protocol  include  the  generation  of  a  homogeneous 
population  of  neural  cells  and  short  NSCs  induction  time.  The  neuronal 
differentiation from this protocol generates high percentage of NSC although 
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1.5 Identification and characterisation of neuronal 
derivatives from ES/EC cells 
One important aspect of ES/EC/EG derived neurons, regardless of the protocol 
applied, is the identification and characterisation of the cell type(s) in the 
differentiated  population.  Not  only  does  in  vitro  differentiation  produce 
different  subtypes  of  neurons,  it  also  generates  astrocytes  and 
oligodendrocytes. Besides that, in most protocols, some differentiation down 
the mesodermal lineage is often unavoidable. The typical approach is to assay 
for the expression of genes that are specific for particular cell types. Such 
genes are often referred to as molecular markers and have been a useful tool 
for gauging differentiation efficiency.  
Markers  are  chosen  because  they  are  known  to  be  expressed  in  particular 
subtypes of cells. These can include markers that should be silenced in the 
differentiated  population.  For  example,  pluripotent  factors  such  as  Oct4, 
Nanog and Sox2 should be absent in neurons derived from ES/EG/EC cells, 
while the expression of these factors indicates the presence of pluripotent 
cells. Most commonly, markers of in vitro neural differentiation are selected 
to  represent  both  early  neural  differentiation  (including  NSCs),  and 
intermediate  and/or  terminal  differentiation  (i.e.  mature  neurons  and  glia 
cells). The application of this method has its caveats, however, as markers 
can  often  span  several  differentiation  stages  or  more  than  one  cell  type. 
Therefore, a cohort of several markers is usually required to interrogate the 
differentiated population at various times during the differentiation period.  
Among  the  key  markers  used  for  detecting  neuronal  differentiation  from 
ES/EC cells at the early stage (EB formation stage-day1 neural differentiation) 
are Nestin, Mash1, Otx1, Otx2, Pax2, Pax5 and Wnt-1 genes (Okabe et al., 
1996; Johnson et al., 1992). Among these markers, Nestin expressed both RNA 
and protein whereas other markers expressed the RNA but not the proteins 
(Rolletschek  et  al.,  2001).  The  markers  used  to  characterise  cells  in 
intermediate and terminal differentiation vary among studies. However the 
most used markers are Neurofilament proteins (NF-160/NF-200), -III Tubulin, 
Synaptophysin  and  the  production  of  neurotransmitter  such  as  dopamine, Chapter 1    30 
serotonin,  GABA  and  glutamate.  Additionally,  GFAP  is  used  to  identify 
glia/astrocyte cell in neuronal differentiation cultures.  
 
1.6 P19 EC cells as a model system for in vitro 
neuronal differentiation  
P19  murine  EC  cells  were  first  introduced  as  an  in  vitro  neuronal 
differentiation model system by McBurney and Jones-Villeneuve in the year 
1982 (Rossant and McBurney, 1982; Jones-Villeneuve, 1982). In these studies, 
RA was used to induce neuronal differentiation through the formation of EBs. 
The  expression  of  neural  related  genes  occurs  in  stages  dependent  on  the 
time  of  differentiation  in  culture,  which  closely  resemble  early 
neuroectodermal development in vivo (Bain et al., 1995; Wobus et al., 1994; 
Staines  et  al.,  1994).  P19  EC  cells  transplanted  into  adult  rat  striatum 
survived and differentiated into functional neurons and glia (Morassuti et al., 
1994).  This evidence suggests that P19 EC cells are a suitable model system 
to study events underlying neuronal differentiation. 
Undifferentiated P19 EC cells were shown to be pluripotent as they give rise 
to cells of all three germ layers when injected into mouse blastocysts (Rossant 
and McBurney, 1982). Undifferentiated EC cells in vitro have the ability to 
self-renew  and  proliferate  at  high  rates,  besides  expressing  gene  profiles 
similar to embryonic stem cells (Andrews et al., 2005;  Niwa et al., 2000). 
Similar to ES cells, P19 EC cells lose the expression of Oct4 and SSEA-1 upon 
differentiation in vitro (Andrews et al., 2005; Niwa et al., 2000). P19 EC cells 
can  be  grown  indefinitely  in  the  undifferentiated  state,  making  it  a  good 
resource for the generation of neurons. 
The RA (All trans RA) protocol for inducing neuronal differentiation from P19 
EC cells can be divided into two stages. Stage one, EB formation, occurs in 
suspension,  whereas  stage  two  involves  differentiation  of  neurons  and 
generation of glia cells in adherent culture (Zhongqiu et al., 2010; Zhigang Jin 
et al., 2008; McBurney, 1993; Johnson et al., 1992; Rossant and McBurney, 
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cultured in suspension with the addition of RA for 2 days and further 2 days 
without RA. By day 4, the cells formed EBs consisting of neuroectodermal cells 
that express the markers Nestin and -III Tubulin, together with the loss of 
the pluripotent marker Oct4 (Teets et al., 2011; Soprano et al., 2007; Bain et 
al., 1995).  
In stage two, neuroectoderm-containing EBs are disaggregated and plated as 
single cells in adherent culture to allow neuronal differentiation. Cells project 
neurite outgrow and first form mature neurons followed by glia cells. A study 
by Staines et al concluded that the morphology of neurons derived from P19 
EC  cells  mimics  those  from  the  rostrum  region  of  the  mammalian  nervous 
system  (Staines  et  al.,  1994).  The  P19-derived  neurons  express  specific 
markers such as Nestin, MAP2, Tau, Neuron specific enolase, Synaptophysin, 
NF-160, NF-200, Mash1 and -III Tubulin (Zhigang Jin et al., 2008; Yi Wei et 
al., 2002; Guan et al., 2001; Rohwedel et al., 1998; Strübing et al., 1995; Bain 
et  al.,  1995;  Johnson  et  al.,  1992).  Glial  cells  appear  later  in  the 
differentiation culture (Day 10 onwards), assayed through the expression of 
Gfap (Hadinger et al., 2009; Santiago et al., 2005).  
Evidence for the functionality of RA-induced neurons from P19 EC cells has 
been  presented  by  various  groups.  McBurney  and  co-workers  showed  that 
these  neurons  establish  axonal-dendritic  polarity  and  form  functional 
excitatory  and  inhibitory  synapses  (Finley  et  al.,  1996;  MacPherson  et  al., 
1997). The neurons are capable of producing GABA, glutamate, neuropeptide 
Y, somatostatin and other neurotransmitters (Macpherson et al., 1997; Lin et 
al.,  1996;  Parnas  and  Linial,  1995).  These  studies  support  the  use  of  P19 
neuronal  differentiation  as  a  suitable  model  for  studying  the  mechanisms 
underlying neural differentiation. 
The  vast  majority  of  studies  using  the  RA-induced  neuronal  differentiation 
from  P19  EC  cells,  besides  characterisation  of  the  system,  are  centred  on 
elucidating  regulatory  factors  that  govern  the  neuronal  differentiation 
process. These factors include TFs (modulating pluripotency, differentiation, 
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microRNAs.  Other  studies  have  investigated  neurotransmitter  receptor 
signalling, the metabolite transport system and electrophysiology.  
1.7 Chromatin and gene transcription 
In  eukaryotes,  DNA  is  organised  into  DNA-protein  complexes  known  as 
chromatin, allowing the efficient “packaging” of genomic DNA (Figure 1.1). 
The fundamental unit of the chromatin is the nucleosome, which is made up 
of four core histone proteins called H2A, H2B, H3 and H4 with 147 bp of DNA 
wound around its surface (Horn and Peterson, 2006; Felsenfeld and Groudine, 
2003). Adjacent nucleosome units are connected by DNA linker histone (10-
100 bp long) resembling a “beads on the string” - like structure. The next 
level of organisation is called the 30 nm meter fibre, which is then folded into 
higher order structures.  
 
Figure 1.1: Organisation of chromatin. 
The fundamental unit of chromatin is the nucleosome, in which DNA is wound 
around  a  core  histone  octamer  resembling  a  “beads  on  the  string”  -  like 
structure. Reproduced from (Felsenfeld and Groudine, 2003).  Chapter 1    33 
Higher  order  chromatin  structure  is  characterised  by  condensed 
heterochromatin  and  euchromatin  regions  within  the  genome. 
Heterochromatin  regions  are  highly  condensed  and  transcriptionally  silent, 
while euchromatin regions are less compact and more transcriptionally active 
(Horn  and  Peterson,  2006).  Two  types  of  heterochromatin  structures  have 
been described: constitutive heterechromatin, which is found at centromeres 
and telomeres, and facultative heterochromatin, which upon certain stimuli 
can become euchromatin, examples include the inactive X chromosome and 
autosomal imprinted genes (Trojer and Reinberg, 2007).  Besides the role of 
efficiently packing genomic DNA, chromatin also functions as platform for the 
regulation  of  gene  transcription.  Gene  expression  can  be  regulated  by 
interrelated processes such as nucleosome remodelling, histone modification 
and  DNA  methylation.  These  processes  along  with  their  cognate  regulatory 
proteins are classified under the general term “epigenetic mechanisms”.  
Studies of gene regulation in pluripotency and self-renewal initially focused 
on  TF  network  regulation,  until  several  recent  papers  highlighted  the 
importance of epigenetic mechanisms in ES cell pluripotency, differentiation 
and early development (Reik et al., 2007). Epigenetic factors that have been 
shown to a play role in the regulation of ES cell pluripotency and neuronal 
differentiation include  covalent  modifications  of histones,  DNA  methylation 
and  ATP-dependent  chromatin  remodelling.  These  various  mechanisms  are 
discussed  below  with  some  examples  from  ES  cells  and  neuronal 
differentiation.  
1.7.1 Histone modification 
Specific residues within the core histone tails, which protrude out from the 
nucleosome  surface,  are  subjected  to  various  reversible  post-translational 
modifications  including  acetylation,  methylation  and  phosphorylation 
(Kouzarides, 2007).  
1.7.1.1  Histone acetylation 
Histone acetylation occurs on lysine residues (K) on N-terminal tails of all four 
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histones H3 (H3K9ac, H3K14ac) and H4 (H4K5ac, H4K8ac, H3K12ac, H3K16ac). 
Histone acetylation is mediated by histone acetyl transferases (HATs), which 
are divided into three main families: the p300/CBP family, MYST family and 
Gcn5/PCAF family (Sterner and Berger, 2000). Histone acetylation is strongly 
linked to activation of transcription (Reid et al., 2000). There is evidence that 
multiple histone acetylation marks can lead to chromatin unfolding in vitro  
(Tse  et  al.,  1998).  However,  it  is  also  known  that  histone  acetylation 
facilitates transcription by acting as a docking or binding site for co-activators 
that  contain  bromodomains  (Hassan  et  al.,  2002;  Agalioti  et  al.,  2002).  In 
contrast,  HAT  activity  is  counteracted  by  histone  deacetylase  enzymes 
(HDAC). In metazoans, HDACs are classified into 3 groups based on sequence 
similarity; Class 1, Class 2 and class 3. As an example, class 1 HDACs include 
HDAC1,  HDAC2  and  HDAC3  and  are  found  in  four  different  multiprotein 
complexes, the Sin3a, NuRD, Co-Rest and NCoR/SMRT complexes.  
In ES cells, the histone acetyltransferase p300 functions as transcriptional co-
activator and regulates the expression of pluripotency-related TFs (Zhong and 
Jin, 2009; Chen et al., 2008). Another HAT, Tip60, was also shown to regulate 
the pluripotency transcription network by targeting genes similar to Nanog 
(Fazzio  et  al.,  2008).  The  Tip60-p400  complex  appears  to  activate  genes 
responsible for repressing key developmental regulators (Fazzio et al., 2008). 
Meanwhile,  HDACs  are  also  essential  for  the  pluripotency  of  ES  cells.  The 
HDAC  Mbd3,  a  core  subunit  of  the  Nucleosome  remodelling  deacetylase 
(NURD) complex, is vital for pluripotency (Denslow et al., 2007; Kaji et al., 
2006).  Mbd3  depletion  in  ES  cells  results  in  defects  in  growth  and 
differentiation (Kaji et al., 2006). Similarly, another  HDAC known as NODE 
interacts with Nanog and Oct4, resulting in the inhibition of developmental 
regulators  in  ES  cells  (Liang  et  al.,  2008).  In  addition,  WUS-interacting 
proteins such as WSIP1 and WSIP2 recruit HDACs to repress the transcription of 
genes that are involved in regulating differentiation (Kieffer et al., 2006). 
The regulation of histone acetylation is also important for the progression of 
ES cells to NSCs and neurons. ES cells appear to have higher global levels of 
histone acetylation than lineage-restricted stem cells and differentiated cells 
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HDAC2  is  up-regulated  while  HDAC1  is  down-regulated  (MacDonald  and 
Roskams,  2008).  Conversely,  HDAC1  expression  is  sustained  in  glia  lineage 
cells  (astrocytes  and  oligodendrocytes),  in  which  HDAC2  is  not  detected 
(MacDonald  and  Roskams,  2008).  Consistent  with  this  data,  the  use  of 
different HDAC mutants showed that HDAC2 inhibits astrocyte differentiation 
(Humprey et al., 2008). The importance of HDACs in neuronal differentiation 
has  also  been  demonstrated  using  the  HDAC  inhibitor  valproic  acid,  which 
induces neuronal differentiation of NSCs but inhibits glia cell differentiation 
(Hsieh et al., 2004). In this study, valproic acid promotes the up-regulation of 
neuron-specific  genes,  including  the  neurogenic  basic  helix-loop-helix 
transcription  factor,  NeuroD,  resulting  in  the  induction  of  neuronal 
differentiation. 
1.7.1.2  Histone Methylation  
Histone methylation can occur on lysine (K) or arginine (R) residues of the 
core histones (Kouzarides,  2007). Each lysine residue can be mono-,  di-  or 
trimethylated  whereas  arginine  can  be  either  mono-  or  dimethylated 
(Kouzarides, 2007). Methylation of histone residues can mediate both active 
and repressive signals, which regulate gene transcription through recruitment 
of specific downstream effector proteins. Histone methylation is catalysed by 
a  range  of  multiprotein  complexes  containing  histone  methyltransferases 
(HMTs).  Among  the  protein  complexes  that  are  involved  in  depositing  and 
removing these histone marks are the trithorax (TrxG) and polycomb (PcG) 
complexes (Muller and Verrijzer,  2009;  Kerppola,  2009;  Schuettengruber et 
al.,  2007).  TrxG  and  PcG  have  reciprocal  functions:  TrxG  proteins  work 
together to activate transcription while PcG proteins repress transcription.  
TrxG  proteins  are  multi-subunit  complexes  that  can  be  generally  classified 
into two categories; the histone modifiers and nucleosome remodelers (Strahl 
and Allis, 2000). The histone modifiers include HMTs that establish histone 
modifications that promote transcription. Among the examples of HMTs in this 
category are TRX and ASH1 that methylate histone H3 lysine 4 (H3K4) active 
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PcG complexes are made up of Polycomb repressive complex 2 (PRC2) and 
Polycomb repressive complex 1 (PRC1). PRC2 complex establishes the histone 
code while PRC1 interprets this code (Levine et al., 2004). The mammalian 
PRC2 complex consist of enhancer of zeste homologue 2 (EZH2), embryonic 
ectoderm development (EED), suppressor of zeste homologue 12 (SUZ12) and 
retinoblastoma-binding protein 4 (RBBP4) (Sparmann and van Lohuizen, 2006). 
EZH2 contains a SET domain that deposits the H3K27me3 inactive chromatin 
mark,  whereas  EED  and  SUZ12  do  not  contribute  to  HMT  activity  but  are 
essential for supporting EZH2 catalytic activity (Cao and Zhang, 2004). The 
inactive chromatin mark established by PRC2 is recognised by PRC1. The PRC1 
complex can take multiple forms that contain a chromobox protein (CBX2, 
CBX4, CBX8) and a polyhomeotic homologue 1 family member (PHC1-3, BMI1 
Ring finger protein 1 (RING1), Ring finger protein 2 (RNF2). In general, CBX 
proteins  contain  a  chromodomain  that  is  responsible  for  recognising  and 
binding  H3K27me3  mark  established  by  PRC2.  BMI1,  RING1  and  RNF2  have 
RING  finger  motifs  that  are  E3  ligases  that  are essential  for  ubiquitination 
(Whitcomb  and  Taylor,  2009).  The  regulatory  effects  of  PcG  and  TrxG  are 
broad  and  are  mediated  through  various  histone  modifications  and 
nucleosome  remodelling.  Some  of  the  specific  examples  in  ES  cells  are 
discussed below. 
Two  key  histone  modifications  that  are  heavily  involved  in  ES  cell  gene 
regulation are H3K4me3 and H3K27me3, which are typically associated with 
active  and  repressive  chromatin  regions,  respectively  (Ku  et  al.,  2008; 
Mikkelsen et al., 2007; Bernstein et al., 2006). A major discovery in ES cell 
biology is the co-occupancy of both H3K4me3 and H3K27me3 on large number 
of promoter sequences (Mikkelsen et al., 2007; Bernstein et al., 2006). These 
regions of chromatin are named “bivalent” domains and are thought to hold 
genes  in  a  poised  state,  ready  to  be  either  transcribed  or  repressed.  This 
bivalent  chromatin  signature  occupies  the  promoters  of  genes  that  are 
involved  in  development  and  lineage  commitment  (Mikkelsen  et  al.,  2007; 
Bernstein et al., 2006). Initial studies suggested a model where this bivalent 
chromatin signature was crucial to the pluripotent status of ES cells (Bernstein 
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bivalent chromatin domains on the promoters of developmentally regulated 
genes in differentiated cell types (Barski et al., 2007; Mikkelsen et al., 2007; 
Azuara et al., 2006).  
The PRC2 complex targets a number of developmentally vital genes and rather 
interestingly these genes are co-occupied by Oct4, Nanog and Sox2 in ES cells 
(Lee et al., 2006). Bernstein et al confirm this model by showing that Oct4, 
Nanog and Sox2 are marked by both H3K27me3 (inactive) and H3K4 (active) 
modification (Bernstein et al., 2006). Most of the bivalent patterns of histone 
modification were erased upon ES cell differentiation into neural progenitor 
cells (Bernstein et al., 2006). The neural genes retained the H3K4 active mark 
and lost the H3K27me3 repressive mark. Additionally, a subset of genes that 
function  in  terminally  differentiated  neurons  gain  H3K27me3  during  the 
transition from ES cell to NSCs (Mohn et al., 2008). These genes eventually 
lose H3K27me3 and hence become expressed upon terminal differentiation of 
neurons. 
1.7.2 DNA methylation  
Like histone methylation, DNA methylation also plays a role in regulating gene 
expression in ES cells. DNA methylation occurs on the cytosine base of the 
DNA  within  CpG  dinucleotides  and  correlated  to  gene  silencing.  DNA 
methylation at promoter regions is inversely correlated with gene activity, 
although this association is dependent on CpG density  within the promoter 
region. Methylated CpG dinucleotides are recognised by methyl-CpG binding 
domain (MBD)-containing protein family member such as MeCP2 and MBD1 and 
consequently suppress the gene expression (Cross et al., 1997;  Nan et al., 
1997).  
DNA methylation is carried out by DNA methyl transferase (DNMT) family of 
enzymes.  The  de  novo  establishment  of  DNA  methylation  is  performed  by 
DNMT3a and DNMT3b, whereas the maintenance of DNA methylation depends 
on  DNMT1.  The  role  of  DNMTs  in  ES  cells  has  been  established  using 
homozygous mutants. DNMT1
-/- ES cells divide and maintain pluripotency in 
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to the lack of repression of pluripotent genes such as Oct4 and Nanog through 
methylation  (Jackson  et  al.,  2004).  DNMT3b  mutant  embryos  appear  to 
develop  normally  before  embryonic  day  9.5  but  consequently  demonstrate 
developmental defects (Okano et al., 1999). 
Similar to somatic cells, ES cells show high global levels of DNA methylation 
with approximately 60-80% methylation in CpG dinucleotides (Meissner et al., 
2008). Extensive mapping shows that DNA methylation profiles in ES cells and 
somatic cells have a bimodal distribution, with most of the genomic regions 
‘largely methylated’ or ‘largely unmethylated’ (Meissner et al., 2008). Almost 
all high density CpG promoter regions enriched for H3K4me3 in ES cells are 
devoid of DNA methylation (Meissner et al., 2008; Mikkelsen et al., 2007). Low 
density CpG promoters, which are generally linked to tissue-specific genes, 
are  mostly  methylated  except  for  a  small  subset  that  is  enriched  for 
H3K4me3/me2  active  marks.  Pluripotency genes  are  generally  enriched  for 
H3K4 methylation and show DNA hypomethylation (Mikkelsen et al., 2007). 
An  example  of  how  DNA  methylation  regulates  gene  expression  during 
differentiation is provided by the GFAP gene. GFAP expression is induced as 
NSCs  differentiate  into  astrocytes  in  foetal  brain.  The  Stat3-binding  site 
within the GFAP promoter in NSCc was found to be highly methylated in NSCs 
(Takizawa  et  al.,  2001).  As  NSCs  differentiated,  the  Stat3-binding  site  is 
demethylated allowing the binding of STAT3 and inducing the expression of 
GFAP.  DNA  methylation  is  also  shown  to  regulate  the  progression  of 
undifferentiated ES cells to NSCs through  RE1 silencing transcription factor 
(REST)/neuron restrictive silencing factor (NRSF) (section 1.7.4). 
1.7.3 ATP-dependent chromatin remodelling  
ATP-dependent  chromatin  remodelling  involves  changes  in  chromatin 
structure through the destabilisation of DNA and histone interactions, and can 
be associated with both transcriptional activation and repression. Depending 
on which remodelling complex is involved, this can enable a nucleosome to 
‘slide’ along the DNA, thus facilitating the access of TFs to the DNA, or it can 
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remodelling complexes consist of four main families: Switching/Sucrose non-
fermenting (SWI/SNF), Imitation of SWI (ISWI), Chromodomain and helicase-
like domain containing (CHD) and Inositol requiring (INO80) (Bao and Shen, 
2007).  Mammalian  SWI/SNF  can  contain  either  Brahma  (BRM)  or  Brahma 
related gene 1 (BRG1) as its core ATPase subunit, and other members of the 
complex are termed Brahma/Brg associated factors (BAFs). 
In ES cells, BRG1 binds to the regulatory regions of Oct4, Nanog and Sox2 and 
is involved in the maintenance of pluripotency and initiation of differentiation 
(Keenen and de la Serna, 2009). The loss of BRG1 leads to the loss of self-
renewal ability in ES cells (Ho et al., 2009; Keenen and de la Serna, 2009). In 
a separate study, BRG1 was shown to be recruited to RE1 sites of REST target 
genes (Ooi et al., 2006). Inhibition of BRG1 activity increased the expression 
of  REST  target  genes,  and  it  was  suggested  that  BRG1  facilitates  the 
interaction  of  REST  with  chromatin,  thus  facilitating  transcriptional 
repression.  
The  role  of  BAF  complexes  was  also  elucidated  in  neural  development 
(Lessard et al., 2007). This study demonstrates the ‘switching’ of BAF member 
expression between NSCs and post-mitotic neurons derived from newly born 
(P0)  mouse  brain.  In  NSCs,  BAF45a  and  BAF53a  are  expressed  and  are 
assembled into the BAF complex, while in post-mitotic neurons, the place of 
BAF45a and BAF53a are taken over by BAF45b and BAF53b. Inhibiting BAF45a 
and BAF53a lead to a reduction in NSC proliferation. Similarly, BAF60c was 
also assembled into the NSC specific BAF complex consisting of BAF45a and 
BAF53a in retina cells (Lamba et al., 2008). BAF60c was shown to promote 
Notch  signalling,  which  inhibits  neuronal  differentiation  but  maintains  the 
proliferation of NSC through the transcriptional activation of basic helix-loop-
helix genes Hes1 and Hes2.   
1.7.4 The role of REST/NRSF complex in ES cells and neuronal 
differentiation 
In  ES  cells  and  non-neuronal  cells,  neuronal  genes  containing  the  21  bp 
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transcription factor (REST) (also known as neuron restricted silencing factor, 
NRSF)  (Lunyak  and  Rosenfel,  2005;  Lunyak  et  al.,  2002).  Rest-null  mice 
develop normally till E9 but dies soon after from unidentified causes (Chen et 
al., 1998). Genome-wide ChIP studies have shown that REST binds close to 
many genes that are expressed in mature neurons (Otto et al., 2007). 
REST represses neuron-specific genes through  the recruitment of HDAC1/2, 
Sin3a and CoRest (Ballas et al., 2001; Andres et al., 1999). During neuronal 
differentiation,  REST  protein  levels  are  reduced,  possibly  through  protein 
degradation,  resulting  in  the  removal  of  REST-associating  transcriptional 
repressors  from  neuronal  genes  (Ballas  et  al.,  2005).  In  terminally 
differentiated non-neuronal cells, long term repression of neuronal genes is 
achieved  through  the  recruitment  of  DNMT1  to  RE1  sites  followed  by  DNA 
methylation and MeCP2 binding (Ballas et al., 2005). Another mechanism by 
which REST may control neuron-specific gene expression is through a neuron 
specific microRNA, mir-9 (Packer et al., 2008). Mir-9 has been shown to target 
Rest  mRNA  and  the  over-expression  of  mir-9  promotes  neuronal 
differentiation.  
1.7.5 The use of P19 EC cells to study epigenetic mechanisms 
Among  the  examples  of  epigenetic-related  studies  in  P19  neuronal 
differentiation  are  those  conducted  by  Hwang  et  al  showing  evidence  of 
chromatin  remodelling  and  TF  regulation  on  the  mu-opoid  receptor  gene 
(MOR) (Hwang et al., 2010; Hwang et al., 2009; Hwang et al., 2007 ). Hwang 
et al showed that in undifferentiated P19 cells, the MOR gene promoter is 
methylated  and  transcription  is  repressed  by  MeCP2.  During  neuronal 
differentiation,  the  promoter  becomes  de-methylated  and  active  histone 
modifications are deposited. This allows binding of the chromatin remodeller 
Brg1, which remodels the nucleosome upstream of the transcription start site, 
thus allowing the transcription factor Sp1 to bind and induce MOR expression 
(Hwang et al., 2007, 2010). This model for MOR regulation was supported by 
similar  experiments  in  micro  dissected  mouse  brain  regions  (Hwang  et  al 
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In a separate study, Wu et al presented evidence for the role of histone marks 
and chromatin remodellers in the regulation of the neurogenin1 gene, which is 
a  basic-helix-loop-helix  protein  crucial  for  neurogenesis  (Wu  et  al.,  2009). 
Upon  RA  induction,  the  repressive  histone  mark  H3K27me3  is  replaced  by 
active  marks  H3K9ac,  H3K14ac  and  H3K4me3.  The  remodeller  Brm  is  then 
recruited, which coincides with the expression of neurogenin1, (Wu et al., 
2009).  Taken  together,  these  studies  not  only  show  the  role  of  epigenetic 
mechanisms  in  regulating  neural-specific  genes,  but  also  demonstrate  the 
suitability of the P19 neuronal differentiation model system for studying the 
epigenetic  events  that  govern  the  transition  from  pluripotency  to  neural 
commitment.  
1.8 Overview of HMG chromosomal proteins 
High Mobility Group (HMG) proteins are a family of nuclear proteins that bind 
DNA  and  nucleosomes  and  induce  changes  in  chromatin  dynamics.  HMG 
proteins  play  important  roles  in  modulating  chromatin  structure,  which 
affects various DNA-dependent activities such as transcription, replication and 
DNA repair (Bustin and Reeves, 1996; Bustin, 1999). HMG proteins are grouped 
into three distinct families based on their unique functional motifs, HMG-AT-
hook (HMGA), HMG-box (HMGB) and HMG-nucleosome binding (HMGN).  
1.9 HMGN proteins; structure and their interaction with 
nucleosomes 
The  HMGN  family  of  proteins  contains  a  functional  motif  that  specifically 
binds the 147 base pair nucleosome core particle. The HMGN family consists of 
5 members encoded by different genes; HMGN1, HMGN2, HMGN3a/b, HMGN4 
and  HMGN5  (previously  known  as  NBP-45  and  NSBP1).  These  proteins  are 
characterised  by  three  distinct  domains,  namely  a  bipartite  nuclear 
localisation signal (NLS), a conserved 30-amino acid long nucleosome-binding 
domain  (NBD)  and  a  negatively  charged  C-terminal  chromatin  regulatory 
domain  (RD),  previous  called  the chromatin  unfolding  domain  (Figure  1.2). 
HMGN1  to  4  are  about  ˜100  amino  acids  long  (HMGN1=96  amino  acids; 
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HMGN4= 92 amino acids) while the recently discovered HMGN5 is composed of 
406 amino acids (Rochman et al., 2010). HMGN3 consists of two splice variants 
called HMGN3a and HMGN3b, with the latter missing most of the RD (West et 
al., 2001). 
The  NBD  of  all  HMGN  proteins  consists  of  a  unique  conserved  octapeptide 
motif, RRSARLSA, which is encoded by exon 3.  This NBD motif is the core 
region that is shown to anchor the HMGN proteins to nucleosome particles. 
Deletion and point mutation analyses of HMGN proteins revealed that while 
other domains of the protein affect the nucleosome binding affinity, mutation 
in the conserved NBD motif abolishes the interaction with nucleosomes (Ueda 
et al., 2008). 
HMGN  proteins  contain  a  high  number  of  charged  amino  acids  and  a 
disordered secondary structure that allows the formation of multiple protein-
protein  complexes  (Singh  et  al.,  2009).  Indeed  HMGN1  and  HMGN2  form 
multiple metastable protein complexes in vivo (Lim et al., 2004).  
HMGN proteins do not bind to specific DNA sequences within chromatin. With 
the  exception  of  HMGN5,  they  appear  to  interact  with  all  nucleosomes 
throughout  the  genome.  Conversely,  mouse  HMGN5  binds  preferentially  to 
nucleosomes  in  euchromatin  regions  and  is  excluded  from  the 
heterochromatin due its highly acidic RD (Rochman et al., 2009).  One of the 
major questions in HMGN biology is whether these proteins are enriched at 
particular chromatin regions, and if so, how are they recruited there?  
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Figure 1.2: HMGN protein structure consist of three distinct domains, 
namely a bipartite nuclear localisation signal (NLS), a conserved 30-amino 
acid long nucleosome-binding domain (NBD) and C-terminal chromatin 
regulatory domain (RD). 
 
1.10 Dynamic binding of HMGNs to chromatin  
The interaction of HMGN proteins with the chromatin is clearly illustrated by 
Catez  et  al  using  fluorescence  recovery  after  photobleaching  (FRAP) 
experiments (Catez et al., 2006; Bustin et al., 2005). This study revealed that 
the interactions of HMGN  proteins and histone H1 with chromatin in living 
cells are dynamic and transient. HMGN proteins constantly move throughout 
the nucleus in a “stop and go” fashion in which each protein associates with a 
specific nucleosome for a limited time and then dissociates and binds to a 
different nucleosome.  
The dynamic interaction of HMGN proteins with chromatin is thought to be 
fundamental  to  their  role  in  chromatin  regulation  (Postnikov  and  Bustin, 
2010). The amount of HMGN protein present in the nucleus is sufficient to 
bind only about 1% of the nucleosomes. Nevertheless, FRAP analysis showing 
that  HMGN  proteins  can  rapidly  associate  and  dissociate  from  chromatin 
indicates  that  they  can  cover  the  entire  genome  in  less  than  one  minute 
(Catez et al., 2006). Thus, the dynamic nature of their binding interaction 
ensures that all nucleosomes will be contacted by HMGN proteins on a regular 
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1.11  HMGN proteins in chromatin structure 
HMGN  proteins  bind  nucleosome  core  particles  and  modulate  chromatin 
structure,  thus  regulating  DNA-dependent  processes.  Initial  studies  showed 
that HMGN proteins increased the DNase I hypersensitivity of transcriptionally 
active  genes,  suggesting  that  the  proteins  decompact  the  chromatin  fibres 
(Weisbrod and Weintraub 1981; Weisbrod et al., 1980).  Successive studies 
using  nuclease  restriction  digestion  and  sedimentation  analysis  provided 
evidence that HMGN proteins reduce the compaction of chromatin assembled 
in vitro (Rochman et al., 2009; Ding et al., 1997; Crippa et al., 1993). 
Several  studies  to  date  are  aimed  at  addressing  the  mechanism  by  which 
HMGN proteins might affect chromatin structure and regulate transcription. 
There is evidence for three general mechanisms:  competition between HMGN 
and  linker  histone  proteins,  inhibition  of  ATP-dependent  chromatin 
remodelling by HMGNs, and the effect of HMGN activity on the levels of post-
translational modification in core histones. 
1.11.1  HMGN antagonises the chromatin condensing activity 
of linker histone H1 
Linker  histone  H1  plays  a  key  role  in  chromatin  compaction  and  various 
studies suggest that HMGN proteins compete with histone H1 for chromatin 
binding sites (Catez et al, 2006; Ding et al., 1997). The binding footprint of 
HMGN1 and HMGN2 partially overlaps that of histone H1 (Alfonso et al., 1994).  
A recent study conducted by Rochman using immunofluorescence analysis in 
mouse cells expressing exogenous HMGN5 indicates that the protein reduces 
the compaction of chromatin fibres and modulates the cellular transcription 
profile  (Rochman  et  al.,  2009).  In  vitro  sedimentation  and  cross-linking 
experiments  further  support  the  model  that  HMGN5  counteracts  the  linker 
histone-mediated  condensation  of  the  chromatin  fibres  (Rochman  et  al., 
2009). However, the evidence that HMGN1 could counteract linker histone-
mediated  compaction  was  less  clear  in  this  study  (Rochman  et  al.,  2009). 
Thus, while there is evidence that HMGN1-4 may compete with linker histones 
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level of chromatin compaction in vivo, or whether this has a direct impact on 
gene transcription.  
1.11.2 HMGN alter the activity of ATP-dependent chromatin 
remodelling complexes 
ATP-dependent  chromatin  remodelling  complexes  play  a  crucial  role  in 
regulating the dynamics of chromatin organisation (Horn and Peterson, 2002; 
Smith and Peterson, 2005). One study conducted by Rattner et al showed that 
HMGN1 and HMGN2 suppress ATP-dependent nucleosome remodelling by ACF 
and  BRG1  (Rattner  et  al.,  2009).  This  report  is  contrary  to  a  previously 
published  study  claiming  that  HMGN1  does  not  affect  the  dynamics  of 
SWI/SNF-dependent  nucleosome  remodelling  (Hill  et  al.,  2005).  Thus  it  is 
possible that HMGN proteins play a role in gene regulation by inhibiting ATP-
dependent  chromatin  remodelers,  but  more  research  is  required  to 
investigate this further.   
1.11.3 HMGN regulate the levels of post-translational 
modification in core histones 
Histone modifications have been shown to play key roles in most biological 
processes including development and cellular differentiation (Berger et al., 
2002; Rice and Allis, 2001; Cheung et al., 2000). There are more than 100 
different  post-translational  modification  associated  with  nucleosomal  core 
histones  (Kouzarides,  2007).  Given  that  HMGN  proteins  bind  specifically  to 
nucleosomes,  it  is  possible  that  they  could  influence  the  levels  of  histone 
modification and hence the organisation of chromatin and cellular processes.  
Analysis of fibroblast cells derived from Hmgn1
-/- mice compared to their wild 
type littermates revealed the loss of HMGN1 corresponded to changes to the 
global  levels  of  H3K14ac,  H3K9ac,  H3S10p,  H3S28p,  H4S1p  and  H2AS1p 
(Postnikov et al., 2006; Lim et al., 2005; Lim et al., 2004). HMGN1 is thought 
to increase H3K14ac by enhancing the activity of HATs rather than inhibiting 
HDACs  (Lim  et  al.,  2005).  In  this  study,  HMGN1
-/-  and  HMGN1
+/+  mouse 
embryonic fibroblast cells (MEFs) treated with trichostatin A (TSA), a HDAC 
inhibitor showed that HMGN1
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to  increased  activity  of  HATs  rather  than  inhibiting  HDACs.  In  the  similar 
study, HMGN1 were shown to affect the expression of a subset of immediate 
early (IE) genes by reducing phosphorylation of histone 3 serine 10 (H3S10p) 
while promoting H3K4ac. 
1.12 Transcription regulation by HMGN proteins 
The  interaction  of  HMGN  proteins  with  chromatin  leads  to  changes  in 
transcriptional  processes  (Rochman  et  al.,  2010;  Bustin,  2001;  Ding  et  al., 
1994;  Paranjape  et  al.  1995).  The  link  between  HMGN  proteins  and 
transcription was first demonstrated by Weisbrod and Weintraub in their work 
using  chromatin  purified  from  chicken  erythrocytes,  which  showed  that 
HMGN1/2 were associated with DNase I hypersensitive regions of the -globin 
gene (Weisbrod and Weintraub, 1979). Subsequent studies also suggested that 
HMGN1/2  bind  preferentially  to  active  genes  (Postnikov  et  al.,  1991; 
Weisbrod, 1982; Gazit et al., 1980; Goodwin et al., 1979). 
Further  evidence  of  the  ability  of  HMGN  proteins  to  act  as  activators  of 
transcription  came  from  studies  conducted  using  SV40  minichromosomes 
isolated  from  CV-1  cells  and  minichromosomes  assembled  in  Drosophila 
embryo or Xenopus egg extracts (Weigmann et al., 1997; Ding et al., 1997; 
Tremethick et al., 1996; Trieschmann et al., 1995; Ding et al., 1994). In each 
system, HMGN1/2 enhanced the rate of transcription only from chromatin but 
not in naked DNA templates, suggesting that HMGN1/2 are chromatin-specific 
transcriptional activators.   
The  studies  above  indicate  that  HMGN  proteins  can  act  as  general 
transcriptional facilitators, but their ability to act as specific transcriptional 
modulators was shown by gene expression profiling in cells lacking a particular 
HMGN variant. The loss of HMGN1 in MEFs altered the expression of 3% of 
active genes (Rubinstein et al., 2005).  Similarly, stable over-expression of 
HMGN3 in Hepa cells affected the levels of 0.8% of expressed genes (West et 
al., 2004). These studies indicate that HMGN proteins affect only subset of 
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Studies using Chromatin Immunoprecipitation (ChIP) have revealed binding of 
HMGN proteins at specific gene targets in specific cell types. For example, 
HMGN3 was shown to bind and activate the genes Glyt1 and Glut2 in Hepa 
cells  and  MIN6  cells,  respectively  (Ueda  et  al.,  2009;  West  et  al.,  2004). 
HMGN1 increases the rate of heat-shock-induced Hsp70 activation by binding 
to the Hsp70 promoter in MEFs (Belova et al., 2008). In contrast, HMGN1 binds 
and represses the Sox9 gene in mouse limb bud micromass cultures (Furusawa 
et  al.,  2006).  Additionally,  HMGN1  binds  to  and  inhibits  the  induction  of 
certain estrogen-induced genes in MCF7 cells and various anisomycin-induced 
immediately early genes in MEFs (Zhu and Hansen, 2007; Lim et al., 2004). 
More recently, a study using ChIP-sequencing and genome-wide analysis has 
revealed  that  HMGN1  in  CD4
+  T  cells  binds  specific  genomic  regions 
corresponding to DNaseI hypersensitive sites, promoters, functional enhancers 
and transcription factor binding sites (Cuddapah et al., 2011). These studies 
suggest  that,  in  addition  to  transiently  interacting  with  all  nucleosomes, 
HMGN1 may be enriched at certain regulatory sites where it may play specific 
roles in gene regulation (Cuddapah et al., 2011). 
HMGN1-4 have similar protein  structures and share functional properties in 
how  they  interact  with  chromatin  and  affect  histone  modifications.  These 
features  lead  to  the  suggestion  that  HMGN  proteins  may  be  functionally 
redundant. However, the studies described above using mice and/or cells with 
altered HMGN content show that the HMGN variants are not fully redundant. 
Furthermore,  direct  comparison  of  transcription  profiles  of  MEFs  in  which 
HMGN1, HMGN3 or HMGN5 are knocked out or overexpressed revealed limited 
redundancy between the variants (Rochman et al., 2011).  
Although  there  are  studies  demonstrating  the  role  of  HMGN  proteins  in 
cellular transcription, the mechanisms of how they affect particular subsets of 
genes and whether they play variant-specific roles in transcription regulation 
remain unclear. Given that HMGN1 and HMGN2 are ubiquitously expressed in 
most adult cells, while HMGN3 and HMGN5 show distinct developmental and 
tissue-specific expression, it is possible that HMGN proteins play key roles in 
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1.13 HMGN knockout mice and their functional analysis 
Knockout mice for HMGN1 and HMGN3 have been developed while  Hmgn2
-/-  
has proven to be embryonic lethal(Bustin Lab communication, although this 
work  has  never  been  published  and  it  is  not  possible  to  mention  at  what 
embryonic stage the embryos die). Hmgn1
-/- mice appear to develop normally 
but are present at a reduced frequency in HMGN1
+/- crosses (Birger et al., 
2005;  Birger  et  al.,  2003).  HMGN1
-/-  mice  demonstrate  differences  in  the 
cellular processes when subjected to stress (Birger et al., 2005; Birger et al., 
2003). When exposed to UV and ionizing radiation, Hmgn1
-/- mice and cells 
derived from these mice show unusual hypersensitivity compared to wild type 
littermates (Birger et al., 2005; Birger et al., 2003). This is thought to be due 
to less efficient nucleotide excision repair of DNA damage in Hmgn1
-/- cells 
(Birger et al 2003, Fousteri et al 2006; Subramanian et al 2009). Meanwhile, 
Hmgn1
-/-  mice  and  cells  exposed  to  ionizing  radiation  reveal  increased 
tumorigenicity due to impaired ability to activate G2-M checkpoint (Birger et 
al., 2005). Hmgn1
-/- mice also show defects in the development of corneal 
epithelium,  which  is  linked  to  the  altered  expression  of  cell  adhesion 
molecules and p63 (Birger et al., 2006).  
Hmgn3
-/- mice appear to develop normally but show mild defects in insulin 
secretion  (Ueda  et  al.,  2009).  Functional  analysis  elucidated  that  HMGN3 
affects the transcription regulation of key genes involved in pancreatic B islet 
cells including Glut2 and Kir6 (Ueda et al., 2009).   
 
1.14 HMGN expression and possible function in 
development and cellular differentiation 
Proper embryonic development and cellular differentiation requires multiple 
changes in gene expression and a pre-programmed pattern of transcription 
activities. It has been shown that precise control of chromatin structure plays 
a crucial role in regulating the outcome of development and differentiation 
processes.  The  chromatin  structure  of  specific  genes  is  crucial  for  the 
maintenance of the pluripotency of the inner cell mass (Boyer et al., 2006). Chapter 1    49 
Remodelling of chromatin is also important for the commitment of pluripotent 
cells to specific lineages (Kondo, 2006) and terminal differentiation (Palacious 
and  Puri,  2006;  Wilson  et  al.,  2005;  Hsieh  and  Gage,  2004).  Given  that 
chromatin  plays  an extensive  role  in  determining  and  carrying out  specific 
pre-programmed gene expression in development and differentiation, it can 
be expected that the HMGN family of chromatin binding proteins would affect 
the outcome of these processes.  
Studies on the role of HMGNs in development and cellular differentiation are 
mainly based on in vitro model systems of mouse, chicken or human cells and 
in vivo functional analysis of knockout mice. The expression patterns of Hmgn 
family  members  in  embryonic  development  and  cellular  differentiation  are 
unique, and suggest a specialised role for each variant. Most of the expression 
data regarding HMGNs are for HMGN1 and HMGN2 only, because they are the 
founding  members  and  have  been  studied  for  over  4  decades.  For  the 
purposes of this discussion, the expression patterns of HMGN1 and HMGN2 are 
considered  together,  followed  by  those  of  HMGN3  and  HMGN5.  HMGN4 
expression has not been studied in the context of development.  
1.14.1 HMGN1 and HMGN2 expression and functional role in 
development and differentiation 
HMGN1 and HMGN2 are ubiquitously expressed in all adult tissues, although 
the  highest  expression  is  detected  during  embryogenesis  (Furusawa  et  al., 
2006;  Lehtonen  et  al.,  2001).  The  expression  of  HMGN1  and  HMGN2  is 
regulated  in  a  developmental-specific  manner,  in  which  the  proteins  are 
progressively  down-regulated  throughout  the  entire  embryo  except  in  cells 
that are committed and continuously undergoing differentiation (Furusawa et 
al., 2006; Lehtonen et al., 2001). In early stage embryogenesis, HMGN1 and 
HMGN2 proteins are detected throughout oogenesis while Hmgn1 and Hmgn2 
transcripts  are  present  beyond  the  two-cell  stage.  When  antisense 
oligonucleotides of HMGN1 and HMGN2 were injected into mouse oocytes, the 
transient loss of HMGN1 and HMGN2 delayed cell cleavage and the onset of 
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In early stage bovine embryo development, HMGN1 and HMGN2 are expressed 
in oocytes but are steadily down-regulated upon fertilization and almost lost 
by the eight-cell stage (Vigneault et al., 2004).  Sustained HMGN2 expression 
in  an  in  vitro  fertilization  study  of  bovine  embryos  showed  that  enhanced 
levels of HMGN2 resulted in the embryos failing to develop into a blastocyst 
due to H3K14ac mediated chromatin remodelling (Bastos et al., 2008).  
In Xenopus development, the Hmgn1 and Hmgn2 genes are expressed in the 
three germinal layers. However the proteins are only detected after the mid-
blastula  transition  and  continue  during  neurula  and  tadpole  embryo 
development  (Korner  et  al.,  2003).  Both  over-expression  and  depletion  of 
HMGN1  and  HMGN2  after  the  mid-blastula  transition  resulted  in  clear 
developmental defects, suggesting that mis-regulation of these proteins leads 
to abnormal development (Korner et al., 2003).  
In  vitro  cellular  differentiation  model  systems  revealed  that  HMGN1  and 
HMGN2  are  linked  to  differentiation  processes  such  as  erythropoiesis, 
myogenesis and chondrogenesis (Furusawa et al., 2006; Lehtonen et al., 2001; 
Crippa et al., 1991;  Pash et al., 1990). During chondrocyte differentiation, 
HMGN1 and HMGN2 have been shown to bind and repress Sox9, which is a 
transactivator and master regulator of chondrogenic fate (Furusawa et al., 
2006).  HMGN1  is  down-regulated  during  chondrocyte  differentiation,  with 
concomitant  induction  of  Sox9  expression  (Furusawa  et  al.,  2006).  HMGN1 
expression is also down-regulated during myogenesis, and over-expression of 
HMGN1 in myoblasts inhibited their differentiation to myotubes (Crippa et al., 
1991; Pash et al., 1990). Taken together, this evidence suggests that HMGN1 
and HMGN2 expression is down-regulated during cellular differentiation and 
over-expression of these proteins inhibits in vitro differentiation.   
In a more recent study, developmentally regulated expression of HMGN1 and 
HMGN2  expression  was  observed  in  hair  follicles  (Furusawa  et  al.,  2009). 
HMGN1  and  HMGN2  are  expressed  some  stem  cells  (undifferentiated  bulge 
cell)  of  the  mature  hair  follicle  (Furusawa  et  al.,  2009).  Both  HMGN1  and 
HMGN2 expression are found in relatively less-differentiated cells (outer root 
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(inner root sheath cells, hair shaft and supra-basal layer) (Furusawa et al., 
2009).  
1.14.2 HMGN3 expression in development and differentiation 
HMGN3  consist  of  2  splice  variants,  HMGN3a  and  HMGN3b,  with  the  latter 
lacking  most  of  the  RD  domain.  HMGN3  protein,  unlike  HMGN1/2,  shows 
tissue-specific  expression.  In  mouse  and  human  tissue,  HMGN3  is  highly 
expressed  in  eye  and  brain  (Ito  and  Bustin,  2002;  West  et  al.,  2001).  In 
embryonic eye development, HMGN3 protein is detected in the presumptive 
corneal  epithelium  and  lens  fibre,  whereas  in  the  adult  eye,  HMGN3  is 
specifically expressed in the lens fibre and inner nuclear layer of the retina 
(Lucey  et  al.,  2008).  HMGN3  expression  is  also  highly  expressed  in  adult 
pancreatic islet cells (Ueda et al., 2009).  
1.14.3 HMGN5 expression in development and differentiation 
HMGN5 is four times longer than other HMGN family members, due to a 300 
amino  acids  C-terminal  domain.  In  mouse  day  7.5  embryos,  HMGN5  is 
expressed in the ectoplacental cone (Shirakawa et al., 2009). HMGN5 is also 
highly expressed in trophoblast giant cells, spongiotrophoblast and trophoblast 
cells  in  the  placental  labyrinth  while  the  expression  in  other  parts  of  the 
embryo remains relatively weak (Shirakawa et al., 2009). These expression 
patterns  suggest  that  HMGN5  may  play  role  in  trophoblast  development  in 
embryogenesis (Shirakawa et al., 2009). During Rcho-1 differentiation, an in 
vitro model system for trophoblast differentiation, HMGN5 was shown to be 
up-regulated (Shirakawa et al., 2009). The depletion and over-expression of 
HMGN5 in this system affected the differentiation-linked expression of several 
prolactin-related genes (Shirakawa et al., 2009). In the same study, HMGN5 
was shown to bind prolactin-related genes in Rcho1 cells but not in H4IIE, a 
non-trophoblastic  cell  line.  These  observations  indicate  that  HMGN5 
modulates expression of specific genes in trophoblast differentiation through 
chromatin  (Shirakawa  et  al.,  2009).    These  results  also  show  that  unlike 
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1.15 Aims and objective of this thesis 
This project was commenced with an aim to study the role of HMGN1-3 in 
stem cells and neural differentiation. P19 EC cells were used as model system 
as they resemble ES cells in their neuronal differentiation ability. The general 
aims of this work are summarised below: 
1.  To characterise the RA-induced neuronal differentiation system of P19 
EC cells. 
2.  To study the expression of HMGN1-3 in undifferentiated and neuronal 
differentiation of P19 EC cells. 
3.  To  establish  siRNA  knockdowns  of  HMGN1-3  in  undifferentiated  cells 
and during neural differentiation. 
4.  To  study  the  changes  of  key  pluripotency  and  neural-specific  genes 
upon HMGN knockdown.  
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Chapter 2 
Materials and Methods 
Materials 
2.1 Cell line and cells 
2.1.1 P19 EC cells 
Undifferentiated  P19  EC  cell  line  was  provided  by  Dr.  Andrew  Hamilton, 
Institute of Cancer Sciences, University of Glasgow. The P19 EC cells provided 
were at passage 14. For ease of labelling and recording, the passage number 
was reset to 0 (P14 = P0).  
2.1.2 Hippocampal neuron from adult brain 
Hippocampal neurons from adult brain at day 18 culture were provided by 
Paul Turko from Dr. Sturt Cobbs’s group from the Section of Neuroscience, 
University  of  Glasgow.  These  cells  were  only  used  for  immunofluorescence 
staining experiments. 
2.2 Reagents 
2.2.1 Antibodies 
Custom antibodies generated by the West lab used in this project are anti- 
mmHMGN1, anti-hsHMGN2, and anti-mmHMGN3a. They were raised against 
the C-terminal 15 amino acids of each protein:  
 
  mm HMGN1:  NQSPASEEEKEAKSD 
  hs HMGN2: KTDQAQKAEGAGDAK (detects both mouse and human 
HMGN2) 
  mouse HMGN3a: VEEAQRTESIEKEGE (detects HMGN3a but not HMGN3b) 
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Custom antibodies were raised in rabbit by Eurogentec and affinity purified. 
Affinity purified anti-HMGN3-2752 was a gift from Dr. Michael Bustin (West et 
al,  2001),  and  was  raised  against  an  internal  peptide  of  human  HMGN3: 
KTSAKKEPGAKISRGA. It detects mouse HMGN3a and HMGN3b. 
Commercially available antibodies used in this project are listed below: 
Table 2.1: List of commercially available antibodies used in this project. 
Antibody  Species raised  Supplier  Catalogue 
number 
OCT4   Goat  Abcam  Ab21603 
MAP2   Mouse   Abcam  Ab24640 
NF-160 kDA  Rabbit   Abcam  Ab9034 
GFAP  Mouse   Abcam  Ab4648 
Alexa Fluor 488   Goat anti-mouse  Invitrogen  A11055 
Alexa Fluor 488   Donkey anti-goat  Invitrogen  A21121 
Alexa Fluor 596   Goat anti-rabbit  Invitrogen  A11012 
-Actin  Goat   Santa Cruz  Sc-1615 
HRP   Goat anti-rabbit  Pierce  HJ108849 
HRP  Rabbit anti-goat  Pierce  31402 
 
 
2.2.2 Oligonucleotide primers  
Custom oligonucleotide primers were purchased from MWG Eurofin. Sequences 
of primers are listed in table 2.3. 
2.2.3 Other reagents 
  All-trans Retinoic Acid (ATRA) (Invitrogen) 
  Ethanol (Fisher) 
  Methanol (Fisher) 
  Freezing Media (Gibco) Chapter 2    55 
2.3 Formulation of buffer solution 
All  buffers  are  prepared  using  sterile  deionised  H2O  and  where  mentioned 
buffers were prepared in 1X PBS (Gibco).  
2 X Sample loading buffer 
-  62 mM Tris-HCI, pH 6.8 
-  2% SDS 
-  10 mM DTT (dithiothreitol) 
-  10% Glycerol 
-  0.01% Bromophenol blue 
 
4 X Gel separating buffer 
-  1.5 M Tris-HCI, pH 8.8 
-  O.4% SDS 
 
 
4 X Gel Stacking buffer 
-  0.5 M Tris-HCI, pH 6.8 
-  O.4% SDS 
 
 
10 X SDS PAGE Running buffer 
-  1.92 M Glycine 
-  250 mM Tris, pH 8.8 
-  1% SDS 
 
1 X Western Transfer buffer 
-  0.192 M Glycine 
-  25 mM Tris, pH 8.8 
-  10% SDS 
 
10 X PBS solution for washing 
-  1.37 M NaCI 
-  27 mM KCI 
-  43 mM Na2HPO4 
-  14.7 mM KH2PO4 
 
Blocking buffer for western blotting 
Following were dissolved in 90 ml of water: 
-  10 ml 10xPBS 
-  1g/5 g Non-fat milk powder(Marvel) OR Bovine Serum Albumin (BSA) 
-  100 µl Tween-20 
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Cell lysis buffer (CLB) 
-  45 mM Tris-HCI pH7.5 or 8 
-  1 mM EDTA 
-  1% SDS 
-  10% Glycerol 
-  0.01% approx bromophenol blue 
-  50 ml Water 
-  Protease inhibitors  
(50  nM  okadaic  acid,  100  µM  sodium  orthovanadate,  10  mM  sodium 
butyrate, 0.5 µg/ml TSA, protease inhibitor tablets from Roche) 
 
Paraformaldehyde 
-  4% paraformaldehyde 
-  1 X PBS 
 
Blocking buffer for immunofluorescence 
-  2.5% BSA 
-  0.03% Triton 
-  1 X PBS 
 
 
 
Methods 
2.4 Tissue culture 
2.4.1 Culturing and passaging of undifferentiated P19 EC cells 
Undifferentiated  mouse  P19  EC  cells  were  cultured  on  untreated  tissue 
culture  plasticware  in  the  absence  of  feeder  cells  in  Minimum  Essential 
Medium  (MEM)-alpha  containing  deoxyribonucleotides,  ribonucleosides  and 
ultraglutamine 1 (Lonza, BE02-002F) supplemented with 7.5% new born calf 
serum  (heat  inactivated,  Source  Bioscience,  7.03Hi)  and  2.5%  fetal  bovine 
serum (heat inactivated, Sigma, F9665) (undifferentiated media) in standard 
conditions  of  5%  CO2  at  37⁰C.  Undifferentiated  cells  were  passaged  every 
second day when approximately 80-90% confluent. For passaging the following 
protocol was followed: 
1.  Media from confluent cell cultures are aspirated and the cell layer was 
briefly rinsed with PBS solution. 
2.  The cell layer was trypsinised by applying Trypsin-0.5 mM EDTA (w.v) 
0.25% (Gibco) solution and incubated at 37⁰C for 1-2 minutes. Chapter 2    57 
3.  Trypsin was deactivated by adding 5 volumes of fresh media and cells 
were transferred to a 15 ml falcon tube using a pipette.  
4.  The cells were collected by centrifugation at 300g for 5 minutes. The 
supernatant was discarded and the cell pellet was resuspended in fresh 
media. 
5.  Cells  were  seeded  into  new  tissue  culture  plasticware  at  a  dilution 
factor of 1:5.  
2.4.2 Cell cryopreservation 
For  preparation  of  frozen  cell  stocks,  cells  were  collected  following  the 
method described in section 2.4.1. The cell pellets were resuspended in 4 ml 
of freezing media (Gibco) solution drop wise. The cells in freezing media were 
distributed into 1 ml aliquots in polypropylene cryotubes. The cryotubes were 
cooled  in  isopropanol  freezing  container  at  -80⁰C  for  72  hours  and  then 
transferred  into  liquid  nitrogen  vapour  phase  for  long  term  storage.  For 
recovery, cell were rapidly thawed at 37⁰C, resuspended in 9 ml fresh media 
and centrifuged at 300g for 4 minutes. The cell pellets was resuspended in 10 
ml fresh media and cultured in a 25 cm
2 vented flask (Nunc). 
2.4.3 Retinoic acid-induced neural differentiation from P19 EC 
cells 
The protocol for RA-induced neural differentiation from undifferentiated P19 
EC cells was carried out as described by McBurney and Jones-Villeneuve with 
several optimised steps discussed in chapter 3 (Runnicki and McBurney, 1987; 
Jones-Villeneuve et al., 1982). This protocol utilises a ‘+2 -2’ procedure that 
involves two stages. The first stage is called the suspension stage to formed 
neuroectodermal  EBs  followed  by  an  adherent  stage  where  the  cells  are 
further differentiated to formed functional neurons and glia (Chapter 3). 
Induction of neural differentiation 
For neural induction, 1 X 10
6 undifferentiated P19 EC cells were seeded in 10 
cm bacteriological petri dishes (Sterilin) in GIBCO™ Minimum Essential Medium 
(MEM)-alpha supplemented with 5% fetal bovine serum (differentiation media) Chapter 2    58 
under standard conditions of 5% CO2 at 37⁰C. All-trans retinoic acid (ATRA) 
was added to a final concentration of 1.0 µM (for optimisation experiment, a 
concentration range of 0.5-2.5 µM was used) and cells were allowed to form 
EBs for 2 days. ATRA stock (1 mM in water) was distributed into 1 ml aliquots 
and stored in the dark at -80⁰C and discarded after 3 months. After 2 days, 
cultures were aspirated into 15 ml falcon tubes and left in tissue culture hood 
for 5 minutes to allow the cells to settle at the bottom of the tube.  The 
media was removed without dislodging the cells at the bottom of the tube and 
immediately resuspended slowly with 10 ml fresh media without ATRA. Cells 
were then cultured under conditions mentioned above for another 2 days.  
Plating cells from EBs  
At this stage, the cells have been in suspension for 4 days (2 days with ATRA 
and 2 days without ATRA). Visible formation of aggregates was observed. The 
aggregates were transferred into 15 ml falcon tubes and left in tissue culture 
hood for 5 minutes to allow the aggregates to settle down at the bottom of 
the  tube.  The  media  was  aspirated  out  and  aggregates  were  washed  with 
MEM-alpha  media  without  serum  and  left  in  the  tissue  culture  hood  for  5 
minutes to allow the aggregates to settle down at the bottom of the tube. 
The media was aspirated and 2 ml Trypsin-0.5 mM EDTA (w.v) 0.25% (Gibco) 
solution was added. The resulting mixture of cell in trypsin solution was very 
gently pipetted up-and-down using a 5 ml pipette to dislodge the aggregates 
and incubated at 37⁰C for 30 seconds. This step is repeated 4 times. After 
that, 4 ml of fresh media (differentiation media) was added to deactivate the 
trypsin. The cells were centrifuged at 300g for 5 mins and the supertanant 
discarded. The cell pellets were resuspended into fresh media (differentiation 
media) and counted. For plating, cells were seeded at 3.5 X 10
6 cells (for 
optimisation,  a  range  of  1.5-7.5  X  10
6  cells  were  used)  into  10  cm  tissue 
culture grade (Nunc) plasticware and grown under standard conditions of 5% 
CO2 at 37⁰C. After 3 days, the media in the culture was removed and replaced 
with fresh media (differentiation media) very gently. Culture was allowed to 
grow up to the required length of time with total RNA and whole cell lysates 
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or 8-well LabTek™ Chamber II (Nalge Nunc) slides and cultured as described 
above.  
2.4.4 Generating HMGN1 and HMGN2 knockdowns 
HMGN1 and HMGN2 knockdowns were generated using siRNA technology. The 
siRNAs  were  obtained  from  Qiagen’s  Flexitube  GeneSolution  system.  The 
transfection reagent, INTERFERin™ and protocol used for these experiments 
were  provided  by  Polyplus.  Detailed  siRNA  screening  and  optimising 
experiments are discussed in chapter 5. The list of siRNA used in this project 
is presented in table 2.2. For HMGN1 targeted knockdown, siRNAs N102 and 
N103 were used, while for HMGN2 knockdown, siRNAs N201 and N204 were used. 
For double knockdown of both HMGN1 and HMGN2, siRNAs N102 and N201 were 
used. Allstars negative control siRNA (Qiagen) was used as a negative control 
that should not have any effect on mammalian cells. siRNA knockdown was 
carried out on undifferentiated P19 EC cells and during neural differentiation.  
Table 2.2: List of siRNA, target sequence and final concentration used in 
knockdown experiments. * siRNAs used for all downstream functional 
experiments. 
Target & siRNA  Target Sequence  Final concentartion 
(nM) 
(after optimisation) 
HMGN1  N101  CCCGTGTTTCTAGTAGAACCA  20 
*HMGN1  N102  CACTGGAACAAGTTCAAAGA  20 
*HMGN1  N103  TTGTGATAATGTGCTGTGAAA  20 
HMGN1  N104  CACAATGTGACTTCAGAGTTT  20 
*HMGN2  N201  CAGATTGATAATTCTGCCTAA  40 
HMGN2  N202  ATCCTTAATGTGAAATGTCAA  40 
HMGN2  N203  AACATAGACTTAATTCCCTTA  40 
*HMGN2  N204  AAGGATCATGTGTCAGTAACA  40 
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siRNA knockdown protocol 
Day 1 
1.  For knockdown in undifferentiated cells, 1 X 10
5 cells were seeded in 1 
ml undifferentiated media into 12-well plates. For knockdown in neural 
differentiating  cells,  the  culturing  conditions  are  similar  to  neural 
differentiation protocol. 
2.  Incubate cells under standard growth conditions of 5% CO2 at 37⁰C for 
24  hours  for  24  hours.  For  knockdown  in  neural  differentiating, 
undifferentiated P19 EC cells were transfected with siRNAs specific to 
HMGN1 and HMGN2. 72 hours post transfection, the cells were induced 
with RA and allowed to form EBs using the similar system explained in 
chapter 3. At day -3 (2
nd day of EBs in suspension) and precisely 12 
hours after seeding, cells were transfected with siRNAs at the similar 
final concentration mentioned above. Cells transfected any time before 
12 hours did not survive. At day 2 (post seeding), media was carefully 
replaced without damaging the cells. Single siRNA transfection on day 1 
neural differentiation was also conducted. At this point, morphology of 
the cells was similar to wild type cells. At day 3, total RNA and whole 
cell lysates were harvested for qRT-PCR analysis and western blotting. 
Day 2  
3.  The culture was 50-60% confluent at this stage for undifferentiated cell 
and  approximately  30-40%  confluent  for  neural  differentiating  cells. 
siRNAs at the final concentration shown in table 2.2 using MEM-alpha 
media  without  serum  with  addition  of  6  µl  and  10  µl  INTERFERin™ 
transfection  reagent  for  single  and  double  siRNA  knockdown 
experiments (in a total volume of 100 µl) was prepared.  
*For  optimisation  of  siRNA  concentration,  a  range  of  5-20  nM  siRNA 
specific to HMGN1 and a range of 5-40nM siRNA specific to HMGN2 was 
tested were tested (Chapter 3).  
4.  The siRNA complex was vortexed and left to incubate for 10-12 minutes 
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5.  The siRNA complex was added drop wise to each well for knockdown in 
undifferentiated  cells.  For  knockdown  in  neural  differentiating cells, 
the  siRNA  complex  was  added  drop  wise  into  neural  differentiating 
culture 12 hours after seeding.  
6.  The cells were then incubated under standard growth conditions for the 
required length of time before sampling to assess the siRNA-induced 
target gene knockdown. 
 
2.5 Protein isolation and analysis by western blotting 
2.5.1 Preparation of whole cell lysates  
1.  Approximately  3.5  x  10
6  cells  (undifferentiated  or  neural 
differentiation) were harvested for western blotting experiments using 
methods  described  for  undifferentiated  and  neural  differentiation 
cultures (section 2.4). 
2.  Cells were washed with PBS and collected by scraping. The cell pellet 
in PBS was centrifuged at 300g for 5 minutes, washed in PBS, counted 
and centrifuge as before. 
3.  The cell pellet was resuspended in 300 µl of ice-cold cell lysis buffer 
and transferred to a 1.5 ml microcentrifuge tube. The samples were 
homogenised using a P1000 pipette and incubated on ice for 5 minutes. 
4.  The samples (whole cell lysates) was either stored in -20 C for short 
term usage or frozen using isopropanol bath to be stored at -80 C for 
long term usage.  
2.5.2 Protein concentration quantification  
The protein concentration in the isolated whole cell lysates was estimated by 
measuring the absorbance at 280 nm using a spectrophotometer. Before SDS-
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Loading Buffer and incubated at 70⁰ C for 10 minutes. Equal concentrations of 
samples  were  then  subjected  to  denaturing  Polyacrylamide  Gel 
Electrophoresis (SDS-PAGE), and the gel was stained with colloidal coomassie 
brilliant  blue  (Fisher)  using  the  methods  described  below  (section  2.5.3). 
Equal concentrations of samples based on the coomassie blue staining were 
then loaded on subsequent gels for protein expression analysis.  
2.5.3 Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Equipment used 
1.  X-Cell Sure Lock
™ Mini-cell electrophoresis tank (Invitrogen). 
2.  X-Cell II blot apparatus module (Invitrogen). 
3.  NuPage
™ 1mm gel casting cassettes (Invitrogen). 
4.  10/15-well 1mm gel combs (Invitrogen). 
 
Gel Casting 
1.  The formulation for a 15% final acrylamide concentration of resolving 
gel was prepared using the solution listed below. The solutions were 
mixed in a 50 ml falcon tube and pipetted into gel casting cassettes. 
The solution was overlaid with dH2O and left to polymerise for 1 hour 
at RT.  
  3.75 ml Resolving Buffer 
  2.81 ml of 40% Acrylamide (37.5 acrylamide: 1 bis-acrylamide) 
  0.83 ml dH2O 
  0.75 ml of 10% SDS 
  0.50 ml of 10% APS 
  0.12 ml TEMED 
 
2.  The  dH2O  layer  was  removed  from  the  gel  cassette  was  removed, 
washed  and  dried  by  blotting  with  filter  paper.  The  solutions  for 
stacking gel listed below were mixed together and pipetted on top of 
the polymerised resolving gel.  A 10/15-well comb was inserted. The 
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  1.5 ml Stacking Buffer 
  0.375 ml of 40% Acrylamide (37.5 acrylamide/ 1 bis-acrylamide) 
  1.05 ml dH2O 
  0.30 ml of 10% SDS 
  0.30 ml of 10% APS 
  0.10 ml TEMED 
 
Electrophoresis of protein samples 
3.  The plastic comb and white tap at the bottom of the polymerised gel 
cassette  were  removed  and  the  wells  were  washed  using  excess  of 
dH2O. 
4.  The gel cassette was placed and clamped into the electrophoresis tank. 
The electrophoresis tank was filled with 1 X SDS-PAGE Running Buffer 
enough to cover the wells (500-600 ml). 
5.  The  proteins  samples,  prepared  earlier  as  described  above,  were 
loaded into each well alongside 5 µl of SeeBlue
® Plus 2 (Invitrogen) pre-
stained markers.  
6.  The gel was run at 130 V constant voltage for 90-110 minutes.  
Protein transfer onto PVDF membrane 
7.  The gel cassette was forced open, and the stacking gel and the foot of 
the  gel  were  removed.  The  remaining  gel  was  transferred  to  a 
container filled with 1 X Western Transfer Buffer and left on an orbital 
shaker for 10 minutes to wash off excess SDS. 
8.  During  the  incubation  of  the  gel,  the  blotting  pads  and  filter  paper 
(Whatman, cut to a size of 7.5 X 8 cm) were soaked in 1 X Western 
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9.  PVDF transfer membrane (Millipore, 0.45 m pore size, cut to a size 7.5 
X 8 cm) was soaked in 100% methanol for 1 minute and then in 1 X 
Western Transfer Buffer. 
10.   The transfer stack was directly assembled into the X-Cell Blot transfer 
apparatus. The arrangement was as follows: 
i.  Top plate of the blot module (cathode) 
ii.  2 X blotting pads 
iii.  Filter paper 
iv.  PVDF transfer membrane 
v.  Gel 
vi.  Filter paper 
vii.  2 X blotting 
viii.  Bottom plate of the blot module (anode) 
 
11.  The transfer blot apparatus was then held together and placed in the 
gel tank. 
12.  The  gel  tank  was  filled  with  1  X  Western  Transfer  Buffer  until  the 
gel/membrane stack was fully immersed in the buffer. 
13.  The  transfer  was  carried  out  at  a  constant  voltage  of  25  V  for  90 
minutes. 
Detection of specific proteins 
Procedures for detection of  specific proteins including membrane blocking, 
incubation with primary and secondary antibodies raised are specific to the 
individual antibodies used. Western blotting using antibodies against HMGN1, 
HMGN2, HMGN3 and -Actin were performed using the conditions described 
below: 
14.  The PVDF transfer membranes were blocked for 1 hour at RT (except 
stated) on an orbital shaker in the following blocking solution: 
  HMGN1: PBS + Tween 20 (0.05%) + Marvel (Non-fat dairy milk) 
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  HMGN2: PBS + Tween 20 (0.05%) + Marvel (Non-fat dairy milk) 
(5%). 
  mHMGN3: PBS + Tween 20 (0.05%) + Marvel (Non-fat dairy milk) 
(5%). 
  HMGN3-2752: PBS + Tween 20 (0.0001%) + Marvel (Non-fat dairy 
milk) (1%) incubated overnight at 4⁰ C. 
  -Actin: PBS + Tween 20 (0.05%) + Marvel (Non-fat dairy milk) 
(5%). 
15. The membranes were then incubated with the primary antibody diluted 
in the corresponding blocking solution and incubated for 90 minutes on 
an orbital shaker. The dilution ratios for all primary antibodies were 
1:2000 
16. The  membranes  were  washed  three  times,  10  minutes  each  on  an 
orbital shaker in PBS + Tween 20 (0.05%) solution. 
17. The  membranes  were  incubated  with  an  appropriate  secondary 
antibody (HRP conjugated goat anti-rabbit or mouse anti-goat) diluted 
1:2000 in PBS + Tween 20 (0.05%) + Marvel (Non-fat dairy milk) (5%) for 
90 minutes.  
18. The  membranes  were  washed  three  times,  10  minutes  each  on  an 
orbital shaker in PBS + Tween 20 (0.05%) solution. 
19. SuperSignal™  West  Dura  Extended  Duration  Substrate  (Pierce)  ECL 
detection  kit  was  used  to  visualise  the  proteins  bands.  SuperSignal™ 
luminal enhancer and stable peroxide solutions were mixed in equal 
proportion and applied onto the membranes.  
20. The  reactions  were  in  the  dark  for  6  minutes  and  the  resulting 
chemiluminescence was detected using a CCD camera imaging system 
(LAS3000, Fuji). Typical exposure time was 2 minutes for all HMGNs and 
1 minute for -Actin to visualise the protein bands. Chapter 2    66 
 
2.6 Real-time PCR for gene expression analysis 
2.6.1 RNA extraction  
Total RNA extractions from cultured cells were conducted using RNeasy
® Mini 
kit from Qiagen following the manufacture’s protocol:  
1.  Cultured cells were washed in PBS, trypsinised and centrifuged at 300G 
for  5  minutes.  Cell  pellet  was  counted  using  haemocytometer  and 
approximately 10
6-10
7 cells were used for each RNA preparation. 
2.  Cells were disrupted by adding 600 µl of buffer RLT. 
3.  Cell  lysate  in  RLT  buffer  was  homogenised  using  0.9  mm  diameter 
needle fitted to an RNase-free syringe. The lysate was passed through 
the needle for approximately 5-9 times. 
4.  One volume (600 µl) of 70% methanol was added to the cell lysate and 
mixed well by pipetting.  
5.  Up to 700 µl of the sample was transferred to an RNeasy spin column 
placed in a 2 ml collection tube. The tube was centrifuged at 10,000 
rpm using a benchtop centrifuge for 15 seconds. The flow-through was 
discarded.  The remaining aliquot of the sample was loaded into the 
sample spin column and centrifuged as above. The flow-through was 
discarded. 
6.  Buffer RW1 at a volume of 700 µl was added to the spin column and 
centrifuge using the same condition described above. The flow-through 
was discarded. 
7.  At  this  point,  on  column  DNase  digestion  using  RNase-free  DNase 
enzyme step was carried out. DNase mix (10 µl DNase stock + 70 µl RDD 
buffer) was added to the sample and left to incubate for 15 minutes at 
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8.  Buffer RPE at a volume of 500 µl was added to the spin column and 
centrifuged  using  the  conditions  above.  The  flow-through  was 
discarded. 
9.  Step 8 was repeated but centrifuged at 10,000 rpm for 2 minutes using 
benchtop centrifuge. The flow-through was discarded. 
10.  The RNeasy spin column was placed into a new 2 ml collection tube. 
The tube was centrifuged at 10,000 rpm for 1 minute using a benchtop 
centrifuge. Any remaining flow-through was discarded. 
11.  The RNeasy spin column was placed into a new 1.5 ml collection tube. 
50 µl of RNase-free dH2O was added and centrifuged at 10,000 rpm for 
1 minute to elute the RNA.  
12.  To  increase  the  concentration of  the  RNA,  the  RNA  suspension  from 
step 11 was pipetted into same spin column and centrifuged as above.  
13.  The final RNA suspension was then transferred into new 1.5 ml RNase-
free microcentrifuge tubes. 
14.  RNA concentration was quantified using spectrophotometer nanodrop. 
15.  RNA samples if to be used immediately for cDNA synthesis was stored in 
-20⁰C or stored in -80⁰C for long term storage.  
2.6.2 Synthesis of cDNA 
Total RNA was extracted using methods described in section 2.6.1. The RNA 
was used in a first strand cDNA synthesis reactions using SuperScript™ III kit 
(Invitrogen). cDNA synthesis was carried out using oligo(dT)20 primer in order 
to  reverse  transcribed  polyadenylated  transcripts  only.  The  following  steps 
were employed: 
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Denaturation/ Annealing steps 
1.  The following reaction was set up and incubated at 65⁰C for 5 minutes 
and then rapidly cooled on ice for 5 minutes. 
 
 
 
 
 
 
 
Reverse transcription  
2.  cDNA synthesis master mix was prepared as below and added to the 
RNA/primer/dNTPs  mix.  The  mix  was  incubated  first  at  25⁰C  for  10 
minutes  and  then  at  50⁰C  for  50  minutes.  The  reaction  was  heat 
inactivated at 85⁰C for 5 minutes.  
 
 
 
 
 
 
RNA digestion 
3.  The RT reaction was cooled on ice for 30 seconds. The RNA component 
was degraded by adding 1 µl of RNase H. The reaction were incubated 
at  37⁰C  for  20  minutes  and  then  either  used  for  Real-time  PCR 
amplification or stored at -20⁰C. 
 
Reagents   Final volume (µl) 
 
RNA (300 ng in 10 µl dH2O)  10 
oligo(dT)20 (100 µM)  0.5 
dNTPs (50 µM)  0.5 
Total  11 
Reagents  Final volume (µl) 
 
5 X RT buffer  3 
DTT (0.1 M)  1 
RNaseOUT™  0.5 
SuperScript™ III  0.5 
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2.6.3 Real-time PCR amplification 
The gene expression profiles studies shown in this project were conducted 
using SYBR
®- green assays. This assay is based on detection of double stranded 
PCR  products  formed  in  the  reaction  using  oligonucleotide  primers.  The 
primers for specific genes were design using either Primer Express or Primer 3 
software. The basic criteria for primer design included designing primers over 
exon-intron-junctions,  melting  temperatures  of  55-60º  and  an  amplicon  of 
100-150 bp were applied. The primer pair sequences were compared against 
the entire mouse genome using BLAST alignment tool. The concentration of 
each primer was optimised, using dissociation curves to detect primer dimer 
formation and standard curves to check PCR efficiency. The list of primer sets 
used and primer efficiency are shown in table 2.3.  
The PCR reaction efficiency achieved for each primer set was calculated using 
standard  curve  by  plotting  Ct  values  vs.  five  serial  dilutions  of  cDNA 
encompassing a range of 10 fold. The primer efficiency was calculated using 
the formula 10
–1/slope where the slope is obtained from the standard curve and 
the theoretical maximum is 2.0, E = 2. This means that during the logarithmic 
phase  of  the  reaction,  the  PCR  product  of  interest  is  doubling  with  each 
cycle.  
The cDNA used in real-time PCR amplification was diluted 1:5, and 5 µl of this 
used in all PCR reactions. The PCR reactions was set up using transparent 96-
well PCR plates (Abgene) in 25 µl reactions, typically in triplicates for each 
sample, by mixing all the reagents shown below. Fast start universal SYBR 
green master mix (Rox) from Roche was used (cat. no. 04 913 914 001). 
 
 
 
SYBR®-green assay  Final volume (µl) 
 
SYBR PCR mix   12.5 
Forward primer (2.5-7.5 µM)  3 
Reverse primer (2.5-7.5 µM)  3 
dH2O  1.5 
Template DNA  5 Chapter 2    70 
 
PCR was performed on an MxPro 3000P (4 filter set plate) (Stratagene) using 
the thermal cycling conditions shown below.  All SYBR green readings were 
normalised to Rox dye fluorescence. A dissociation curve (double stranded 
PCR product melting curve) was carried out to allow screening for non-specific 
products amplified. 
Segment  Number of cycles  Thermal cycling condition 
1 
 
1 
 
10 minutes  95⁰C 
2  40  15 seconds  95⁰C 
1 minute  60⁰C 
3  1  1 minute  95⁰C 
30 seconds  55⁰C 
30 seconds  95⁰C 
 
Table 2.3: List of oligonucleotide primers used for real-time (qRT-PCR) 
analysis. 
Gene  Primer  Sequence   Primer 
Efficiency 
Hmgn1 
 
Forward 
Reverse 
AGAGACGGAAAACCAGAGTCCAG 
CGTGATGGATGCTTAGTCGGA 
1.98 
Hmgn2  Forward 
Reverse 
AAAAGGCCCCTGCGAAGAA 
TGCCTGGTCTGTTTTGGCA 
1.96 
Hmgn3a  Forward 
Reverse 
GAAGAAGGAAGAAAAGCAGGAAGC 
CATTTGCAGATGGTGCAGTACC 
1.93 
Hmgn3b  Forward 
Reverse 
TGGAGAGGAAGGCACAGAGAAC 
TCCACGACAATTCACTCTCCCT 
1.98 
GlyT1a  Forward 
Reverse 
TGAACGCAAGAGTCTGCAAGT 
GGCACAGCACCATTCAACATC 
1.95 
GlyT1b  Forward 
Reverse 
ACCCCTTCCCCAGAACAGAAT 
CCCACGCTCGTCAGTACAAACT 
1.92 
GlyT2  Forward 
Reverse 
ATGCCACGGTATGGAAGGATG 
CAGTTGTTGTGGAATTTGTT 
2.0 
Nestin  Forward 
Reverse 
AAAGTTCCAGCTGGCTGT 
CACTTCCAGACTAAGGGACAT 
1.95 
Map2  Forward 
Reverse 
TCTGCCTCTAGCAGCCGAAG 
CACTGTGGCTGTTTGTTCTG 
1.96 
Nse  Forward 
Reverse 
CTCATCCTGCCTGTGCCGGCCTT 
TGAGGGTGTGGTACACCTCTGC 
1.97 
Nf-160 kDa  Forward 
Reverse 
CTCAGCAGCTACCAGGACAC 
CGATCTCGATGTCCAGGGCC 
1.94 
Nmda- 
receptor 
subunit 2 
Forward 
Reverse 
GGCTTCTACAGAATCCCCGT 
TTCTGCGCTGCCCGGCCCTCGT 
1.93 
Gfap  Forward 
Reverse 
CAACCTGGCTGCGTATACCAG 
TTAAGAACTGGATCTCCTCC 
1.95 Chapter 2    71 
Oct4  Forward 
Reverse 
CGTTCTCTTTGGAAAGGTGTTCA 
GGTTCTCATTGTTGTCGGCTTC 
1.98 
Nanog  Forward 
Reverse 
ACCTGAGCTATAAGCAGGTTAAG 
TCAGACCATTGCTAGTCTTC 
2.0 
Sox2  Forward 
Reverse 
GGAACAGCATGGCGAGCGG 
CGTTCATGTGCGCGTAGCTG 
1.96 
Rest  Forward 
Reverse 
GTGCGAACTCACACAGGAGAACG 
AGTCCGCATGTGTCGCGTTAGA 
1.94 
Zfp521  Forward 
Reverse 
GAGCGAAGAGGAGTTTTTGG 
AGTTCCAAGGTGGAGGTCAC 
1.95 
Gapdh  Forward 
Reverse 
GATGCCCCCATGTTTGTGAT 
GGTCATGAGCCCTTCCACAAT 
2.0 
α-tubulin  Forward 
Reverse 
ACCCACGGTCATCGATGAAGTT 
TCCTTGCCAATGGTGTAGTGGC 
1.98 
-Actin  Forward 
Reverse 
GTGAAAAGATGACCCAGATC 
GTGTGGGTGACCCCGTCTCC 
1.97 
Mash1  Forward 
Reverse 
CCAACTGGTTCTGAGGACCTG 
CTGCCATCCTGCTTCCAAA 
1.93 
Mash2  Forward 
Reverse 
TTTTTCGAGGACGCAATAAGC 
ACCAGTCAAGGTGTGCTTCCA 
1.95 
 
2.6.4 Real-time PCR analysis 
Acquisition of Ct values 
Real-time PCR amplification curves were analysed using MxPro v4.10 software 
as follows: 
1.  Baseline  fluorescence  levels  were  calculated  based  on  the  readings 
obtained for cycles between 5 and 10 (at least 5 cycles before the log 
phase of amplification). 
2.  Threshold fluorescence was set at the level of mid-log phase on the 
amplification curves for individual primer sets. 
3.  Threshold crossing point (Ct) values for individual PCR reactions were 
extracted and further analysed using Microsoft Excel.  
4.  Gene expression data were analysed using the comparative Ct method 
(discussed below).  
 
 
Selection of housekeeping gene 
For the selection of best housekeeping gene (HKG), the expression of Gapdh, 
α-tubulin and -actin was analysed using geNORM algorithm (Vandesompele et Chapter 2    72 
al.,  2002).  The  geNORM  software  calculates  geometric  averages  from  Ct 
values obtained from different samples and ranks the best HKG that should be 
used as a normalising factor. The best HKGs listed in sequence are Gapdh, α-
tubulin and -actin. The margin of difference between the HKGs tested was 
small and gene expression profiles analysed using any of the HKGs showed 
similar results. Detailed description and formulas used to calculate the best 
HKG are given in geNorm manual available from  
http://medgen.ugent.be/~jvdesomp/genorm/geNorm_manual.pdf 
Comparative Ct quantification method and statistical analysis 
1.  A  fold  change  in  gene  expression  is  calculated  using  delta-delta  Ct 
values. 
          Delta () Ct values were calculated as followed: 
          Ct= Ct(HKG)-Ct (GOI), where 
          HKG-housekeeping gene 
          GOI-Gene of interest, whose expression is to be quantified 
 
2.  Delta-delta (Ct) values were calculated as followed: 
          Ct= Ct (internal control or reference) – Ct (sample), where 
Internal control or reference is the arbitrary selected sample (most of 
the time undifferentiated or wild type) to which GOI expression levels 
are compared. 
 
3.  A fold change in gene expression levels relative to reference sample 
was calculated as followed: 
          Fold Change = N^
(Ct), where N is set as 2. 
          The  data  analysed  using  N  =  2  rather  than  the  calculated  primer 
efficiency  (table  2.3)  did  not  alter  the  results  presented  in  results 
chapters. Error bars are calculated using standard deviation from PCR 
triplicates reflecting well to well efficiency of PCR reaction.  
 
4.  For  statistical  analysis  to  compare  undifferentiated  cells  with 
differentiated cells, or wild-type with knockdown cells, a two sample 
equal  variance  Student’s  T-test  using  two-tailed  distribution  was Chapter 2    73 
applied  using  Microsoft  Excel.  P-values  below  0.001,  P<0.001  were 
marked in the results as * while P-values above 0.001, P>0.001, were 
marked as N.S (not significant). P-values were calculated for results in 
chapter  4  and  chapter  5.  Bonferroni  correction  was  applied  for 
undifferentiated  wild-type  with  knockdown  data  (n=6  genes,  total 
number of 6 genes in 2 biological replicates). The alpha value (α) was 
set as 0.01 (a 1 in 100 likelyhood of the observed change being due to 
chance),  and  the  value  of  0.0016  was  obtain  after  bonferroni 
correction,  α/n.  For significance  analysis,  P<  0.001  was  selected  for 
higher stringency. However, it can be argued that using the Bonferroni 
correction to lower the alpha value in this context is irrelevant as to 
the number of genes (n) tested is small.  
 
2.7 Immunofluorescence 
2.7.1 Immunofluorescence staining 
Immunofluorescence (IF) analysis in this project was carried out to study the 
distribution of HMGN proteins and the expression of neural and glia markers. 
The general protocol involving all antibodies is as follows.  
1.  Undifferentiated  P19  EC  cells  were  seeded  on  a  4-well  Lab-Tek™  II 
chamber slide at 4.5 X 10
5 cells per slide, one day before fixing the cells 
for IF analysis. For IF analysis in neural differentiation, single cells from 
EBs were plated at 4.5-4.8 X 10
6 cells and later fixed at the sampling time-
points (days 3, 6, 9). For hippocampal neuron staining, cells were provided 
at day 18 culture grown on cover slips in 6-well plates. 
2.  Cells from all the conditions were washed twice with 1 X PBS solution and 
fixed with 4% paraformaldehyde for 30 minutes at RT. 
3.  Cells  were  then  washed  very  gently  to  remove  any  excess 
paraformaldehyde using 1 X PBS. This step is repeated 5 times. Chapter 2    74 
4.  To  quench  any  excess  aldehyde  components  in  the  fixed  cells,  50  mM 
ammonium chloride solution for 10 minutes at RT. 
5.  This first quenching step is followed by the second quenching step by using 
20 mM fresh glycine solution for 10 minutes at RT. 
6.  The fixed cells were washed with 1 X PBS and incubated in blocking buffer 
( 2.5% BSA, 0.3% Triton in 1 X PBS) for 1 hour at RT. 
7.  The  samples  were  then  incubated  with  individual  primary  antibodies 
diluted in blocking solution for 1 hour at RT. The table below shows the 
dilution for the primary antibodies used. 
Primary Antibodies  Dilution 
HMGN1  1:1000 
HMGN2  1:1000 
mHMGN3a (detects HMGN3a)  1:5000 
2752 (detects both HMGN3a and HMGN3b)  1:10,000 
OCT4  1:500 
MAP2  1:200 
NF-160 kDA  1:500 
GFAP  1:200 
 
8.  The samples were then washed 5 times using 1 X PBS + 0.1% Triton. 
9.  The  samples  were  then  incubated  with  corresponding  Alexa  Fluor 
(Invitrogen) secondary antibodies that were prepared at a dilution of 
1:1000 in blocking solution.  
10.  The samples were then washed 5 times using 1 X PBS + 0.1% Triton. 
11. One final wash was done in dH2O and the slides were mounted with 
cover  slips  using  Prolong®  Gold  (Invitrogen)  containing  the  blue-
fluorescent nuclear counter stain DAPI. Slides were left to dry in the 
dark at RT. Chapter 2    75 
12.  Slides were then stored either in 4⁰C for short term or -20⁰C for up to 
4 weeks before analysing images. 
 
2.7.2 Immunofluorescence image analysis 
IF images were taken using Olympus (IX51) microscope at 40 X objective using 
filters corresponding to the wavelength of the Alexafluor-tagged secondary 
antibodies. The exposure time was manually set and at least 10-30 field of 
images  were  taken  for  one  sample.  The  images  were  then  analysed  using 
ImageJ software.   76 
 
Chapter 3 
Optimisation and characterisation of Retinoic 
acid-induced P19 neuronal differentiation 
 
 
3.1 Introduction  
The mammalian central nervous system consists of many subtypes of neurons 
and  glia  cells.  Neurogenesis  is  a  differentiation  program  defined  by  the 
successive development  of  neural  progenitor  cells,  which  then give  rise to 
neurons,  glia/astrocytes  and  oligodendrocytes.  Elucidating  the  mechanism 
involved in neurogenesis is essential to understanding the development of the 
central nervous system. Various model systems are used to study neuronal 
differentiation  especially  those  derived  from  pluripotent  ES/EC/EG  cells. 
Pluripotent  ES/EC/EG  cells  are  undifferentiated  cells  that  possess  the 
capacity  to  differentiate  into  endoderm,  ectoderm  and  mesoderm  in  vitro 
under appropriate culture conditions or specific chemical inducers. RA is a 
known chemical inducer that triggers the ectoderm lineage commitment of 
pluripotent ES/EC/EG cell in vitro.  
P19  EC  cells  induced  with  RA  generate  specific  type  of  neurons  and  glia 
(Runnicki  and  McBurney,  1987;  Jones-Villeneuve  et  al.,  1982).  Upon  RA 
induction, undifferentiated P19 EC cells through the formation of EBs give rise 
to neuronal and glia cells that mimic the developmental process occurring in 
vivo (Bain et al., 1995; Wobus et al., 1994; Staines et al., 1994; Morassuti et 
al., 1994; Runnicki and McBurney, 1987; Jones-Villeneuve et al., 1982). The in 
vitro  differentiation  capacity  of  P19  EC  cells  have  been  previously 
characterised  using  neuron  and  glia  specific  markers  by  several  groups 
(Zhongqiu  Xie  et  al.,  2010;  Zhigang  Jin  et  al.,  2009;  Yi  Wey  et  al.,  2002; 
McBurney, 1993; Johnson et al., 1992; McBurney and Rodgers, 1982; Jones-
Villeneuve et al., 1982).  
One of the protocols that are often used in inducing neural commitment in 
P19 EC cells is the RA-induce formation of EBs in suspension. The RA-induced Chapter 3    77 
EB  formation  protocol  for  neuronal  differentiation  is  particularly  good  for 
producing neurons since it takes a shorter time to generate neuronal cultures 
compared to other methods that do not utilise EB formation. This protocol 
normally utilises a ‘+2  -2’ procedure that involves two stages (Figure 3.1).  
The first stage is called the suspension stage to form neuroectodermal EBs 
followed by an adherent stage where the cells are further differentiated to 
formed functional neurons and glia. At this point the cells form committed 
neuroectodermal  EBs  that  are  then  seeded  in  adherent  culture  to  further 
differentiate (stage 2).  
The  characterisation  of  RA-induced  P19  neuronal  differentiation  is  often 
carried  out  using  gene  markers  specific  to  neuronal  and  glia  cell  types. 
Although  this  model  system  has  been  previously  described,  there  are 
variations  in  the  protocol  that  may  alter  the  outcome  of  neuronal 
differentiation.  
The aims of this chapter are to address crucial factors and steps in the RA 
protocol  in  generating  a  more  robust  system  in  producing  neuronal 
differentiation from P19 EC cells.  
 
3.2 Objectives 
1.  To optimise key steps of RA-induced P19 neuronal differentiation: 
(a) Analyse the pluripotent state of ‘early and late’  undifferentiated 
cells in culture using molecular marker Nanog. 
(b) Study the optimal RA concentration required for increased neuronal 
differentiation capacity based on Nanog and Map2 markers. 
(c) Study  the  optimal  seeding  density  for  EBs  required  for  increased 
neuronal  differentiation  capacity  based  on  Mash1  and  Mash2 
markers.  Chapter 3    78 
2.  To characterise the P19 neuronal differentiation model system using a 
cohort of markers specific to undifferentiated cells, neural progenitors, 
neuronal and glia cells.   
 
 
Figure 3.1: An outline of the RA-induced P19 neuronal differentiation 
model system.   
Undifferentiated cells were treated with RA for 2 days in suspension before 
removing  the  RA  by  changing  the  media  and  left  for  another  2  days  in 
suspension to form neuroectodermal EBs. EBs were then plated in adherent 
cultures for neuronal differentiation.  
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3.3 Analysis of Nanog expression to determine 
pluripotency in subcultured P19 undifferentiated 
cells 
P19 EC cells can be maintained in their undifferentiated state  in vitro and 
induced to achieve directed differentiation of all three germ layers (Martin, 
1980).  Due  to  the  innate  ability  of  EC/ES/EG  cells  to  differentiate,  the 
maintenance of their pluripotent state in culture is critical. Undifferentiated 
mouse ES cells grow in rounded colonies with well defined edges as opposed 
to  their  differentiated  counterparts  that  appear  as  individual  cells  with  a 
flattened  morphology  (Brook  and  Gardner,  1997).  In  order  to maintain the 
undifferentiated state, mouse ES cells are grown in sub- confluent density and 
routinely passaged every 2-3 days (Matise et al., 2000; Tompers and Labosky, 
2004). Undifferentiated P19 EC cells grow in a monolayer and are cultured at 
higher densities compared to mouse ES cells. At low densities, P19 EC cells 
differentiate spontaneously and therefore are always cultured approximately 
at a cell confluency of 70-80% (Rudnicki and McBurney, 1987).  In order to 
assess  the  pluripotency  state  of  mouse  ES/EC/EG  cells,  several  features 
including  morphological  conditions,  expression  of  surface  markers  such  as 
stage-  specific  embryonic  antigen  SSEA-3,  and  expression  of  several 
pluripotency associated transcription factors such as Oct4, Nanog and Sox2 
have been employed (Andrews et al., 1996; Niwa et al., 2000; Lebkowski et 
al., 2001).  
P19 EC  cell line (passage 14)  used in this research were obtained from Dr 
Andrew Hamilton (University of Glasgow). The passage number was re-set to 
passage 0 (passage 14 = passage 0). The relative RNA expression of stem cell 
marker Nanog was analysed using RT-PCR to determine the pluripotent state 
of P19 EC cells. Nanog, a homeodomain protein, is a transcription factor that 
regulates  the  expression  of  a  set  of  target  genes  involved  in  ES  cell 
pluripotency and is drastically down-regulated upon differentiation (Mitsui et 
al., 2003). Nanog expression in undifferentiated P19 EC cells was monitored 
between passages 2 (early) to 10 (late) (Figure 3.2). The cells in the different 
passages were seeded at similar densities and had near similar cell confluency 
of 70-80% on sampling time-points.  Chapter 3    80 
 
Figure 3.2: Expression of the pluripotecy marker Nanog decreases with 
passage number for undifferentiated P19 EC cells.  
RNA levels are normalised using Gapdh as the control housekeeping gene and 
shown relative to P2 levels. Error bars reflect standard deviation from three 
RT-PCR reaction replicates.  
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A gradual decline in Nanog expression was observed, and that by passage 8, 
the  expression  was  reduced  by  50%.  This  suggests  a  gradual  decrease  in 
pluripotency state of undifferentiated P19 EC cells with time in culture.  
However,  the  cells  in  passage  8  and  10  showed  morphology  similar  to 
undifferentiated  EC  cells  and  in  passage  2-  6.  Besides  that,  there  was  no 
evidence  of  the  cells  in  passage  8  and  10  showing  commitment  to  the 
ectodermal  lineage  when  they  were  subjected  to  qRT-PCR  with 
oligonucleotide primers specific to the ectodermal marker gene Nestin (data 
not  shown).  Taken  together,  although  the  cells  in  the  later  stage  of  the 
culture (P8-P10) showed a drop in Nanog RNA levels, they did not display the 
morphology or lineage- specific gene expression that represents ectodermal 
commitment. Nevertheless, to avoid variation that could be caused by the 
drop in Nanog RNA levels, differentiation experiments using undifferentiated 
P19 EC cells were conducted between passage 4 and 6. Further confirmation 
of the pluripotency state between “early and late” stage of undifferentiated 
P19 EC cell could be investigated by RNA expression profiling of other stem 
cell specific genes such as Oct3/4, Sox2, and Rex1. Besides that, cells from 
passage 10 could be subjected to directed differentiation in vitro to analyse 
the lineage specific reprogramming capacity compared to cells from passage 
2.   
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3.4 Retinoic acid dosage determines the rate of 
neuronal differentiation in P19 EC cells.  
Retinoic  acid  (RA)  signalling  and  regulation  is  essential  for  embryonic 
development and cellular differentiation (Clagett-Dame and De Luca, 2002; 
Ross et al. 2000). In the developing nervous system, RA has shown to play 
crucial roles in patterning of the neural plate and neuronal differentiation 
(Liu et al., 2001; Glover et al., 2006 Jones-Villeneuve et al., 1982). Mouse 
EC/ES/EG cells can be induced with RA to differentiate into neurons in vitro 
(Rohwedel et al., 1999; Jones-Villeneuve et al., 1982). RA-induced neuronal 
differentiation protocols mostly rely on the formation of floating aggregates 
called  embryoid  bodies  (EBs)  which  gives  rise  to  neuroectodermal  cells 
(Mansergh  et  al.,  2009;  Okabe  et  al.,  1996;  Bain  et  al.,  1995).  These 
programmed EBs are then plated in adherent culture to further differentiate 
into  specific  neuronal  cells  that  include  Glutamatergic,  GABAergic, 
motorneurons, interneurons and dividing glial cells (Sanalkumar et al., 2010; 
Kaomei Guan et al., 2001). EC/ES/EG derived neuronal cells expressed neuron 
specific  genes  in  a  developmentally  controlled  manner  (Jung  et  al.,  2010; 
Kaome  Guan  et  al.,  2001).  Genes  such  as  Neurofilament  68  kDa  (NFL), 
Neurofilament 160 kDa (NFM) and Microtuble- associated protein 2 (Map2) are 
expressed early in the EBs as compared to genes involved in the formation of 
neural  specific  receptors  such  N-methly-D-  Aspartate  (NMDA)  and  Gamma-
aminobutyric acid  (Sanalkumar et al., 2010; Rohwedel et al., 1999; Strübing 
et al., 1995). Undifferentiated P19 EC cells induced with RA differentiate into 
neurons  and emulate  the expression  profile  of  neuronal cells  derived  from 
ES/EG cells (Teets et al., 2011, Zhongqiu Xie et al., 2010, Jones-Villeneuve et 
al., 1982).  
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Figure 3.3: Retinoic acid concentration affects the efficacy of neuronal 
differentiation  
RNA expression is normalised to Gapdh and shown relative to undifferentiated 
cells. (a) & (b) Nanog and Map2 RNA expression of EBs treated with 0.5 µM, 
1.0 µM and 1.5 µM RA. (c) & (d) Expression of Nanog and Map2 RNA in day 3 
and day 6 neural differentiation from EBs treated with 0.5 µM, 1.0 µM and 1.5 
µM  RA.  Error  bars  reflect  standard  deviation  from  three  RT-PCR  reaction 
replicates. Neuronal differentiation was conducted using the same batch of 
undifferentiated P19 EC cells. 
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The rate of neuronal differentiation in P19 EC cells is RA dosage- dependent 
(Edwards and McBurney, 1983). P19 aggregates exposed to doses of RA in the 
range of 0.1 µM- 1.0 µM were capable of generating neuron and glia cells. The 
concentration of RA used in P19 neuronal differentiation studies mostly vary 
between 0.1 µM and 0.5 µM. To determine the optimal concentration of RA 
required for efficient programming of undifferentiated P19 EC cells to neurons 
and glia, P19 aggregates were treated with increasing amount of RA (0.5 to 
1.5 µM) and subjected to qRT- PCR to analyse expression of Nanog pluripotent 
marker  and  Map2  neuronal  marker.  Optimal  RA  concentration  is  selected 
based  on  aggregates  that  demonstrate  increased  expression  of  Map2  in 
parallel to the loss of Nanog signalling relative to undifferentiated cells. 
P19 EC cells were differentiated into neurons using the protocol described in 
section 2.4.3. Briefly, a single batch of undifferentiated cells were grown in 
suspension and separately treated with increasing concentrations of RA from 
0.5 µM to 1.5 µM. The EBs formed were trypsinised and plated at 3.5 X 10
6 
cells in adherent culture for 3 or 6 days. RNA was isolated from EBs, D3, D6 
and undifferentiated cells.  For qRT-PCR, cDNA prepared from isolated RNA 
was  amplified  using  oligonucleotide  primers  specific  to  Nanog,  Map2  and 
Gapdh (housekeeping gene). Normalised Nanog and Map2 RNA levels in EBs, 
day  3  and  day  6  of  neuronal  differentiation  were  calculated  relative  to 
undifferentiated cells (Figure 3.3). Nanog RNA levels were dramatically down-
regulated  in  EBs  treated  with  0.5,  0.1  and  1.5  µM  RA,  relative  to 
undifferentiated  cells  (Figure  3.3a).  The  loss  of  Nanog  expression  in  EBs 
treated with three different dosages was similar suggesting that a minimum 
0.5uM RA to be sufficient in inducing the silencing of Nanog transcription in 
EBs.  Conversely,  the  rate  of  neuronal  differentiation  based  on  Map2 
expression  showed  a  RA  dose-dependent  fold  increase  in  EBs  relative  to 
undifferentiated cells (Figure 3.3b). EBs treated with 1.5 µM RA showed the 
highest fold increase of 7000 compared to 5000 and 4000 for EBs treated with 
1.0 µM and 0.5 µM respectively.  
In attempt to determine neuronal differentiation capacity of the EBs treated 
with 0.5-1.5 µM RA, EBs were plated and allowed to differentiate for 6 days. 
Map2  neuronal  marker  expression  was  analysed  to  determine  the  rate  of Chapter 3    85 
differentiation. For the purpose of discussion, the different samples in this 
experiment are defined using the time-point and the RA concentration used, 
for an example, day 3 cells derived from 0.5 µM RA will be denominated as D3 
(0.5RA). Rather surprisingly, D3 (0.5RA) and D6 (0.5RA) showed re-emergence 
of Nanog pluripotent marker (Figure 3.3c). The RNA levels of Nanog at D3 
(0.5RA)  and  D6  (0.5RA)  were  4  and  1.8  folds  lower  compared  to 
undifferentiated cells. The expression of Nanog in D3 (1.0RA & 1.5RA) and D6 
(1.0  &  1.5RA)  had  decreased  to  levels  below  10  folds  compared  to 
undifferentiated cells. 
Map2 neuronal marker analysed in day 3 and day 6 cultures provide evidence 
that  EBs  treated  with  1.0  µM  and  1.5  µM  RA  had  higher  neuronal 
differentiation  capacity  compared  to  EBs  treated  with  0.5  µM  RA  (Figure 
3.2d).  Map2  RNA  levels  in  D3  (0.5RA)  demonstrated  a  fold  increase  of  70, 
compared to the 130 fold increase achieve in D3 (1.5RA). Similarly, D6 (1.0RA) 
showed approximately 160 fold induction in Map2 RNA levels compared to 50 
fold induction in D6 (0.5RA). D3 (1.0RA) showed higher expression of Map2 
compared to D3 (1.5RA) suggesting that the latter dosage had increase the 
capacity of neuronal differentiation. 
These  findings  demonstrate  a  correlation  between  the  RA  concentrations 
required  for  programming  of  neuronal  differentiation.  Efficient  neuronal 
differentiation  based on  the  loss  of  Nanog  expression and up-regulation  of 
Map2 was achieved with 1.0 µM and 1.5 µM RA. Undifferentiated cells treated 
with 0.5 µM RA had characteristics of neural-lineage commitment in EBs, but 
express Nanog when further differentiated in culture. In this experiment, cells 
treated  with  2.0  µM  and  2.5  µM  RA  had  proved  to  be  toxic  and  induced 
enormous cell death. EBs programmed with RA concentration of 2.0 µM and 
2.5 µM when plated had failed to further differentiate let alone survive in 
culture.  
Both  RA  dosages  of  1.0  µM  and  1.5  µM  demonstrated  higher  efficacy  in 
inducing neuronal differentiation compared to 0.5 µM. The RA dosage of 1.5 
µM had slightly higher efficiency in inducing neuronal differentiation based on 
Map2 expression. However, the RA concentration of 1.0 µM was used in all Chapter 3    86 
subsequent neuronal differentiation experiments for few reasons. Firstly, the 
RA concentration of 1.0 µM was selected so that the results obtain here could 
be compared to the studies in the literature that utilise the similar RA dosage 
in inducing neuronal differentiation. Secondly, the results obtained here are 
conducted only using one neuronal marker (Map2) and this may not signify the 
overall rate of neuronal differentiation. 
                                                                
3.5 Mash1 and Mash2 reciprocal expression analysis 
used in determining optimal seeding density for 
neuronal differentiation 
Since  the  introduction  of  P19  in  vitro  model  system,  various  studies  were 
conducted in characterizing RA-induced neuronal differentiation and could be 
assume as a well established and widely used protocol. However, one key area 
of the protocol that is unclear is the density of cells from RA programmed EBs 
that  needed  to  be  plated  in  adherent  culture  for  the  differentiation  and 
maturation  of  neurons.  In  RA-induced  P19  EC  neuronal  differentiation 
protocol, EBs are formed in suspension for 4 days to derived neuroectodermal 
committed cells. These EBs are then trypsinised and plated as single cell in 
adherent culture, a step often referred to as “plating of EBs or aggregates”. 
The plating density in previous reports varies between groups or is most often 
left unstated. To study whether the cell density at plating is crucial in RA-
induced neuronal differentiation protocol and also to determine the optimal 
cell density, single cells derived from EBs were seeded at varying densities 
and  examined  for  morphological  differences  and  analysed  for  Mash1  and 
Mash2 RNA expression.  
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Figure 3.4: Plating density affects the efficacy of neuronal differentiation 
as assayed by Mash1 and Mash2 expression.  
RNA  expression  is  normalised  to  Gapdh  and  showed  relative  to 
undifferentiated cells. (a) & (b) Mash1 and Mash2 RNA expression in day 3 and 
day 6 neural differentiation derived from EBs seeded using 3.5 X 10
6, 5.5 X 10
6 
and 7.5 X 10
6 cells. Error bars reflect standard deviation from triplicates of 
RT-PCR reaction. 
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P19 EC cells were differentiated into neurons using the protocol described in 
section 2.4.3. Briefly, cells were treated with 1.0 µM RA in suspension for 4 
days to form EBs. EBs were then trypsinised and seeded in adherent culture at 
densities ranging from 1.5 X 10
6 to 9.5 X 10
6 per 10 cm tissue culture dish. 
Five different cell densities were tested; 1.5 X 10
6, 3.5 X 10
6, 5.5 X 10
6, 7.5 X 
10
6 and 9.5 X 10
6. Neuronal cultures from cells seeded at 1.5 X 10
6 failed to 
survive and by day 2 had severe cell death (data not shown). On the contrary, 
cultures seeded at 9.5 X 10
6 cells, although they showed neuronal morphology 
as early as 16 hours after plating had become confluent by the beginning of 
day  2.  If  not  passaged  at  this  point,  the  cells  failed  to  survive  and 
demonstrated enormous cell death. Neuronal cultures derived from EBs plated 
at  3.5  X  10
6,  5.5  X  10
6  and  7.5  X  10
6  showed  proper  differentiation  into 
neuronal cell types (data discuss below).   
Two key morphological cues including average axon length and time-scale of 
non-neuronal  dividing  cell  appearing  in  culture  was  carefully  observed  to 
discriminate between cultures seeded at 3.5 X 10
6, 5.5 X 10
6 and 7.5 X 10
6. In 
general, axon length is a characteristic of culture differentiating into neuronal 
cell types. Whereas the time-scale in which dividing cells appear in culture 
can  be  explained  by  previous  studies  that  show  RA-induced  P19  EC  cells 
differentiate into neurons in a developmentally dependent manner (Bain and 
Gottlieb, 1994; Runnicki and McBurney, 1987; Jones-Villeneuve et al., 1982). 
Neuronal differentiation of P19 EC cells develop in two stages. First is the 
post-mitotic cell stage which includes predominantly neuronal cells in culture 
followed by dividing cell stage which consist of non-neuronal cell such as glia 
and  possibly  neural  progenitor  cells.  The  average  axon  length  between 
cultures seeded at 3.5 X 10
6, 5.5 X 10
6 and 7.5 X 10
6 is almost similar to each 
other in both day 3 (Figure Appendix 1). However, the time-scale in which 
dividing cells appear in culture vary significant between the different plating 
densities. Neuronal culture seeded at 3.5 X 10
6 had dividing cells appearing 
from day 4-5 onwards. Whereas dividing cells in both cultures seeded at 5.5 X 
10
6 and 7.5 X 10
6 became visible as early as day 3 (data estimated by eye). 
These disparities in the neuronal differentiation suggested that the seeding 
density of EBs could be crucial in determining directed neurogenesis in vitro.  Chapter 3    89 
Mash1 and Mash2 are mammalian homologues of the Drosophilla achaete-scute 
genes  that  encodes  for  the  basic  helix-loop-helix  family  of  transcription 
factors (Johnson et al., 1990). In Drosophilla, these proteins are required for 
the  development  of  neurons  in  the  central  and  peripheral  nervous  system 
(Ghysen and Dambly-Chaudiere, 1988). MASH1 is expressed in a subset of cells 
in  the  central  and  peripheral  nervous  system  during  rat  embryonic 
development (Lo et al., 1991). In P19 EC cells, Mash1 mRNA is undetectable in 
undifferentiated  cells  but  is  expressed  to  high  levels  upon  RA  induction 
coinciding  with  neuronal  differentiation  (Bain  et  al.,  1994;  Johnson  et  al., 
1992). In contrast, Mash2 mRNA is expressed in undifferentiated cells and is 
dramatically down-regulated upon RA treatment (Johnson et al., 1992). Thus, 
the  reciprocal  expressions  of  Mash1  and  Mash2  in  P19  system  are  relevant 
molecular markers when studying RA-induced neuronal differentiation.  
To determine optimal seeding densities, RNA levels of Mash1 and Mash2 were 
analysed.  cDNA  was  generated  from  RNA  obtained  from  day  3  and  day  6 
cultures and cDNAs were subjected to qRT-PCR for primers specific to Mash1 
and Mash2. Normalised Mash1 and Mash2 RNA levels in day 3  and day 6 of 
neuronal differentiation are shown relative to undifferentiated cells (Figure 
3.4).  Mash1  RNA  was  induced  by  approximately  100  fold  at  day  3  neural 
differentiation from cultures seeded at 3.5 X 10
6, 5.5 X 10
6 and 7.5 X 10
6 
(Figure 3.4a). Mash1 RNA levels in day 6 were induced to up to approximately 
250 fold from the three different seeding densities. Similar levels of Mash1 
induction suggest that the three different seeding densities support neuronal 
differentiation to similar extent.  
However,  the  analysis  of  Mash2  RNA  demonstrated  increased  expression  in 
neuronal cultures seeded at higher density (5.5 X 10
6 and 7.5 X 10
6) compared 
to the lower density of 3.5 X 10
6 (Figure 3.4b). These results suggest that the 
seeding density of 3.5 X 10
6 produces a neuronal culture that is more highly 
committed to neural differentiation due to its low expression of Mash2. In 
contrast neuronal cultures seeded using 5.5 X 10
6 and 7.5 X 10
6 contains a sub-
population of cells that are still expressing Mash2 albeit at lower levels than 
undifferentiated  cells.  These  results  not  only  established  an  optimal  EBs 
seeding density that is required for a controlled and directed differentiation Chapter 3    90 
but also highlighted the crucial step in RA-induced neuronal differentiation 
protocol.  
 
3.6 Characterisation of retinoic acid induced P19 
neuronal differentiation  
3.6.1 Pluripotent markers Oct4, Nanog and Sox2 are down-
regulated upon retinoic acid induction 
Several  markers  including  surface  markers,  intracellular  markers  and 
transcription factors have been used to characterise mouse EC/ES/EG cells. 
The analysis  of these  markers is  used  to  identify  the  “state” of  EC/ES/EG 
cells,  thus  allowing  accurate  categorisation  of  the  cells  into  the 
undifferentiated state or committed lineages such as endoderm, mesoderm 
and ectoderm. Among the commonly used markers are transcription factors 
that have been shown to regulate the state of EC/ES/EG cells.  OCT4, NANOG 
and SOX2 are transcription factors that are crucial for the maintenance of the 
pluripotent  state  (Chambers  et  al.,  2007;  Masui  et  al.,  2007;  Niwa  et  al., 
2000). The inactivation of this transcription factor network has been linked to 
the  loss  of  the  pluripotent  state  and  aberrant  differentiation  of  EC/ES/EG 
cells (Avilion et al., 2003; Mitsui et al., 2003; Nichols et al., 1998).  
OCT4 (Pou5f1) is grouped into the Octamer class of TF that regulate target 
genes that are involved in pluripotency (Boyer et al., 2005). SOX2 is a member 
of the High mobility group (HMG) box DNA binding protein family, and acts as 
co-activator  for  Oct4  in  targeting  pluripotency  related  genes  (Niwa,  2001; 
Ambrosetti  et  al.,  1997).  NANOG  is  a  homeobox  domain  TF  that  is  closely 
regulated by the binding of OCT4/SOX2 to its promoter sequence and plays a 
role  in  BMP  dependent  signalling  in  regulating  pluripotency  (Suzuki  et  al., 
2006).  
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Figure 3.5 Oct4 RNA and protein are highly expressed in undifferentiated 
cells and are loss upon RA-induced neuronal differentiation.  
(a) Oct4 RNA expression during P19 neuronal differentiation. RNA levels are 
normalised using α-tubulin and shown relative to undifferentiated cells. Error 
bars reflect standard deviation between three RT-PCR reaction replicates. (b) 
Immunofluorescence staining of OCT4 during neuronal differentiation. (c) No 
primary  (but  Alexa  Fluor  596  Goat  anti-Rabbit)  and  secondary  (but  OCT4) 
antibodies controls conducted in undifferentiated cells. Scale bar, 20 µM. 
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Figure 3.6 Nanog and Sox2 expressions are down-regulated upon RA-
induced neuronal differentiation. 
Expression  levels  are  normalised  using  Gapdh  as  the  control  housekeeping 
gene  and  expressed  relative  to  undifferentiated  cells.  Error  bars  reflect 
standard deviation between three technical RT-PCR reaction replicates. 
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All three OCT4, SOX2 and NANOG share similar expression profiles in which 
they are found to be expressed highly in pluripotent cells of embryo and cell 
lines  derived  from  thereof and  are  markedly  down-regulated  upon  somatic 
differentiation into committed lineages. This expression pattern allows them 
to be used as molecular markers in studying pluripotent versus differentiated 
cells.  
The expression of OCT4, NANOG and SOX2 were analysed in RA-induced P19 
neural differentiation. The differentiation protocol was carried out following 
the  similar  RA  2+  2-  model  with  incorporation  of  the  optimised  conditions 
described above. Briefly, P19 EC cells from passage 4-6 was treated with 1.0 
µM RA in suspension for 2 days before replacing the media and allowing the 
formation of neuroectodermal EBs for another 2 days in suspension.  EBs were 
than seeded at 3.5 X 10
6 in adherent culture and allowed to differentiate for 
nine days. RNA isolated from day 3, day 6 and day 9 was used to generate 
cDNA and subjected to qPCR analysis. For qRT-PCR, primers specific to Oct4, 
Nanog and Sox2 were analysed. Both Gapdh and α-tubulin were individually 
used as normaliser and both sets of data were comparable. Protein expression 
of  one  of  the  markers  was  confirmed  using  immunofluorescence  with  an 
antibody specific to OCT4.  
Oct4 RNA and protein levels in RA-induced P19 neuronal differentiation are 
shown in Figure 3.5a. As expected,  Oct4 RNA was high  in undifferentiated 
cells  and  was  lost  upon  RA-induced  neuronal  differentiation.  OCT4  protein 
expression reflects the mRNA in being  highly expressed in undifferentiated 
cells and undetectable upon neuronal differentiation (Figure 3.5b). Likewise 
the RNA expression of Nanog and Sox2 was down-regulated upon RA induction 
(Figure  3.6).  The  expression  of  Oct4,  Nanog  and  Sox2  demonstrates  the 
pluripotent state of undifferentiated P19 EC cells. Upon RA-induced neuronal 
differentiation, the loss of all three pluripotent markers suggests the cells in 
day 3, day 6 and day 9 have undergone lineage-specific commitment. These 
results also suggest that the cultures at day 6 and 9, although heterogeneous 
had eliminated any subset of undifferentiated cells that may interfere in the 
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3.6.2 RA- induced P19 EC expressed markers specific to 
neurons and glia 
P19 EC cells treated with RA differentiate into neural progenitors, neuron and 
glia (Bain et al., 1994; Jones-Villeneuve et al., 1983). Identification of neural 
subtypes and glia generated in vitro rely on the use of cell specific molecular 
markers.  However,  the  dependence  on  the  markers  has  its  limitation.  For 
instance,  Nestin  which  is  a  good  marker  for  neural  progenitors  is  also 
expressed  in  differentiated  non  neural  cells.  The  expression  patterns  of 
markers are also shown to be markedly different between RNA and protein. 
For example, RNA levels of NF-160 kDa (NFM) are detected as early as in EBs 
and Day 1 after plating but the proteins are only detected in the later stages 
of  neural  differentiation  (Kaomei  Guan  et  al.,  2001).  Hence,  a  cohort  of 
markers  (RNA  and  protein)  in  combination  with  morphological  indicators  is 
required to determine cell types. Besides that, it is critical to include markers 
that are known to be absent.  
For the characterisation RA-induced P19 neuronal differentiation culture, a 
set of markers pertaining to neural progenitors, differentiated neuron and glia 
were  analysed.  The  markers  used  are  categorised  based  on  their  function 
(Table 3.1). The RNA sample used to study the expression these genes was 
similar to that use for Oct4 analysis (section 3.6.1).  
Table 3.1: List of neuronal markers used in the characterisation of RA-
induced P19 neuronal differentiation.  
Markers  Cellular Function  Cell type 
Microtubule-Associated Protein 2 
(Map2) 
Cytoskeleton  Neuron 
Neurofilament-160 kDa (NFM)  Cytoskeleton  Neuron 
Nestin  Cytoskeleton  Neuron progenitors 
Neuron-specific Enolase (NSE)  Metabolising enzyme  Differentiated 
Neurons 
N-Methyl-D-Aspartic Acid 
receptor (NR2a) 
Neurotransmitter 
receptor 
Differentiated 
Neurons 
Glial-Fibrillary acidic protein 
(GFAP) 
Cytoskeleton  Glia 
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3.6.2.1  Map2 RNA and protein is expressed in P19 neuronal differentiation 
Map2 is member of the MAP/Tau family that possess microtubule stabilising 
activity along with the role of regulating microtubule networks in the axon 
and dendrites of neurons (Felgner et al., 1997; Weisshaar et al., 1992).  Map2 
exists in three isoforms called Map2a, Map2b and Map2c depending on their 
amino-terminal projection domain. Map2c is the predominant form and has a 
shorter  amino-terminal  domain  than  Map2a  and  Map2b  (Kalcheva  et  al., 
1995).  In  vivo,  the  expression  of  MAP2  is  mainly  neuronal,  but  MAP2 
immunoreactivity  is  also  observed  in  non-neuronal  oligodendrocytes.  MAP2 
expression is detected in the early stages of neuronal development and in 
adulthood,  concurrent  with  the  expression  of  neuron-specific  α-tubulin 
(Menezes  and  Luskin,  1994).  MAP2  is  known  to  segregate  into  nascent 
dendrites after axonogenesis and as a result it is localised in the cell bodies 
and  dendrites  of  mature  neurons  (Matus,  1990).  In  vitro  EC  neuronal 
differentiation  using  RA  showed  expression  of  Map2  RNA  in  the  early 
differentiation  stage  followed  by  a  lag  phase  before  the  presence  of  the 
protein (Xu et al., 2011).  
To  determine  whether  RA-induced  P19  cells  differentiate into  neurons  and 
express neuron specific markers, qRT-PCR and Immunofluorescence to study 
Map2 RNA and protein levels were carried out. For qRT-PCR analysis of Map2, 
primers were design against a target mRNA region that is specific to all three 
Map2  isoforms.  Similarly,  immunoreactivity  of  MAP2  antigen  was  detected 
using antibody that recognises all three isoforms. Map2 RNA and protein levels 
in  differentiating  P19  cultures  are  shown  relative  to  undifferentiated  cells 
(Figure  3.7).  MAP2  was  induced  by  30  fold  in  day  3  neural  differentiation 
compared to undifferentiated cells suggesting that the culture is committed 
to the neural-lineage.  
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Figure 3.7: Map2 expression is induced to high levels upon neural 
commitment from undifferentiated P19 EC cells.   
(a) Map2 RNA expression during P19 neuronal differentiation. RNA levels are 
normalised using α-tubulin and shown relative to undifferentiated cells. Error 
bars reflect standard deviation between three RT-PCR reaction replicates. (b) 
Immunofluorescence staining of MAP2 during neuronal differentiation. (c) No 
primary  (but  Alexa  Fluor  596  Goat  anti-Rabbit)  and  secondary  (but  MAP2) 
antibodies controls conducted in day 6. Scale bar, 20 µM. Chapter 3    97 
To analyse MAP2 protein expression, immunofluorescence was conducted in 
the differentiating P19 cultures (Figure 3.7b). The cells were fixed for MAP2 
staining concurrent with RNA isolation used in the qRT-PCR analysis. Controls 
to determine cross-reactivity absence of antibodies were done on day 6 neural 
differentiation  (Figure  3.7c).  MAP2  immunoreactivity  was  not  present  in 
undifferentiated  cells  and  is  only  detected  upon  RA  induction.  MAP2 
immunofluorescence  staining  was  found  to  be  strongest  in  day  6  culture 
compared  to  day  3  and  day  9.  These  results  although  demonstrate 
inconsistence between RNA and protein expression is in line with the evidence 
of Map2 expression in differentiating neurons derived from EC cells. Map2 RNA 
and protein expression in differentiating P19 cultures suggest the cells are 
undergone neural commitment upon RA induction.  
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3.6.2.2  NF-160  kDa and Nestin are expressed in P19 neuronal 
differentiation 
NF-160 kDa (NF-M), a member of the neurofilament family, plays a role in the 
assembly of neuronal filaments and in stabilising of axons, along with other 
intermediate  filament  proteins  (Walker  et  al.,  2001).  NF-160  kDa  is 
concomitantly  expressed  with  the  emergence  of  neurite  formation  in  the 
central nervous system (Nixon and Shea, 1992). In addition, the expression of 
NF-160 kDa was previously reported in differentiating neuronal cells derived 
from ES/EC cells (Kaomei Guan et al., 2001; Bain et al., 1996).  
To analyse whether RA- induced P19 differentiating cultures express NF-160 
kDA, qRT-PCR using specific primers to NF-160 kDa mRNA was performed. To 
validate the RNA expression, immunofluorescence using NF-160 kDA specific 
antibody was carried out. NF-160 kDA RNA is up-regulated upon RA induction 
in  differentiating  P19  cells  (Figure  3.8a).  The  RNA  levels  of  NF-160  kDA 
demonstrated a 1600 fold increase on day 3 neural differentiation compared 
to undifferentiated cells and decreased at day 6 and day 9.However, the RNA 
level  of  NF-160  kDA  on  day  9  is  still  250  fold  higher  from  that  seen  in 
undifferentiated cells. The RNA expression pattern of NF-160 kDA mirrors that 
of  Map2.  To  analyse  NF-160  kDA  protein  expression  in  P19  neuronal 
differentiation,  immunofluorescence  was  conducted  (Figure  3.8b).  NF-160 
immunoreactivity was not detected in undifferentiated P19 EC cells (Figure 
3.8b). Day 3 and day 6 showed positive staining for NF-160 kDa with the clear 
appearance of dendrites and axons. The results demonstrate RA-induced P19 
EC cells differentiate into neurons with appropriate cytoskeleton morphology. 
Another  key  question  that  arises  from  EC/ES/EG  derived  neuronal 
differentiation  is  the  identification  of  neural  progenitor  type  cells.  At  the 
early stage the most common NPC marker is Nestin (Wiese et al., 2004; Lee et 
al., 2000). Most studies classify Nestin as a marker for NSCs (Podgornyi, 2006; 
Savchenko et al., 2005; Wiese, 2004; Fukuda et al., 2003; Lee et al., 2000; 
Lendahl  et  al.,  1990),  whereas  some  studies  claim  Nestin  is  expressed  in 
differentiated cells, particularly astrocytes (Nakamura et al., 2003; Clarke et 
al., 1994).  Chapter 3    99 
 
 
 
Figure 3.8: NF-160 kDa is highly expressed in day 3 and 6 neural 
differentiation from undifferentiated P19 EC cell. 
(a) NF-160 kDa RNA expression during P19 neuronal differentiation. RNA levels 
are normalised using α-tubulin and shown relative to undifferentiated cells. 
Error  bars  reflect  standard  deviation  between  three  RT-PCR  reaction 
replicates.  (b)  Immunofluorescence  staining  of  NF-160  kDa  during  neuronal 
differentiation.  (c)  No  primary  (but  Alexa  Fluor  596  Goat  anti-Rabbit)  and 
secondary (but NF-160 kDa) antibodies controls conducted in day 3. Scale bar, 
20 µM.       Chapter 3    100 
 
Figure 3.9: Nestin neural progenitor marker is induced upon RA-induced 
neural differentiation from P19 EC cells  
RNA  levels  are  normalised  using  α-tubulin  and  shown  relative  to 
undifferentiated cells.  Error  bars  reflect  standard  deviation  between  three 
RT-PCR reaction replicates. 
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Nestin,  a  type  VI  intermediate  filament  protein  is  expressed  in  the 
development  of  the  central  nervous  system  and  found  mainly  in  neural 
progenitor  cells  (Wiese,  2004;  Zimmerman  et  al.,  1994).  In  vivo,  Nestin 
expression is detected in neuronal tissue during embryonic development, and 
in adult brain is localised to both neurons and glia (Dahlstrand et al., 1995; 
Hockfield  and  Mckay,  1985).  Nestin  expression  has  also  been  shown  to  be 
abundant  in  damaged  brain  tissue  and  various  nervous  system  tumors 
(Biagiotti et al., 2006; Kambara et al., 2005; Almqvist et al., 2002; Holmin et 
al., 2001; Kaya et al., 1999).  
ES cells initiate Nestin expression upon neural induction and up-regulate it 
during  neuronal  differentiation  (Smukler  et  al.,  2006).  In  contrast,  P19  EC 
cells  maintain  a  basal  level  expression  of  nestin  which  is  up-regulated 
immediately  upon  neural  commitment  (Jin  et  al.,  2006).  The  factors  that 
regulate nestin expression are not fully determined,  however Tanaka et al 
demonstrated that group B1/C Sox and class III Pou TFs interact synergistically 
to activate Nestin expression via its neural enhancer element (Tanaka et al., 
2004).  
The  RNA  levels  of  Nestin  is  normalised  to  α-tubulin  in  P19  neuronal 
differentiation  is  presented  relative  to  undifferentiated  cells  (Figure  3.9). 
Nestin is induced by 8 folds compared to undifferentiated cells. These results 
imply that RA-induced P19 EC cells give rise to neural progenitors. Although it 
has been reported that Nestin is also expressed in non-neural dividing cells in 
differentiation cultures, high nestin expression on day 3 where the culture is 
post-mitotic  suggest  that  the  cells  expressing  this  marker  are  most  likely 
neural progenitors (Jin et al., 2006; Lee et al., 2000). The interesting aspect 
of nestin RNA expression compared to all the other markers analysed, is the 
fact that the magnitude of RNA induction is the lowest. If the results of day 3 
were  to  be  analysed  separately,  Nestin  RNA  levels  demonstrated  a  fold 
increase of 8 whereas the markers such as NF-160 showed an up-regulation of 
1600 fold both compared to undifferentiated cells. This is due to the fact that 
Nestin  RNA  is  present  at  basal  levels  in  undifferentiated  P19  EC  cells 
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3.6.2.3  RA-induced P19 cells expressed neuron specific markers  NSE 
and NMDA receptor 
Having  shown  that  undifferentiated  P19  EC  cells  upon  RA  induction, 
differentiate into neurons based on Map2 and NF-160 kDa expression, the next 
step was to investigate whether these cells express genes required for normal 
neuronal function.  In order to address neuron functionality, markers specific 
to NSE and NMDA receptor were assayed.  NSE is a major glycolytic enzyme 
that  is  found  in  neurons  (Kato  et  al.,  1984).  The  expression  of  NSE  was 
previously  shown  to  play  a  role  in  synaptic  junction  processing  in  neurons 
(Whitehead et al., 1982).  
NMDA receptors play a role in the excitatory transport channel for the influx 
of Ca2+ ions and are crucial regulator of neuronal differentiation (Ghiani et 
al., 2007; Tozuka et al., 2005). NMDA receptors subunits are classified into 
NR1, NR2 and NR3. NR2 binds glutamate and consist of 4 different isoforms 
term NR2a-d. NR2 containing NMDA receptors have been previously reported 
to be expressed in P19 neuronal differentiation upon RA induction (Georgiev 
et al., 2008). Together, NSE and NMDA receptor markers provide evidence for 
neuron functionality in differentiating neuron culture. 
The RNA levels of Nse and NR2a are normalised to α-tubulin in P19 neuronal 
differentiation is presented relative to undifferentiated cells (Figure 3.10). 
Nse expression is up-regulated upon RA induction with maximum expression 
on day 6 and day 9. NR2a expression showed sharp increase from day 6 to day 
9.  The  striking  difference  between  Nse  and  NR2a  RNA  levels  with  other 
markers analysed is the later onset of expression. These results suggest that 
the neuronal cells derived from P19 EC cells show that cells are undergone 
appropriate differentiation and has taken up usual neural functionality. 
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Figure 3.10: Nse and Nmda receptor are expressed in the later stages of 
neural differentiation derived from P19 EC cells.     
RNA  levels  are  normalised  using  α-tubulin  and  shown  relative  to 
undifferentiated cells.  Error  bars  reflect  standard  deviation  between  three 
RT-PCR reaction replicates. 
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3.6.2.4  Glia cell marker is expressed in the later stage of RA- induced P19 
differentiation     
In developing central nervous system, the formation of glia/astrocyte cells is 
begins  after  the  development  of  neurons  (Sauvageot  and  Stiles,  2002). 
Similarly  the  manifestation  of  glia/astrocyte  cells  is  delayed  in  in  vitro 
neuronal differentiation of EC cells (Yi Wey et al., 2002). The most common 
marker used to identify glia/astrocyte cells is GFAP. GFAP is a member of the 
Class  III  Intermediate  filament  proteins  that  plays  a  role  in  maintaining 
glia/astrocyte  cell  integrity.  There  are  8  different  GFAP  isoforms  in  which 
GFAPα is the most predominant form.  
To  identify  the  presence  of  glia/astrocytes  in  RA-  induced  P19  neuronal 
differentiation,  Gfap  RNA  and  protein  levels  were  analysed.  For  RNA 
detection,  primers  specific  to  Gfapα  were  used  for  qRT-PCR  analysis.  The 
protein  expression  was  detected  using  immunofluorescence.  Gfap  RNA  and 
protein  levels  in  RA-induced  P19  neuronal  differentiation  are  shown  as 
comparison to undifferentiated cells (Figure 3.11). The RNA levels of Gfap are 
undetected  till  day  6  of  neural  differentiation  (Figure  3.11a).  From  day  6 
onward,  a  dramatic  up-regulation  is  observed  with  fold  increase  of  8000 
compared to undifferentiated cells. These results suggest that Gfap RNA is 
only induced in the later stages of P19 neuronal differentiation. In contrast, 
GFAP  is  barely  detected  in  any  of  the  neural  differentiation  time  points 
analysed (Figure 3.11b). Day 9 showed weak staining for GFAP of suggesting 
probably  that  glia/astrocyte  cells  starting  to  form  in  the  differentiation 
cultures. This result does not come as a surprise as previous studies in P19 
neuronal differentiation although showed the emergence of Gfap RNA, only 
showed the manifestation of the protein from day 14 neural differentiation 
onwards (Hádinger et al., 2009).  Chapter 3    105 
 
     
 
Figure 3.11: Gfap RNA levels are induced to high levels from day 6 
whereas the proteins are detected on day 9 of P19 neural differentiation. 
(a) Gfap RNA expression during P19 neuronal differentiation. RNA levels are 
normalised using α-tubulin and shown relative to undifferentiated cells. Error 
bars reflect standard deviation between three RT-PCR reaction replicates. (b) 
Immunofluorescence staining of GFAP during neuronal differentiation. (c) No 
primary  (but  Alexa  Fluor  488  Goat)  and  secondary  (but  GFAP)  antibodies 
controls conducted in day 9. Scale bar, 20 µM. 
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3.7 Discussion 
The RA-induced P19 neuronal differentiation provides a model system to study 
the mechanisms underlying EC cell pluripotency and its ability to differentiate 
(Runnicki  and  McBurney,  1987;  Jones-Villeneuve  et  al.,  1982).  The  major 
advantage of the P19 EC cell line due to their transformed nature, can grow 
indefinitely in culture without expensive media or growth factors. Previous 
reports  on  the  characterisation  of  P19  neuronal  differentiation  show 
variability in the concentration of RA used to induced EB formation and the 
plating density to obtain neuronal differentiation. The studies in this chapter 
addressed key steps in the existing differentiation protocol, which increased 
the capacity of neuronal differentiation in culture. The two key steps are RA 
concentration and EBs seeding density in determining the extent of neuronal 
differentiation.  
When  the  project  started,  most  of  the  studies  in  the  literature  using  P19 
neuronal  differentiation  system  used  0.5  µM  RA.  The  increasing  RA 
concentration analysis had managed to induce neuron specific marker Map2. 
However, 0.5 µM RA showed incomplete neural lineage commitment with the 
manifestation of a population of cells in the differentiated cultures expressing 
pluripotent marker Nanog. RA dosage of 1.0 µM but not 1.5 µM was used in all 
subsequent analysis although the latter showed slightly better efficiency in 
producing  neuronal  differentiation  cultures.  The  dosage  of  1.0  µM  RA 
compared to 1.5 µM RA was deem optimal and most appropriate as it falls 
within the optimal range previously reported (Teets et al., 2011; Bain et al., 
1995; Edwards and McBurney, 1983). Besides that, a year after this project 
started, more groups using RA-induced P19 neuronal differentiation reported 
the use of 1.0 µM RA although none explained the significance (Georgiev et 
al., 2008; Zhigang Jin et al., 2009).  
Thus in order to be able to compare the characteristics of this P19 neuronal 
differentiation  system  with  previous  studies,  an  RA  dosage  of  1.0  µM  was 
applied.  However,  it  is  clear  that  1.5  µM  RA  can  also  be  used  for  neural 
programming.  This  RA  dosage  dependence  analysis  shows  that  the 
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crucial. Furthermore, it is clear that gene expression should be analysed up to 
day 6 after plating in order to ensure that Nanog expression is completely 
suppressed  and  undifferentiated  cells  are  not  present  in  the  neuronal 
differentiation culture. 
The optimal seeding density of EBs in adherent cultures was addressed using 
Mash1 and Mash2 markers. Mash1 and Mash2 markers provide more sensitive 
indication of the neuronal differentiation state compared to markers such as 
Oct4  and  Map2.  A  previous  report  demonstrated  the  importance  of 
maintaining cell-to-cell contact during P19 neuronal differentiation (Schmidt 
et al., 1992). Using molecular markers Mash1 and Mash2 was the key in this 
experiment. Markers such as Oct4 and Map2 were sharply down-regulated and 
up-regulated,  respectively,  upon  RA  induction  and  therefore  were  not 
sensitive enough. This could be a major reason why the EBs plating step was 
not previously identified as a crucial step in the differentiation protocol. At 
seeding densities lower than 2.5 X 10
6 the differentiation cultures failed to 
survive whereas at densities higher than 5.5 X 10
6 the cultures had retained a 
population  of  cells  expressing  the  undifferentiated  marker  Mash2.  These 
results suggest that a cell-to-cell contact-dependent signalling mechanism is 
important for P19 neuronal differentiation. 
RA-induced  neuronal  cells  derived  from  pluripotent  ES/EC  cells  expressed 
neuron specific genes in a developmentally controlled manner (Rohwedel et 
al., 1999). Profiling of molecular markers is the most commonly used method 
for characterising neuronal differentiation in vitro. The expression profiling is 
based on genes that are known to be expressed upon neural induction and 
specific  to  subtypes  of  neuron  and  glia  cells.  In  this  chapter,  a  cohort  of 
marker  was  analysed  and  the  RA-induced  P19  differentiation  showed 
programming to the neural lineage. The differentiation cultures expressed the 
neuron specific markers and the loss of pluripotency markers. A marker for 
Glia cells was detected in the later stage of differentiation (day 9). The RNA 
levels of the neuronal markers were detected in the EBs stage onwards but 
not the proteins. Protein levels of NF-160 and Map2 are detected from day 3 
and 6 respectively. Markers such as NMDA-NR2 and NSE are expressed in the 
later stage of differentiation coinciding with functional neurons. These results Chapter 3    108 
are  comparable  to  previous  studies  that  show  neuronal  and  glia  marker 
expressions in ES/EC cells (Rohwedel et al., 1999; Bain et al., 1995; Fraichard 
et al., 1995; Strübing et al., 1995, Strübing et al., 1995). 
3.8 Conclusion 
The characterisation results in this chapter show that RA-induced P19 cells 
have undergone programming and differentiate into neurons and possibly glia 
over a period of 9 days. However, the neuronal differentiation carried out 
here, is over a short length of time and may not be fully functional in inducing 
neuronal signalling and synaptic transmission as terminal neurons. 
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Chapter 4 
Characterisation of HMGN expression in neural 
differentiation of P19 EC cells and hippocampal 
neurons from adult mouse brain 
 
4.1 Introduction 
The  HMGN  proteins  are  a  family  of  non-histone  proteins  that  bind  the 
nucleosome  and  alter  the  organisation  of  the  chromatin  structure  (Bustin, 
2001).  The  control  of  embryonic  development  depends  on  the  precise 
regulation of tissue specific gene expression. The structure of the chromatin 
plays a key role in determining gene expression programs. Thus, nucleosome 
binding proteins such HMGNs are expected to be important for the regulation 
of development and cellular differentiation. 
HMGN  proteins  are  divided  into  five  members,  HMGN1  through  HMGN5. 
HMGN3 is the only member to have splice variants,  HMGN3a and HMGN3b. 
HMGN1  and  HMGN2  are  the  founding  members  of  the  family,  followed  by 
HMGN3 and HMGN4. HMGN5 has been recently discovered and is unique in 
terms  of  its  molecular  structure  when  compared  to  other  HMGN  members 
(Shirakawa et al., 2000).  
The interest in studying HMGN proteins in embryonic stem cells and neuronal 
differentiation comes from a previous study conducted by Dr. Katherine L. 
West (West et al., 2004). In that study, over-expression of HMGN3 in Hepa 
cells up-regulated a specific gene target, GlyT1. GlyT1 is a gene that encodes 
Glycine  transporter  1  protein  that  plays  a  crucial  role  in  neurons.  GLYT1 
protein is responsible for the re-uptake of extracellular glycine at the synaptic 
junction of neurons (Zafra et al., 1997; Jursky and Nelson, 1996; Johnson and 
Asher,  1987).  Glycine  is  an  inhibitory  neurotransmitter,  whose  synaptic 
concentration is regulated by GLYT1 to ensure proper processing of motor and 
sensory  information  (Cubelos  et  al.,  2005;  Lim  et  al.,  2004).  The  study 
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affects transcription but also suggested that HMGN3 may play a role in the 
proper functioning of neurons.  
Since HMGN  genes are regulated in a developmental-stage specific manner 
during  mouse  embryogenesis  and  cellular  differentiation  (Furusawa  et  al., 
2006; Lehtonen et al., 1998), it is hypothesised that they may play a role in 
embryonic  stem  cell-derived  neuronal  differentiation.  The  role  of  HMGN 
proteins  in  neuronal  differentiation  has  not  yet  been  studied.  In  order  to 
study  whether  HMGNs  play  a  role  in  embryonic  stem  cells  and  neuronal 
differentiation,  RA-induced  neuronal  differentiation  of  P19  EC  cells  was 
employed.  The  characterisation  and  optimisation  of  RA-induced  neuronal 
differentiation was shown in the previous chapter. The HMGN members that 
were  included  in  this  study  are  HMGN1,  HMGN2,  HMGN3a  and  HMGN3b. 
HMGN4 and HMGN5 were not studied in this project. The reasons for studying 
the selected members of HMGN are based on their significance relating to the 
project. HMGN1 and HMGN2 remain the best characterised members of the 
family, whereas HMGN3 has been shown to be expressed in glial cells, a cell 
type associated with neurons (Ito and Bustin, 2002). HMGN4 is closely related 
to HMGN2 and is thought to have similar functions (Birger et al., 2001), while 
HMGN5 has a long acidic C terminal domain that is different from all the other 
members (Rochman et al., 2005). From here onwards whenever HMGNs are 
referred to in the text, it refers to HMGN1, HMGN2, HMGN3a and HMGN3b. 
The aims of this chapter are to study the expression of HMGNs during RA-
induced P19 neuronal differentiation and in EBs. This chapter also describes 
the expression of HMGNs in hippocampal neuronal cultures derived from adult 
mouse brain.  
 
4.2 Objectives 
1.  To analyse the expression of HMGN RNA and protein levels in neural 
programmed EBs. 
2.  To analyse the expression of HMGN RNA and protein levels in neural 
differentiation of P19 EC cells. Chapter 4    111 
3.  To study the cellular localisation of HMGN proteins in undifferentiated 
and neural differentiated P19 cells.  
4.  To  study  the  expression  of  HMGN  proteins  in  hippocampal  neuronal 
culture from adult mouse brain. 
 
4.3 Expression of HMGN in RA-induced EBs derived 
from P19 EC undifferentiated cells. 
P19  EC  undifferentiated  cells  can  be  induced  using  RA  to  form  EBs  that 
consists  of  neuroectodermal  cells  (Chapter  3).  RA  triggers  an  intrinsic 
transcription program that allows the activation of neuroectodermal-specific 
genes via the formation of EBs. The expression of HMGNs has not previously 
studied in the RA-induced EBs. In order to understand whether HMGNs may 
play  a  role  in  the  programming  of  EBs,  their  expression  levels  were 
investigated first of all.  
Having extensively validated the RA-induced P19 neuronal differentiation in 
the previous chapter, the RNA and protein levels of HMGN1, HMGN2, HMGN3a 
and HMGN3b were analysed in the programmed EBs. The RNA and protein used 
in these analyses are from the same biological samples used in characterising 
the cell-specific markers in chapter 3. HMGNs RNA levels were analysed using 
qRT-PCR as described in chapter 2. To validate the RNA expression, western 
blots were carried out using antibodies specific to HMGNs.  
HMGN1  and  HMGN2  RNA  levels  demonstrated  a  8  and  6  fold  increases, 
respectively,  in  RA-induced  EBs  compared  to  undifferentiated  cells  (Figure 
4.1a  and  4.1c).  HMGN2  protein  levels  had  increased  in  EBs  compared  to 
undifferentiated cells (Figure 4.1d). In contrast, the protein levels of HMGN1 
showed a slight decrease in EBs compared to undifferentiated cells (Figure 
4.1b).  Chapter 4    112 
 
 
Figure 4.1: HMGN1 expression shows discrepancies between RNA and 
proteins levels whilst HMGN2 expression is up-regulated in RA-programmed 
EBs.  
(a) & (c) qRT-PCR analysis of HMGN1 and HMGN2 in RA-programmed EBs shown 
relative to undifferentiated cells.  RNA levels are normalised to Gapdh and 
presented relative to undifferentiated cells. Error bars reflect the standard 
deviation from RT-PCR triplicates from one biological replicate. * P< 0.001, 
was  calculated  from  Ct  average  of  3  biological  replicates  compared  to 
undifferentiated. (b) & (d) Western blots using whole cell extracts showing 
the expression HMGN1 and HMGN2. The western blotting images correspond to 
the similar biological replicate in (a). The western blotting images of (HMGN1 
& -Actin, HMGN2 & -Actin) are from the same gel. 
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Figure 4.2: The RNA expression of HMGN3a and HMGN3b are up-regulated 
whilst the protein levels are slightly down-regulated in RA-programmed 
EBs.  
(a) & (B) qRT-PCR analysis of HMGN3a and HMGN3b in RA-programmed EBs 
shown relative to undifferentiated cells. RNA levels are normalised to Gapdh 
and  presented  relative  to  undifferentiated  cells.  Error  bars  reflect  the 
standard deviation from RT-PCR triplicates from one biological replicate. N.S, 
p> 0.001. p values were calculated from Ct average of 3 biological replicates 
compared  to  undifferentiated.  (b)  &  (d)  Western  blots  using  whole  cell 
extracts showing the expression HMGN3a and HMGN3b. The western blotting 
images correspond to the similar biological replicate in (a) & (b). The western 
blotting images are from the same gel.  
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The changes in HMGN3a and HMGN3b RNA levels were not significant in EBs 
compared to undifferentiated cells (Figure 4.2a and 4.2b). The protein levels 
of HMGN3a and HMGN3b decreased in EBs compared to undifferentiated cells 
(Figure 4.2c). It is interesting to note that even though the levels of HMGN1 
and HMGN2 mRNA increased by over 6 fold in EBs, the protein levels were 
either  unchanged  (HMGN1)  or  only  slightly  increased  (HMGN2).  These 
experiments were carried out at least in 3 separate biological replicates and 
all the results yielded the similar expression profiles. Discrepancies between 
RNA  and  protein  levels  in  HMGNs  expression  in  EBs  suggest  a  possible 
mechanism  involving  post-transcriptional  regulation  in  turning  mRNA  to 
protein.  
4.4 Expression of HMGN in P19 neuronal differentiation 
The expression of HMGN proteins has been linked to cellular differentiation 
processes such as erythropoiesis, myogenesis, osteoblast differentiation and 
kidney organogenesis (Crippa et al., 1991; Begum et al., 1990; Shakoori et al., 
1993; Lehtonen and Lehtonen, 2001). Studies using knockout mice, transient 
depletion  and  over-expression of these  proteins  have  provided  evidence  of 
their role in cellular differentiation during embryonic development (Korner et 
al., 2003, Mohamed et al., 2001 and Pash et al., 1993). These studies suggest 
a  possible  correlation  between  regulated  HMGN  expression  and  cellular 
differentiation. However, studies on the expression patterns of HMGN during 
neuronal differentiation in vitro have not been performed.  
Using the P19 neuronal differentiation system described in chapter 3, HMGN 
RNA and protein levels were analysed. The RNA and protein obtained were 
from the same biological replicates used for the characterisation of marker 
genes in chapter 3. The expression profiling analyses were carried out on 3 
different biological replicates to avoid any technical false positives.  Gapdh 
and  α-tubulin  were  used  as  normalisers,  and  both  sets  of  results  were 
comparable (data normalised using α-tubulin not shown). Days 3, 6 and 9 were 
selected to compliment the characterisation data of cell-specific markers in 
chapter 3. HMGN RNA and protein studies were carried out as described in 
Chapter 2.  Chapter 4    115 
4.4.1 Expression of HMGN1 in the neuronal differentiation of 
P19 EC cells 
Normalised  HMGN1  RNA  levels  were  calculated  relative  to  undifferentiated 
cells  and  presented  as  day  3,  day  6  and  day  9  of  neural  differentiation 
cultures  (Figure  4.3).  Overall,  Hmgn1  RNA  levels  decreased  upon  neural 
induction  compared  to  undifferentiated  cells.  Day  3  neural  differentiation 
showed the major decrease in expression by almost 50%. The RNA levels of 
HMGN1  in  day  6  and  day  9  decreased  to  around  80%  compared  to 
undifferentiated cells. However the data point for day 9 was not significant 
based on the P-values.  
To  validate  the  RNA  profile  of  Hmgn1,  western  blotting  was  performed  to 
assay protein levels. HMGN1 protein levels were slightly up-regulated during 
neuronal  differentiation  compared  to  undifferentiated  cells  (Figure  4.3). 
Comparable  western  blotting  results  were  obtained  in  3  independent 
biological replicates (data not shown). Similar to the HMGNs expression results 
found in EB, there were discrepancies between RNA and protein expression 
data. The P values indicate that the decreased in RNA levels found in day 3  
are significant although the protein levels were slightly elevated.   
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Figure 4.3: HMGN1 RNA and protein expression during neural 
differentiation of P19 EC cells. 
(a) qRT-PCR analysis of HMGN1 RNA levels in RA-induced neural differentiation 
on days 3, 6 and 9 shown relative to undifferentiated cells. RNA levels are 
normalised to Gapdh and presented relative to undifferentiated cells. Error 
bars  reflect  the  standard  deviation  from  RT-PCR  triplicates  from  one 
biological replicate. * P< 0.001 was calculated from Ct average of 3 biological 
replicates  compared  to  undifferentiated.  N.S,  p>  0.001  compared  to 
undifferentiated.  (b)  Western  blots  using  whole  cell  extracts  showing  the 
expression  HMGN1.  The  western  blotting  images  correspond  to  the  similar 
biological replicate in (a). The western blotting images are from the same gel. 
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4.4.2 Expression of HMGN2 in the neuronal differentiation of 
P19 EC cells 
During  neuronal  differentiation,  Hmgn2  RNA  levels  demonstrated  a  gradual 
increase from days 3 to 9 (Figure 4.4a). The expression of Hmgn2 RNA was 
highest on day 9, with a 2.3 fold increase compared to undifferentiated cells. 
Day  3  and  day  6  had  near  similar  levels  of  HMGN2  expression  which  is 
approximately  1.5  fold  higher  compared  to  undifferentiated.  Similarly,  the 
levels  of  HMGN2  protein  were  up-regulated  during  neuronal  differentiation 
compared  to  undifferentiated  cells  (Figure  4.4b).  These  results  show  that 
HMGN2  expression  profiles  are  up-regulated  upon  neural  commitment  and 
neuronal  differentiation.  The  regulated  expression  of  HMGN2  suggests  a 
possible role in the differentiation of P19 EC cells.  
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Figure 4.4: Expression of HMGN2 is up-regulated upon neural 
differentiation of P19 EC cells.  
(a) qRT-PCR analysis of HMGN1 RNA levels in RA-induced neural differentiation 
on  days  3,  6  and  9  relative  to  undifferentiated  cells.  RNA  levels  are 
normalised to Gapdh and presented relative to undifferentiated cells.  Error 
bars  reflect  the  standard  deviation  from  RT-PCR  triplicates  from  one 
biological replicate. * P< 0.001 was calculated from Ct average of 3 biological 
replicates compared to undifferentiated. (b) Western blots using whole cell 
extracts  showing  the  expression  HMGN2.  The  western  blotting  images 
correspond  to  the  similar  biological  replicate  in  (a).The  western  blotting 
images are from the same gel. 
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4.4.3 Expression of HMGN3 in the neuronal differentiation of 
P19 EC cells 
HMGN3a and HMGN3b RNA and proteins were expressed at very low levels in 
undifferentiated  P19  EC  cells  (Section  4.3).  In  programmed  EBs,  the  RNA 
levels of HMGN3a and HMGN3b were found to be increased but the protein 
levels did not alter significantly. During neuronal differentiation of P19 cells, 
HMGN3a  and  HMGN3b  demonstrated  an  up-regulation  in  their  expression 
(Figure 4.5). Relative to undifferentiated cells, HMGN3a RNA levels increased 
from 5 fold at day 3 to 15 fold at day 9 (Figure 4.5a and 4.5b). Similarly 
HMGN3b RNA levels increased between 10 fold at day 3 to approximately 20 
fold at day 9. To validate the RNA expression profile of HMGN3a and HMGN3b, 
western blots were performed using an antibody that detects both isoforms. 
Overall,  the  protein  levels  of  HMGN3a  and  HMGN3b  demonstrated  an  up-
regulation during neuronal differentiation of P19 EC cells (Figure 4.5c). These 
results  show  that  HMGN3a  and  HMGN3b  expression  levels  are  linked  to 
differentiation  and  these  proteins  may  play  a  role  in  the  process  of 
neurogenesis.  
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Figure 4.5: Expression of HMGN3a and HMGN3b are up-regulated upon 
neural differentiation of P19 EC cells. 
(a)  &  (b)  qRT-PCR  analysis  of  HMGN3  RNA  levels  in  RA-induced  neural 
differentiation of days 3, 6 and 9 relative to undifferentiated cells. RNA levels 
are  normalised  to  Gapdh  and  presented  relative  to  undifferentiated  cells. 
Error bars reflect the standard deviation from RT-PCR triplicates from one 
biological replicate. * P< 0.001 was calculated from Ct average of 3 biological 
replicates compared to undifferentiated. (c) Western blots using whole cell 
extracts  showing  the  expression  HMGN3.  The  western  blotting  images 
correspond  to  the  similar  biological  replicate  in  (a)  &  (b).  The  western 
blotting images are from the same gel. 
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4.5 Cellular localisation of HMGN in undifferentiated 
P19 EC cells.  
HMGNs  are  nucleosome  binding  proteins  and  are  found  to  be  distributed 
throughout the nucleus (Hock et al., 1998; Postnikov et al., 1997). Previous 
studies have shown that HMGN1 and HMGN2 are highly dynamic in the nucleus 
and  that  their distribution  is  transcription  dependent (Misteli et  al.,  2000; 
Hock et al., 1998). Studies on HMGN3 expression in adult mouse brain and 
retina show that the protein is localised in the nucleus (Lucey et al., 2008; 
West  et  al.,  2004;  Ito  and  Bustin,  2002).  The intra-nuclear organisation  of 
HMGN proteins in P19 EC cells has not been studied.  
The RNA and protein expression patterns of HMGNs shown in section 4.3 and 
4.4  do  not  show  whether  HMGN  proteins  are  ubiquitously  expressed  in  all 
cells. In order to study whether HMGN proteins are present in all cells or a 
particular cell type, immunofluorescence using antibodies specific to HMGN1, 
HMGN2  and  HMGN3  was  performed  using  undifferentiated  and  neural 
differentiating cultures. Firstly, immunofluorescence studies were conducted 
in undifferentiated cultures, using the protocol described in chapter 2. These 
experiments  were  done  in  parallel  to  the  immunofluorescence  studies  of 
Oct4, Nanog and Sox2 presented in chapter3. The results showed here are 
representative of 3 biological replicates tested and at least 30 fields of images 
taken under 40 X objective. 
HMGN1 is ubiquitously expressed in undifferentiated cells (Figure 4.6a). The 
expression of HMGN1 seems to be evenly distributed in the nuclei of all cells. 
Single cell images clearly show that HMGN1 is localised within the nucleus and 
not the cytoplasm (Figure 4.6b). The expression of HMGN2 is similar to that of 
HMGN1 in undifferentiated P19 EC cells. HMGN2 is ubiquitously expressed in 
all cells and is localised within the nucleus and not the cytoplasm (Figure 4.7a 
and 4.7b).   
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Figure 4.6: Expression of HMGN1 protein is ubiquitous and localises within 
the nuclei of undifferentiated P19 EC cells.  
(a) Detection by immunofluorescence of HMGN1 protein in undifferentiated 
P19 EC cells. Scale bar = 20 µm. (b) Image digitally re-sized from (a) using 
image J to show single cell resolution image of HMGN1 protein. Scale bar = 25 
µm. (c) Control immunofluorescence experiments conducted without primary 
(left) or secondary (right) antibodies. Red= HMGN1, Blue= DAPI and Purple= 
HMGN1 and DAPI merge. Each image is representative of 30 images taken from 
separate biological replicates. Immunofluorescence images were taken at 40 X 
objective and analysed using ImageJ software. 
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Figure 4.7: Expression of HMGN2 protein is ubiquitous and localises within 
the nuclei of undifferentiated P19 EC cells.  
(a) Detection by immunofluorescence  of HMGN2 protein in undifferentiated 
P19 EC cells. Scale bar = 20 µm. (b) Image digitally re-sized from (a) using 
image J to show single cell resolution image of HMGN1 protein. Scale bar = 25 
µm. (c) Control immunofluorescence experiments conducted without primary 
(left) or secondary (right) antibodies. Red= HMGN2, Blue= DAPI and Purple= 
HMGN2 and DAPI merge. Each image is representative of 30 images taken from 
separate biological replicates. Immunofluorescence images were taken at 40 X 
objective and analysed using ImageJ software.  
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Figure 4.8: HMGN3a and HMGN3b proteins are ubiquitously expressed but 
predominantly localise with the cytoplasm. 
(a)  Detection  by  immunofluorescence  of  HMGN3a  and  HMGN3b  proteins  in 
undifferentiated P19 EC cells. Scale bar = 20um. (b) & (c) Image digitally re-
sized from (a) using image J to show single cell resolution image of HMGN1 
protein.  Scale  bar  =  25  µm.  (d)  Control  immunofluorescence  experiments 
conducted  without  primary  (left)  or  secondary  (right)  antibodies.  Red= 
HMGN3,  Blue=  DAPI  and  Purple=  HMGN3  and  DAPI  merge.  Each  image  is 
representative  of  30  images  taken  from  separate  biological  replicates. 
Immunofluorescence images were taken at 40 X objective and analysed using 
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HMGN3 detection via immunofluorescence was conducted using an antibody 
named HMGN3-2752 that detects both HMGN3a and HMGN3b. This antibody 
was  previously  used  to  detect  HMGN3  proteins  in  different  mouse  brain 
regions,  and  showed  HMGN3  localisation  within  the  nuclei  (Ito  and  Bustin, 
2002). In undifferentiated P19 EC cells, HMGN3 was found to be ubiquitously 
expressed  in  all  cells  (Figure  4.8a).  However,  rather  surprisingly  HMGN3 
distribution was predominantly localised to the cytoplasm of undifferentiated 
cells (Figure 4.8b and 4.8c). These results are representative of at least 7 
biological replicates. 
Further experiments were carried out to see whether this localisation was an 
artefact.  First,  HMGN3-2752 antibody used in the Western Blot experiment 
detected both HMGN3a and HMGN3b at the correct sizes and no other proteins 
were detected, ruling out a problem with antibody specificity (refer to figure 
4.5). Nevertheless, a different antibody raised against a C-terminal peptide of 
HMGN3a  (named  mouse  HMGN3a  or  mHMGN3a)  was  used  in  3  biological 
replicates to analyse the cellular localisation of the proteins. Similar to the 
pattern observed using HMGN3-2752 antibody, HMGN3a protein was found to 
be localised within the cytoplasm of the cells (data not shown).  
The analysis of HMGN3 localisation was also performed using methanol as the 
fixation agent instead of paraformaldehyde to rule out possible artefacts that 
may arise from the fixation agent. Results obtained from methanol fixed cells 
showed  similar  results  in  which  HMGN3  proteins  were  predominantly 
cytoplasmic (data not shown). Finally, immunofluorescence studies of HMGN3 
were conducted in a range of undifferentiated cells from early passage to late 
passage,  and  all  experiments  showed  that  HMGN3  is  predominantly 
cytoplasmic (data not shown). Taken together, these results demonstrate that 
HMGN3, although ubiquitous expressed is predominantly within the cytoplasm. 
These results raise several questions about the role HMGN3 in P19 EC cells and 
whether  it  acts  through  a  different  mechanism  compared  to  HMGN1  and 
HMGN2.  
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4.6 Cellular localisation of HMGN proteins in neural 
differentiated cultures of P19 EC cells. 
HMGNs were all ubiquitously expressed in undifferentiated cells with HMGN1 
and  HMGN2  localised  to  the  nucleus  while  HMGN3  was  found  to  be 
cytoplasmic. The next question is whether the localisation patterns of HMGNs 
in  undifferentiated  cells  are  similar  in  neural  differentiating  cultures. 
Immunofluorescence analysis using similar conditions were performed on day 
3 and day 6 neural differentiation cultures. These cultures were previously 
validated  for  neuronal  markers  (Chapter  3).  The  results  shown  here  are 
representative of 2 biological replicates. 
HMGN1 and HMGN2 were ubiquitously expressed in day 3 neural differentiated 
cultures (Figure 4.9a and Figure 4.9b). Similar to the undifferentiated cells, 
HMGN1 and HMGN2 were found to be localised within the nucleus. HMGN3 was 
expressed  in  all  neuronal  differentiating  cells  on  day  3  and  day  6  (Figure 
4.9c).  Importantly,  the  distribution  pattern  of  HMGN3  is  similar  to 
undifferentiated cells in which the protein is localised within the cytoplasm. 
Overall,  these  results  suggest  that  HMGN  proteins  are  ubiquitous  in  their 
expression  upon  neural  differentiation.  HMGN1  and  HMGN2  are  localised 
within the nuclei whereas HMGN3 is predominantly found in the cytoplasm 
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Figure 4.9: Expressions of HMGN proteins in RA-induced neural 
differentiation of P19 EC cells.  
Detection  by  immunofluorescence  of  (a)  HMGN1  on  day  3  neural 
differentiation, (b) HMGN2 on day 3 neural differentiation and (c) HMGN3a 
and HMGN3b on day 6 neural differentiation. Scale bar = 20um. Red= HMGNs, 
Blue= DAPI and Purple= HMGNs and DAPI merge. Each image is representative 
of 30 images taken from separate biological replicates. Immunofluorescence 
images were taken at 40 X objective and analysed using ImageJ software.  
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4.7 HMGN expression in hippocampal neurons 
HMGN proteins are ubiquitously expressed in neuronal differentiating P19 EC 
cells. HMGN1 and HMGN2 are localised within the nucleus whereas HMGN3 is 
predominantly cytoplasmic. All previously reported HMGN expression in vivo 
showed  that  the  proteins  were  localised  within  the  nucleus  (Lucey  et  al., 
2008; West et al., 2004; Ito and Bustin, 2002). To investigate whether the 
cytoplasmic localisation of HMGN3 is a common feature of neuronal cultures, 
or whether it is specific to P19 cells, the localisation of HMGNs in primary 
mouse neuronal cultures was examined.  
To obtain primary neuronal cultures, a collaboration with Dr. Stuart Cobb was 
established  (University  of  Glasgow).  Paul  Turko  (PhD  student  in  Dr.  Stuart 
Cobb’s group) had kindly contributed neurons derived from the hippocampus 
region of the adult mouse  brain grown in culture for 18 days. The day 18 
hippocampal neuronal cultures had shown to express several neuronal and glia 
markers such as MAP2 and GFAP (Dr. Stuart Cobb, personal communication). 
Besides  that,  these  cultures  had  shown  normal  neurotransmitter  signalling 
indicating  the  presence  of  functional  neurons  (Dr.  Stuart  Cobb,  personal 
communication).  
Immunofluorescence studies to detect HMGN proteins were conducted on day 
18 hippocampal cultures. These experiments were conducted on neurons from 
2 separate adult mice and the results presented here are representative of 
both biological replicates. Overall, HMGN proteins were found to be localised 
with  the  nuclei  (Figure  4.10).  Interestingly,  HMGN  proteins  were  not 
ubiquitously  expressed  in  day  18  neuronal  cultures  (overlaid  images  with 
DAPI).  Approximately  half  the  cells  in  the  neuronal  culture  were  not 
expressing  HMGN  proteins.  These  results  suggest  that  HMGN  proteins  were 
only expressed in specific neurons or glia from the hippocampal regions and 
raise the question of their selective roles in these cells. In order to investigate 
which neurons or glia express HMGN proteins, an experiment using several cell 
markers could be used. 
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Figure 4.10: Expressions of HMGN proteins are not ubiquitous in day 18 
hippocampal neuronal cultures. 
Detection by immunofluorescence of (a) HMGN1, (b) HMGN2 and (c) HMGN3a 
and HMGN3b in day 18 hippocampal neuronal culture. Scale bar = 20 µm. (d) 
Control  immunofluorescence  experiments  conducted  without  primary 
antibody. Red= HMGNs, Blue= DAPI and Purple= HMGNs and DAPI merge. Each 
image  is  representative  of  10  images  taken  from  separate  biological 
replicates.  Immunofluorescence  images  are  taken  at  40  X  resolution  and 
analysed using ImageJ software.  
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4.8 Discussion 
Previous studies on HMGN proteins in differentiation models have been carried 
out in chondrocyte, myoblast and erythopoietic cells (Furusawa et al., 2006; 
Crippa et al., 1991; Begum et al., 1990). Studies from these model systems 
had  one  major  outcome,  with  results  demonstrating  a  down-regulation  of 
HMGN1 and HMGN2 proteins upon cellular differentiation. Over-expression of 
HMGN  proteins  halted  the  differentiation  process  (Begum  et  al.,  1990).  In 
contrast, results shown here demonstrate a clear up-regulation of HMGN2 and 
HMGN3  expression  during  neural  differentiation  of  P19  EC  cells,  whereas 
HMGN1 protein levels were not significantly changed. One possibility for the 
contrasting results could be due to the timing of the neuronal differentiation. 
The cultures shown here are at an early stage and have only undergone a 
short  phase  of  differentiation  (up  to  day  9).  Expression  of  HMGNs  may 
decrease if the cultures were allowed to differentiate further.  
HMGN proteins were found to be ubiquitously expressed in undifferentiated 
and  neural  differentiated  P19  EC  cells.  HMGN1  and  HMGN2  were  localised 
within  the  nucleus.  Rather  interestingly,  HMGN3,  although  ubiquitously 
expressed in undifferentiated and neural differentiated cells, was found to be 
predominantly  cytoplasmic.  Cytoplasmic  localisation  of  HMGN  proteins  in 
interphase cells has not been reported before, although it is known that the 
nuclear localisation of these proteins is regulated by phosphorylation. A study 
conducted  by  Prymakowska-Bosak  et  al  in  2002  showed  that  mitotic 
phosphorylation  of  HMGN1  protein  inhibited  its  nuclear  import  thus  the 
protein were predominantly cytoplasmic following the completion of mitosis 
(Prymakowska-Bosak et al., 2002). These results demonstrate that there are 
other  possible  mechanisms  that  may  cause  HMGN3  to  be  localised  in  the 
cytoplasm  in  P19  EC  cells.  Further  studies  on  HMGN  localisation  in  other 
ES/EC/EG cells would determine whether this distribution is a general pattern 
in all embryonic-derived pluripotent cells or if it is only specific to P19 EC 
cells. 
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Studies on day 18 hippocampal neuronal culture showed that HMGN proteins 
were  localised  within  the  nuclei.  These  results  also  showed  that  HMGN 
proteins were not expressed in all cells. Day 18 hippocampal neuronal cultures 
have been shown to express both MAP2 and GFAP (Dr. Stuart Cobb, personal 
communication). Future studies using double immunofluorescence labelling of 
HMGNs and specific neuronal or glia markers could be performed on these 
cells to analyse the type of cells that are expressing the proteins. The results 
may be crucial in understanding the role of HMGN in neurons and glia culture. 
This  chapter  investigates  the  expression  of  HMGN  RNA  and  protein  in 
undifferentiated and neural differentiating P19 EC cells. The results suggest 
that P19 EC cells are a good model system to study the role of HMGNs in 
pluripotency and neuronal differentiation.  
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Chapter 5 
HMGN1 and HMGN2 knockdown affect the 
expression of key genes in undifferentiated P19 
EC cells and RA-induced neural differentiation 
 
 
5.1 Introduction 
This  chapter  addresses  the  question  of  what  is  the  possible  role  of  HMGN 
proteins in P19 EC cell-derived neural differentiation?  Previous studies show 
that HMGN1 and HMGN3 can modulate specific gene expression by directly 
binding directly to their targets, for example Sox9 and GlyT1a, respectively 
(Furusawa  et  al.,  2006;  West  et  al.,  2004).  As  the  results  presented  here 
suggest that two of the HMGN proteins are induced upon neural induction, it 
was  hypothesised  that  HMGN  proteins  could  affect  the  expression  of  gene 
targets that are important for neural commitment or function. In order to 
address this question, siRNA-based knockdown of HMGN  proteins in P19 EC 
cells was employed. At this stage, the decision was taken to exclude HMGN3 
from  further  experiments  due  to  its  unusual  cellular  localisation  in  both 
undifferentiated  and  neuronal  cells.  In  addition,  Hmgn3  RNA  expression  is 
around 100-600 fold lower than that of Hmgn1/2 during neural differentiation, 
and so may have a less crucial role than the more abundant isoforms (Chapter 
4- Hmgn RNA ratio). The possible approaches that may be taken to investigate 
HMGN3  in  P19  EC  neural  differentiation  are  discussed  in  Chapter  6 
(Conclusions and future perspectives).  
The aim of this chapter is to investigate the role of HMGN1 and HMGN2 in 
pluripotency  and  neural  differentiation  of  P19  EC  cells.  It  describes  the 
establishment  of  HMGN1/2  knockdowns  in  P19  EC  cells,  followed  by 
experiments to investigate the effect of the knockdowns on the expression of 
genes specific to pluripotency and neural differentiation.  Chapter 5    133 
5.2 Objectives 
1.  To establish and validate HMGN1/2 knockdowns using specific siRNAs in 
undifferentiated P19 EC cells. 
2.  To  analyse  the  effect  of  HMGN1/2  knockdown  on  the  expression  of 
genes of interest (GOI) in undifferentiated cells. 
3.  To  study  the  RA  neural  induction  and  differentiation  ability  of 
undifferentiated P19 EC cells lacking HMGN1/2. 
4.  To  establish  and  validate  HMGN1/2  knockdowns  in  neural 
differentiation from P19 EC cells. 
5.  To  analyse  the  effect  of  HMGN1/2  knockdown  on  the  expression  of 
genes of interest (GOI) in RA-induced day 3 neural differentiation. 
 
5.3 Establishing an siRNA-based protocol for HMGN1 
and HMGN2 knockdown  
To  establish  functional  studies  on  the  role  of  HMGN1/2  in  P19  EC  cells, 
knockdown  experiments  using  siRNA-based  technology  were  employed.  A 
siRNA knockdown approach was selected for two main reasons: 1) siRNA-based 
knockdown,  once  established,  is  a  rapid  and  convenient  way  to  obtain 
functional  data.  2)  Identification  of  siRNA  sequences  that  are  efficient  in 
knocking down HMGN proteins would enable them to be used in short hairpin 
RNA (shRNA) vectors for long term knockdown experiments.  
The  siRNA  library  for  HMGN1  and  HMGN2  was  purchased  from  Qiagen’s 
Flexitube GeneSolution system.  This system provides 4 pre-selected siRNA 
sequences for one target that are designed based on their HP OnGuard siRNA 
design  method.  Among  the  key  features  of  this  siRNA  design  method  are 
accurate  siRNA  design  based  on  the  latest  NCBI  data  set  and  specific 
improvement  to  avoid  off-target  effects  (see  chapter  2  for  details  and Chapter 5    134 
sequences).  The  siRNAs  for  HMGN1  and  HMGN2  is  shown  in  table  5.1.  The 
siRNAs  are  re-named,  for  example  siRNA  N101,  N1=target  (HMGN1=N1/ 
HMGN2=N2) whereas the subscripted 01 refers to the siRNA variant.  
The  siRNA  knockdowns  were  carried  out  in  P19  EC  cells  according  to 
manufacturer’s  protocol,  except  that  a  different  transfection  reagent  was 
utilised  (Chapter  2).  The  siRNA  initial  knockdown  screens  were  conducted 
using 3 different final siRNA concentrations of 5 nM, 10 nM and 20 nM for 48 
hours (data not shown). The western blot results from this experiment showed 
that N102 and N103 knocked down HMGN1 protein levels by slightly more than 
60% when used at 20 nM, whereas 5 nM and 10 nM had no or little knockdown 
of HMGN1 protein when compared to untreated cells and cells transfected 
with  a  negative  control  siRNA.  Data  from  the  initial  knockdown  screen 
demonstrated that N102 and N103 were the most efficient siRNAs when used at 
20 nM final concentration. Two siRNAs to target HMGN1 as opposed to just one 
were  used  for  subsequent  experiments  to  act  as  a  biological  validation 
control.  
Next, a time-course analysis of HMGN1 knockdown levels when transfected 
with N102 and N103 siRNAs at a final concentration of 20 nM was performed 
(Figure 5.1). Briefly, undifferentiated P19 EC cells were transfected with N102, 
N103 and negative control siRNAs for 48 hours before changing the media. The 
cells were then left to grow and passaged every two days. Whole cell lysates 
were collected at the indicated time points and assayed for HMGN1 protein 
levels. Results shown in figure 5.1 indicate that both siRNAs N102 and N103 
generated  more  than  90%  knockdown  of  HMGN1  protein  levels  at  72  hours 
after transfection. The protein levels were restored close to wild type levels 
by 6 days after transfection. These results show that N102 and N103 siRNAs, 
when used at a final concentration of 20nM, efficiently knockdown HMGN1 
protein levels for almost 4 days (48-120 hours). The negative control siRNA in 
this experiment was used at 20 nM and the HMGN1 protein levels remained 
unaltered. Another validation experiment was conducted using an Alexafluor 
tagged siRNA (provided by Qiagen) to monitor if the siRNA used transfected 
most  of  the  cells  in  the  culture.  Results  showed  that  the  siRNAs  had 
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The initial screen for HMGN2 knockdown using the four different siRNAs at 5 
nM, 10 nM and 20 nM did not show efficient levels of knockdown (data not 
shown). A second test was performed using a concentration range of 20-40 nM 
over 5 days, and western blot results demonstrated that almost 90% of HMGN2 
protein was knocked down at 72 hours following the transfection of 40 nM N201 
and N204 (Figure 5.2). The negative control siRNA in this experiment was used 
at 40 nM and the protein levels remained unaltered. HMGN2 protein levels 
were restored to almost wild type levels from day 5 onwards (120 hours). 
From  these  results,  it  is  evident  that  a  higher  concentration  of  siRNA  is 
required to knock down HMGN2 compared to HMGN1. This is not surprising as 
HMGN2 is more abundant than HMGN1 and HMGN3 in P19 EC cells (Chapter 4). 
For subsequent functional experiment in P19 EC cells, N102 and N103 siRNAs for 
HMGN1 and N201 and N204 for HMGN2 at final concentrations of 20 nM and 40 
nM,  respectively,  were  used.  The  optimal  conditions  for  knocking  down 
HMGN1 and HMGN2 are summarised in table 5.2. 
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Table 5.1: siRNA library and their designated names for HMGN1 and HMGN2 
knockdown. 
 
Target  siRNAs 
N=target; 0X= siRNA variant 
 
 
HMGN1 
N101 
N102 
N103 
N104 
    
 
HMGN2 
N201 
N202 
N203 
N204 
 
 
 
 
 
 
 
Table 5.2: Summary of the knockdown conditions for HMGN1 and HMGN2 in 
P19 EC cells. 
 
siRNA variant  Optimal 
concentration 
(nM) 
Knockdown time 
point 
(hours) 
Knockdown levels 
(˜% compared to 
wild type) 
N102  20  72  90 
N103  20  72  90 
N201  40  72  85 
N204  40  72  90 
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Figure 5.1: siRNA knockdowns reduce levels of HMGN1 protein to 
approximately 90% after 72 hours post transfection in undifferentiated 
P19 EC cells. 
(a)  &  (b)  Western  blot  analysis  showing  time-course  expression  of  HMGN1 
after  transfection  with  N102  and  N103  siRNAs  at  20  nM  final  concentration. 
siRNAs  were  removed  from  media  after  48  hours  and  cells  were  passaged 
every  two  days.  WT=  wild  type,  -ve=  negative  control  siRNA,  no  siRNA= 
transfection  reagent  without  siRNA.  Western  blotting  images  are  from 
separate gels for each panel in (a) & (b). 
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Figure 5.2:  HMGN2 knockdown is achieved using siRNA at 40nM final 
concentration of after 72 hours post-transfection in undifferentiated P19 
EC cells. 
Time-course and siRNA concentration analysis of HMGN2 knockdown.  Western 
blot  analysis  from  whole  cell  lysates  showing  time-course  expression  of 
HMGN2  after  transfection  with  increasing  amounts  of  siRNA.  siRNAs  were 
removed from media after 48 hours and cells were passaged every two days. 
WT= wild type, -ve= negative control siRNA, no siRNA= transfection reagent 
without siRNA. Western blotting images are from separate gels for each panel. 
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5.4 Validating HMGN1 and HMGN2 knockdowns in P19 
EC cells 
In order to investigate the role of HMGNs in P19 EC cells, HMGN1 and HMGN2 
knockdowns were performed in three independent biological replicates using 
the conditions summarised in table 5.2. Total RNA and whole cell lysates were 
collected 72 hours post transfection and qRT-PCR and western blotting was 
used to confirm HMGN knockdown.  
5.4.1 HMGN1 and HMGN2 knockdowns in undifferentiated P19 
EC cells 
HMGN1 knockdowns were performed using the N102 and N103 siRNAs at a final 
concentration of 20 nM. The negative control siRNA was also transfected at 20 
nM to assess for off-target effects of the knockdown system. HMGN1 RNA and 
protein were dramatically knocked down at 72 hours post transfection using 
both  N102  and  N103  siRNAs  (Figure  5.3).  RNA  levels  dropped  by  70%  in  the 
knockdown experiments compared to wild type levels (Figure 5.3a & 5.3b). 
HMGN1 protein levels were knocked down by approximately 90% compared to 
wild type levels (Figure 5.3c). Both N102 and N103 show comparable knockdown 
efficiency at the RNA and protein levels.  
In previous studies, it has not been clear whether reduced expression of one 
HMGN  family  member  is  compensated  by  the  over-expression  of  another. 
Furusawa et al showed that compensation of the HMGN1 knockout by HMGN2 
does not occur at the protein level, but found higher enrichment of HMGN2 at 
the Sox9 gene when HMGN1 is depleted (Furusawa et al., 2006). This raises 
the  question  of  whether  knocking  down  HMGN1  leads  to  a  compensatory 
increase in HMGN2 expression. However, the data in figure 5.3c show that the 
expression of HMGN2 is unchanged in P19 EC cells where HMGN1 is knocked 
down.  
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Figure 5.3 HMGN1 protein levels are knockdown by more than 90% in 
undifferentiated P19 EC cells. 
Undifferentiated  P19  EC  cells  were  transfected  with  N102  and  N103 
individually. After 72 hours, total RNA and whole cell lysates were harvested 
for qRT-PCR analysis and western blotting from independent sample. (a) & (b) 
show RNA levels of HMGN1 normalised to -Actin and shown relative to wild 
type  cells  (WT).  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. * P< 0.001 was calculated from Ct 
average of 2 biological replicates compared to WT. (c) Western blots showing 
expression of HMGN1 and HMGN2 with -Actin as the loading control. HMGN2 
protein  expression  is  not  altered  upon  HMGN1  knockdown.  The  western 
blotting images correspond to the similar biological replicate in (a) & (b). The 
western blotting images of HMGN1 and -Actin are from the same gel. WT= 
wild  type,  -ve=  negative  control  siRNA,  no  siRNA=  transfection  reagent 
without siRNA.  
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Figure 5.4 HMGN2 protein levels are knockdown by more than 90% in 
undifferentiated P19 EC cells.  
Undifferentiated  P19  EC  cells  were  transfected  with  N201  and  N204 
individually. After 72 hours, total RNA and whole cell lysates were harvested 
for qRT-PCR analysis and western blotting from independent sample. (a) & (b) 
show RNA levels of HMGN2 normalised to -Actin and shown relative to wild 
type  cells  (WT).  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. * P< 0.001 was calculated from Ct 
average of 2 biological replicates compared to WT. (c) Western blots showing 
expression  of  HMGN2  and  HMGN1  expression  with  -Actin  as  the  loading 
control.  HMGN1 protein expression is not altered upon HMGN2 knockdown. 
The western blotting images correspond to the similar biological replicate in 
(a) & (b). The western blotting images of HMGN2 and -Actin are from the 
same gel.  WT= wild type, -ve= negative control siRNA, no siRNA= transfection 
reagent without siRNA. 
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HMGN2  knockdowns  were  performed  using  N201  and  N204  siRNAs  at  a  final 
concentration of 40 nM. The negative control siRNA was also transfected at 40 
nM final concentration. Total RNA and whole cell lysates were harvested at 72 
hours after transfection and analysed using qRT-PCR and western blots. RNA 
levels show HMGN2 knockdown of up to 70% and 65% in N201 and N204 siRNA 
transfections, respectively (Figure 5.4a and 5.4b). HMGN2 protein levels show 
more than 90% depletion in knockdown experiments compared to wild type. 
HMGN1 protein levels remain unaltered upon HMGN2 knockdown, again ruling 
out any compensatory effects at the protein level (Figure 5.4c middle panel).  
5.4.2 HMGN1 and HMGN2 double knockdown in 
undifferentiated P19 EC cells 
After establishing robust knockdown systems in undifferentiated P19 EC cells 
using  specific  siRNAs  towards  either  HMGN1  or  HMGN2,  it  was  considered 
whether both the siRNAs could be used simultaneously to generate a double 
HMGN1  and  HMGN2  (HMGN1/2)  knockdown.  There  is  obvious  advantage  of 
having double knockdown as it could be used to address the effects of the loss 
of the predominant HMGN family members in P19 EC cells. To my knowledge, 
there have not been reports of double HMGN1 and HMGN2 knockdown in a 
differentiation model system.  
To produce double HMGN1/2 knockdown, N102 and N201 siRNAs were selected, 
and transfected at 20 nM and 40 nM, respectively. The double transfection 
produced dramatic knockdown for both HMGN1 and HMGN2 at the RNA and 
protein levels after 72 hours (Figure 5.5). RNA levels of HMGN1 and HMGN2 
were reduced by approximately 90% compared to wild type (Figure 5.5a and 
5.5b), and HMGN1 and HMGN2 proteins were undetectable (Figure 5.5c). The 
concentration of negative control was performed at 40 nM. The morphology of 
the knockdown cells was similar to that of the untransfected cells, although 
the cells did appear to proliferate more slowly.  Chapter 5    143 
 
Figure 5.5: HMGN1 and HMGN2 proteins are lost following double 
knockdown in undifferentiated P19 EC cells 
A combination of siRNAs targeting HMGN1 (20 nM) and HMGN2 (40 nM) were 
transfected simultaneously. After 72 hours, total RNA and whole cell lysates 
are harvested for qRT-PCR analysis and western blotting from independent 
sample (a) & (b) HMGN1 and HMGN2 RNA levels normalised to  -Actin and 
shown relative to wild type cells. Error bars reflect the standard deviation 
from  RT-PCR  triplicates  from  one  biological  replicate.  *  P<  0.001  was 
calculated from Ct average of 2 biological replicates compared to WT. (c) 
Western  Blotting  demonstrating  the  expression  of  HMGN1  (top  panel)  and 
HMGN2  (middle  panel)  with  -Actin  as  the  loading  control.  The  western 
blotting images correspond to the similar biological replicate in (a) & (b). The 
western blotting images of HMGN1 and -Actin are from the same gel. WT = 
wild type, -ve = negative control siRNA. 
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5.5 HMGN knockdowns in undifferentiated cells down-
regulate the expression of key pluripotency genes 
The  expression  of  several  genes  of  interest  (GOIs)  was  analysed  in 
undifferentiated HMGN1/2 knockdown cells in order to investigate whether 
HMGN1/2  regulate  genes  that  are  important  for  P19  EC  identity  and 
pluripotency.  The  genes  analysed  were  the  pluripotency  regulators  Oct4, 
Nanog and Sox2, as well as the glycine transporters GlyT1 and Glyt2, and the 
transcriptional regulator REST. As shown in chapter 3, Oct4, Nanog and Sox2 
are highly expressed in undifferentiated P19 EC cells. Their expression is lost 
upon  RA-induced  neural  induction,  and  they  remain  silenced  during  neural 
differentiation.  In  contrast,  all  neural  related  genes  tested  were  not 
expressed  in  undifferentiated  cells,  except  for  a  basal  level  of  nestin 
expression. 
To study the differential expression of GOIs, total RNA was isolated from wild 
type cells and those transfected with negative control siRNA, two siRNAs each 
for HMGN1 and HMGN2 and double HMGN1/2. Gene expression was assayed by 
qRT-PCR, normalised to -actin or Gapdh, and expressed relative to levels in 
wild type cells. These are the same samples in which HMGN1/2 expression was 
analysed in figures 5.3, 5.4 and 5.5. 
Knockdown of HMGN1,  HMGN2 or HMGN1/2 in undifferentiated cells down-
regulated the expression of Oct4, Nanog and Sox2 by more than 80% in all 5 
knockdown experiments (Figure 5.7). Two different siRNAs for each target act 
as positive controls to validate the loss of function experiments. The results 
obtained here are not due to a general loss in mRNA transcription as the total 
RNA quality from knockdown cells was similar to wild type cells. There were 
insignificant changes in the Ct values of the GAPDH housekeeping gene, and 
normalising the GOI to two different housekeeping genes (Gapdh and -Actin) 
produces  similar  results.  These  data  sets  are  comparable  between  three 
independent biological replicates.  Chapter 5    145 
 
 
 
Figure 5.7: HMGN knockdowns in undifferentiated P19 EC cells 
dramatically down-regulated pluripotency genes Oct4, Nanog and Sox2. 
HMGN1, HMGN2 and HMGN1/2  were knocked down using specific siRNAs in 
undifferentiated cells. Ct values from knockdown cells were normalised to -
actin and shown as relative to wild type levels. Error bars reflect the standard 
deviation from RT-PCR triplicates from one biological replicate. * P< 0.001 
was calculated from Ct average of 2 biological replicates compared to WT. 
WT= wild type, -ve= negative control siRNA.  
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5.6 HMGN2 knockdown in undifferentiated cells down-
regulates GlyT1a gene but does not affect the 
expression of GlyT2 
Previous studies from our lab have shown that HMGN3 binds to and regulates 
the expression of the glycine transporter GlyT1a in Hepa cells (West et al., 
2004).  Consequently,  we  were  interested  to  investigate  whether  Glyt1a 
expression is altered following HMGN1/2 knockdown in P19 EC cells. 
GlyT1a belongs to the Na
+/Cl
- glycine transporter family that plays a role in 
the re-uptake of glycine molecules from the synaptic junctions (Zafra et al., 
1997; Jursky and Nelson, 1996; Adams et al., 1995; Johnson and Asher, 1987). 
GlyT1  is  predominantly  expressed  in  neurons  and  glia  of  the  CNS,  with 
additional  expression  in  liver,  lung  and  stomach,  while  GlyT2  expresion  is 
neuron specific (Aragon et al., 2003; Adams et al., 1995; Kim et al., 1994; Liu 
et al., 1993; Smith et al., 1992).   
GlyT1a gene is expressed at basal levels in undifferentiated P19 EC cells and is 
induced  to  moderate  levels  upon  neural  induction  (Figure  5.8).  GlyT1b 
expression  is  very  low  in  neural  differentiated  cells  and  not  present  in 
undifferentiated cells (data not shown). GlyT2 is detected at very low levels 
in undifferentiated cells and is highly expressed upon neural induction (Figure 
5.8).  
Knockdown  of  HMGN1  and/or  HMGN2  in  undifferentiated  cells  resulted  in 
variable levels of GlyT1a down-regulation (Figure 5.9). Only one of the HMGN1 
siRNAs significantly affected GlyT1a expression (N103), whereas both HMGN2 
siRNAs  reduced  GlyT1a  expression  by  over  50%.  The  effect  of  the  double 
HMGN1/HMGN2 knockdown was similar to that of knocking down HMGN2 on its 
own. Data from two other biological replicates gave similar results.  This data 
suggests  that  HMGN2  is  a  positive  regulator  of  GlyT1a  expression  in 
undifferentiated  P19  EC  cells.  In  contrary,  GlyT2  gene  expression  remains 
unchanged in the knockdown cells when compared to wild type cells (Figure 
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Figure 5.8: GlyT1a and GlyT2 expression during RA-induced P19 EC cell 
differentiation. 
RNA  levels  are  normalised  using  α-tubulin  and  shown  relative  to 
undifferentiated cells. Error bars reflect the standard deviation from RT-PCR 
triplicates from one biological replicate. * P< 0.001 was calculated from Ct 
average of 2 biological replicates compared to undifferentiated. 
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Figure 5.9: GlyT1a is down-regulated whereas GlyT2 is unchanged upon 
HMGN knockdowns in undifferentiated P19 EC cells. 
HMGN1,  HMGN2  and  HMGN1/2  were  knockdown  using  specific  siRNAs  in 
undifferentiated cells. Ct values from knockdown cells were normalised to -
actin and shown relative to wild type levels. Error bars reflect the standard 
deviation from RT-PCR triplicates from one biological replicate. * P< 0.001 
was calculated from Ct average of 2 biological replicates compared  to WT. 
N.S, p> 0.001, compared to undifferentiated. P values for GlyT2 RNA analyses 
are above 0.001, P>0.001. WT= wild type, -ve= negative control siRNA.  
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5.7 Expression of Rest and various neural lineage-
specific genes remained unchanged following 
HMGN knockdowns in undifferentiated cells 
Rest, (RE1 silencing transcription factor, also known as NRSF), has been shown 
to  act  as  a  factor  that  negatively  regulates  neural  lineage-specific  gene 
expression in undifferentiated ES cells (Singh et al., 2008; Ballas et al., 2005). 
Rest is highly expressed in undifferentiated cells and is dramatically down-
regulated  upon  neural  induction  (Loh  et  al.,  2006;  Ballas  et  al;  2005). 
Similarly, in P19 EC cells, Rest RNA is highly expressed in undifferentiated 
cells and is down-regulated upon RA-induced neural differentiation (data not 
shown).  
HMGN1,  HMGN2  and  HMGN1/2  knockdowns  did  not  significantly  alter  the 
expression  of  Rest  in  undifferentiated  P19  EC  cells  (Figure  5.10).  The 
expression levels of several neural lineage specific genes were also studied 
and found to be unaltered following HMGN knockdown: Nestin, Zfp521, Map2, 
NmdaR2,  Nse,  Nf-160  kDa  and  Gfap.  These  genes  are  expressed  at  basal 
(nestin  and  zfp521)  or  very  low  levels  in  undifferentiated  cells,  and  so  it 
would be difficult to detect any further down-regulation following HMGN1/2 
knockdown.  
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Figure 5.10: Rest expression in undifferentiated P19 EC cells remained 
unchanged after HMGN knockdowns. 
HMGN1,  HMGN2  and  HMGN1/2  were  knockdown  using  specific  siRNAs  in 
undifferentiated cells. Ct values from knockdown cells were normalised to -
actin and shown relative to wild type levels. Error bars reflect the standard 
deviation from RT-PCR triplicates from one biological replicate. P values for 
Rest RNA analyses compared to WT are above 0.001, P>0.001. WT= wild type, 
-ve= negative control siRNA.  
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5.8 HMGN1/2 depletion in undifferentiated cells does 
not have a long term effect on neural commitment.   
The  data  in  the  previous  section  shows  that  HMGN  knockdowns  in 
undifferentiated  P19  EC  cells  leads  to  a  down-regulation  of  several 
pluripotency-related genes. However, HMGN1, HMGN2 and HMGN1/2 depleted 
cells did not show premature neural lineage commitment, as indicated by the 
unchanged  expression  of  neural  genes.  Because  of  the  dramatic  loss  in 
pluripotency gene expression, the question arises as to whether HMGN1/2-
depleted cells have the same ability as wild type cells to be programmed into 
neural commitment using RA, and if so, do the cells produce neuronal cell 
types?  
To address these questions, HMGN1/2 depleted cells were treated with RA 
and then allowed to form EBs. The illustration of the experimental design is 
shown in Figure 5.11a. Briefly, siRNA-transfected cells were treated with RA 
after  48  hours  and  allowed  to  form  EBs  using  the  same  neuronal 
differentiation protocol as described in chapter 3. Total RNA was harvested 
from EBs and day 3 neural differentiation for qRT-PCR analysis.  
Neuronal marker gene expression (Nestin, Map2, NF-160 kDa, Nse) in EBs and 
day 3 neural cells was not altered in cells derived from HMGN1/2-depleted 
P19  cells.  The  expression  of  Nestin  following  RA  induction  in  HMGN1/2 
depleted  cells  and  control  cells  is  presented  as  example  in  Figure  5.11b. 
However,  it  is  important  to  note  that  the  transient  nature  of  the  siRNA 
transfection means that the HMGN1/2 expression had returned back to wild 
type levels by the end of EB formation (see figures 5.1 and 5.2). Thus, this 
experiment  shows  that  transient  knockdown  of  HMGN1/2  during  the  initial 
stages  of  RA  treatment  does  not  have  a  long  term  effect  on  the  neural 
commitment and differentiation of P19 EC cells.  
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Figure 5.11: HMGN1/2 depletion in undifferentiated cells does not have a 
long term effect on neural commitment.   
(a)  Schematic  diagram  showing  the  experimental  design  used  to  induce 
HMGN1/2 depleted cells to neural commitment. (b) Expression of Nestin in 
EBs and day 3 neural cells was similar in HMGN1/2 depleted cells compared to 
the control. Ct values from knockdown cells and –ve siRNA control transfected 
cells were normalised to -actin and shown relative to undifferentiated cells 
(independent  sample).  -ve=  negative  control  siRNA.  Error  bars  are 
representative of three technical replicates. 
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5.9  HMGN1 and HMGN2 knockdown during neural 
differentiation of P19 EC cells  
The second main objective of this chapter is to investigate the role of HMGN1 
and HMGN2 during neural differentiation. The approach taken was to generate 
knockdowns  of  HMGN1,  HMGN2  and  HMGN1/2  at  an  early  stage  of  neural 
differentiation,  and  then  to  assay  the  expression  of  neural  markers  such 
Nestin, Map2 and NF-160 kDA at day 3.   
In order to maximise the efficiency of HMGN1 and HMGN2 knockdown in the 
early neuronal differentiation phase, two rounds of siRNA transfection were 
performed.  The  protocol  for  knocking  down  HMGN  proteins  is  discussed  in 
chapter 2. Undifferentiated P19 EC cells 72 hours prior to RA programming 
were  transfected  with  siRNAs  specific  to  HMGN1  and  HMGN2  (similar  to 
section  5.4).  HMGN1,  HMGN2  and  double  HMGN1/2  knockdown  cells 
(undifferentiated), were induced with RA and allowed to form EBs using the 
system explained in chapter 3. Second siRNA transfections were performed on 
day -3 (EB) and also precisely 12 hours after seeding, using the same siRNA 
concentrations described above. Cells transfected earlier than 12 hours after 
plating did not survive. At day 2 (post seeding), media was carefully replaced 
without damaging the cells. At this point, morphology of the cells was similar 
to wild type cells. Total RNA and whole cell lysates were harvested at day 0 
and day 3 for qRT-PCR analysis and western blotting.  
Four different transfection experiments were conducted using N102 and N201 
individually, N102 and N201 in combination and a negative control siRNA. No 
significant knockdown of HMGN levels was observed at day 0, suggesting that 
siRNA transfection of EBs is inefficient (data not shown). However, single and 
double HMGN knockdowns were observed at day 3 (Figure 5.12). HMGN1 and 
HMGN2 RNA levels were knocked down by more than 75% in cells transfected 
with N102 and N201 siRNAs respectively (Figure 5.12a, top panel). In the double 
knockdown experiments, both HMGN1 and HMGN2 RNA levels were knocked 
down by more than 65% compared to wild type cells (Figure 5.12a, bottom 
panel). Chapter 5    154 
               
 
Figure 5.12: HMGN1, HMGN2 and HMGN1/2 knockdowns in day 3 neural 
differentiation 
Day 0 cells, 12 hours after plating out, were transfected with siRNAs N102, 
N201 and N102 & N201 in combination to knockdown the proteins. (a) RNA levels 
of HMGN1 and HMGN2 on day 3, normalised to wild type cells (WT). Error bars 
reflect  the  standard  deviation  from  RT-PCR  triplicates  from  one  biological 
replicate. (b) Western blots showing HMGN1 and HMGN2 protein expression on 
day  3  with  -Actin  as  the  loading  control.  The  western  blotting  images 
correspond  to  the  similar  biological  replicate  in  (a).  The  western  blotting 
images of (HMGN1 & -Actin, HMGN2 & -Actin) are from the same gel. 
 WT= wild type, -ve= negative control siRNA.  
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Although the level of HMGN1 mRNA was reduced by more than 75% in N102 
transfected cells, the level of HMGN1 protein was only reduced by 30% (Figure 
5.12b). The level of HMGN2 protein knockdown was greater, with a reduction 
of more than 70% protein in N201-transfected cells. Cells transfected with both 
N102  and  N201  siRNAs  had  50%  and  70%  reduction  in  HMGN1  and  HMGN2 
proteins levels, respectively. HMGN1 protein levels in N201 transfections were 
higher  compared  to  wild  type  levels  but  similar  to  the  negative  control. 
HMGN2 protein expression remains unchanged in cells transfected with N102 
siRNA. HMGN protein levels in transfected cells recovered to wild type levels 
by day 6 (data not shown). The RNA data presented here are based on one 
biological replicate as other attempts at knocking-down HMGN1 and HMGN2 
using siRNAs had failed. Statistical analysis could not be carried out due to 
this reason. However, the data from Ct values for D3 knockdown compared 
wild type demonstrated changes in the expression of some target genes.   
 
5.10 HMGN2 knockdown during neural differentiation 
down-regulates Rest expression 
HMGN1 and HMGN2 knockdowns in undifferentiated cells do not affect the 
expression of Rest RNA levels, as shown earlier. As mentioned above, Rest 
expression  is  highest  in  undifferentiated  cells  and  is  down-regulated  upon 
neural differentiation. When HMGN2 protein is knocked down by 70% in day 3 
neural differentiation, Rest expression is significantly reduced by more than 
70%  compared  to  wild  type  cells  (Figure  5.13).  The  expression  of  rest  is 
reduced by 40% in cells knocked down for both HMGN1 and HMGN2.  
These  results  suggest  that  HMGN2  knockdown  specifically  affected  Rest 
expression in day 3 neural differentiation. A similar pattern of reduced Rest 
expression is not observed in N102 transfected cells. This could be because 
HMGN1 is not a positive regulator of Rest in day 3 cells, or it could be that the 
weak knockdown of HMGN1 makes it harder to detect changes in target gene 
expression. These data suggest a possible role for HMGN2 in maintaining Rest 
expression during neural differentiation.  Chapter 5    156 
 
 
 
Figure 5.13: HMGN2 knockdown in day 3 neural differentiation cells down-
regulates Rest expression. 
HMGN1, HMGN2 and HMGN1/2 were knocked down using specific siRNAs, and 
expression of Rest assayed in day 3 neural cells by qRT=PCR. Ct values from 
knockdown cells were normalised to -actin and shown relative to wild type 
levels. Error bars reflect the standard deviation from RT-PCR triplicates from 
one biological replicate. WT= wild type, -ve= negative control siRNA.  
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5.11 HMGN knockdown during neural differentiation 
affects the expression of early neural induced 
genes 
Nestin is a well known neural stem cell marker (Wiese, 2005). It is expressed 
at basal levels in undifferentiated P19 EC cells and is induced by about 10 fold 
upon  neural  induction  (Chapter  3).  When  HMGN1  is  knocked  down  during 
neural differentiation, Nestin expression at day 3 is up-regulated by about 80% 
(Figure 5.14). The increase in nestin expression is less in HMGN2 knockdown 
cells,  and  in  the  double  HMGN1/2  knockdown  cells  it  is  not  significantly 
different to the control cells. The fact that the double knockdown does not 
replicate  the  data  for  the  HMGN1  single  knockdown  is  concerning,  and 
indicates that this experiment needs to be repeated with additional siRNAs 
before drawing any conclusions. 
The role of Zfp521 in ES cell neural differentiation was first shown by Kamiya 
et al, demonstrating that Zfp521 directly activates early neural genes through 
the association with p300 (Kamiya et al., 2011). The expression of Zfp521 is 
not detected in undifferentiated ES cells and is up-regulated by approximately 
60 fold upon neural induction (Kamiya et al., 2011). In the P19 system, Zfp521 
expression was low in undifferentiated cell and induced to high levels upon 
RA-induced neural differentiation (data not shown). The highest expression 
was found in day 3 neural differentiation cells. Interestingly, the expression of 
Zfp521  is  down-regulated  upon  HMGN1  and/or  HMGN2  knockdown  (Figure 
5.14). The greatest reduction was in the double HMGN1/2 knockdown cells, 
where Zfp521 expression is down-regulated by 60%. The results shown here 
suggest a possible role for HMGN proteins in regulating Zfp521 expression.  
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Figure 5.14: HMGN knockdowns in neural differentiating cells affect the 
expression of Nestin and Zfp521.  
HMGN1, HMGN2 and HMGN1/2 were knocked down using specific siRNAs, and 
Nestin and ZFP521 expression assayed on day 3 of neural differentiation. Ct 
values from knockdown cells were normalised to -actin and shown relative to 
wild  type  levels.  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. WT= wild type, -ve= negative control 
siRNA.  
 
 Chapter 5    159 
5.12 HMGN knockdowns during neural differentiation 
affect the expression of neural specific genes 
The genes Map2, NF-160 kDa, Nse and Nmda-receptor subunit 2 (Nmdar2) are 
not expressed in undifferentiated P19 EC cells, but are induced upon neural 
differentiation (Chapter 3). Map2 and NF-160 are expressed most highly on 
day 3 of neural differentiation, and whereas Nse and Nmdar2 expression is 
highest  from  day  6  onwards.  The  expression  of  these  genes  following 
knockdown of HMGN proteins during neural differentiation was assayed on day 
3.   
Map2 expression was not significantly altered in any of the knockdown cells. 
NF-160 expression was up-regulated in the HMGN1 single knockdown and the 
double HMGN1/2 knockdown cells, but was unaffected by the HMGN2 single 
knockdown (Figure 5.15).  This suggests that HMGN1 may have a repressive 
effect of NF-160 expression during neural differentiation. 
The expression of Nse and Nmda-receptor subunit 2 had opposite patterns in 
HMGN  knockdown  cells  (Figure  5.16).  The  expression  of  Nse  was  down-
regulated by approximately 30% in HMGN1, HMGN2 and HMGN1/2 knockdown 
cells, although the reduction in HMGN1 knockdown cells was not significant 
due to large error bars. In contrast, Nmdar2 expression was up-regulated by 3-
4 fold in HMGN2 and HMGN1/2 double knockdown cells.  The effect of the 
HMGN1  knockdown  was  much  weaker,  suggesting  that  HMGN2  may  repress 
Nmdar2 expression during neural differentiation.  
GlyT2 expression is highest on day 3 of neural differentiation (Figure 5.8). 
HMGN2 knockdown during neural differentiation reduced GlyT2 expression by 
75%,  whereas  the  HMGN1  knockdown  and  the  double  HMGN1/2  knockdown 
reduced GlyT2 expression by about 40%  compared to wild type cells (Figure 
5.17). In contrast, there was a trend towards increased expression of GlyT1a 
in the HMGN1 and HMGN2 single knockdowns, although the large error bars 
rendered these changes insignificant.   
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Figure 5.15: Map2 expression remained unchanged but NF-160 kDa is up-
regulated following HMGN knockdowns. 
HMGN1, HMGN2 and HMGN1/2 were knocked down using specific siRNAs, and 
MAP2 and NF-160 kDa expression assayed on day 3 of neural differentiation. Ct 
values from knockdown cells were normalised to -actin and shown relative to 
wild  type  levels.  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. WT= wild type, -ve= negative control 
siRNA.  
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Figure 5.16: Nse and Nmda-receptor subunit 2 demonstrate complimentary 
expression pattern in HMGN knockdown cells. 
HMGN1, HMGN2 and HMGN1/2 were knocked down using specific siRNAs, and 
NSE and NMDA-NR2a expression assayed on day 3 of neural differentiation. Ct 
values from knockdown cells were normalised to -actin and shown relative to 
wild  type  levels.  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. WT= wild type, -ve= negative control 
siRNA.  
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Figure 5.17: GlyT2 expression is significantly down-regulated in HMGN2 
knockdown cells. 
HMGN1, HMGN2 and HMGN1/2 were knocked down using specific siRNAs, and 
GlyT1a and GlyT2 expression assayed on day 3 of neural differentiation. Ct 
values from knockdown cells were normalised to -actin and shown relative to 
wild  type  levels.  Error  bars  reflect  the  standard  deviation  from  RT-PCR 
triplicates from one biological replicate. WT= wild type, -ve= negative control 
siRNA.  
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5.13 Discussion 
5.13.1 HMGN knockdowns in undifferentiated and neuronal 
differentiating P19 cells 
HMGN1 and HMGN2 proteins were transiently knocked down using siRNAs in 
both undifferentiated and RA-induced neural differentiation of P19 cells. The 
protocol used to knockdown HMGN1 and HMGN2 during neural differentiation 
involved  two rounds of siRNAs transfections, one during the EB stage and one 
shortly  after  plating  the  cells  out  on  day  0.  However,  first  round  of 
transfection  did  not  knockdown  HMGN1  and  HMGN2,  when  the  cells  were 
assayed at day 0 (before plating). HMGN1 and HMGN2 knockdowns were only 
obvious in day 3 neural differentiation. These results suggest that the changes 
in  the  expression  of  GOIs  on  day  3  are  solely  due  the  loss  of  HMGN1  and 
HMGN2  during  neural  differentiation  and  not  the  effect  of  improper  RA-
induced neural cell programming due to the first round of siRNA transfection.  
The knockdowns of HMGN1 or HMGN2 did not affect the expression of other 
HMGN family members. HMGN1 knockdown did not alter the levels of HMGN2 
protein and vice-versa. In addition, neither knockdown of HMGN1 nor HMGN2 
changed the expression of HMGN3a and HMGN3b RNA (data not shown). These 
results suggest that the loss of one HMGN member is not compensated by the 
increased expression of another member.  
It is however important to note that HMGN1 and HMGN2 knockdown results in 
D3 neural differentiation was from one biological replicate only. Therefore, 
statistical  analysis  to  measure  significance  could  not  be  carried  out.  More 
biological  replicates  must  be  conducted  to  be  able  to  justify  the  results 
presented here.  
5.13.2 HMGN knockdowns affect the expression of 
pluripotency-related genes in undifferentiated cells 
In undifferentiated cells, HMGN1 and HMGN2 knockdowns lead to a reduction 
in  the  expression  of  pluripotency-related  genes  Oct4,  Nanog  and  Sox2, Chapter 5    164 
whereas  Rest  expression  was  unaffected.  These  results  suggest  that  both 
HMGN1 and HMGN2 may be positive regulators of the key pluripotency genes.  
To investigate whether the knockdown cells that have lost 80% of some of 
their  key  pluripotency  regulators  are  actually  being  engaged  into  cell 
commitment programmes, the expression of various neural lineage genes was 
examined: Nestin, Zfp521, Map2, NmdaR2, Nse, Nf-160 kDa, GlytT2 and Gfap. 
These  are  all  present  at  very  low  levels  in  undifferentiated  cells,  and  no 
change  in  their  expression  was  observed  following  HMGN  knockdown.  The 
continued presence of Rest in the HMGN knockdown cells might explain why 
these neural lineage-specific genes remained silent, even though Oct4, Nanog 
and  Sox2  were  down-regulated.  In  the  future,  large  scale  gene  expression 
profiling  could  be  used  investigate  whether  these  knockdown  cells  express 
genes  that  are  characteristic  of  commitment  towards  the  mesodermal, 
endodermal or ectodermal lineages.   
Several studies show that Rest expression is positively regulated by Oct4 and 
Nanog  (Kim  et  al.,  2008;  Loh  et  al.,  2006;  Boyer  et  al.,  2005).  Oct4  and 
Nanog-dependent regulation of Rest does not fit the results presented here, 
as  Rest  levels  remained  unchanged,  even  though  Oct4  and  Nanog  are 
dramatically down-regulated upon HMGN knockdown. Two possible hypotheses 
can be used to explain this data. Firstly, the already synthesised Oct4 and 
Nanog proteins may be still present in the cells even though RNA levels are 
down-regulated,  thus  maintaining  Rest  expression.  Secondly,  HMGN1  and 
HMGN2 proteins may play a dual role by acting as positive regulators of Oct4 
and Nanog (hence the down-regulation of these genes in the HMGN knockout 
cells),  while  also  inhibiting  Rest  expression,  with  the  net  result  that  Rest 
expression is not significantly altered in the HMGN knockdown cells.   
5.13.3 HMGN knockdowns affected the expression of neural-
related genes in day 3 cells 
In  day  3  of  neural  differentiation,  knockdown  of  HMGN1  and/or  HMGN2 
affected  the  expression  of  7  out  of  9  neural  lineage  genes  tested.  Rest, 
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whereas Nestin, Nf-160 kDa Nmdar2 were up-regulated. Map2 and Glyt1a were 
unaffected. Large scale gene expression profiling is required to investigate 
whether HMGNs affect the majority of neural lineage genes in a similar way, 
but the implication from this small scale study is that HMGNs may play a key 
role in regulating the identity and function of neuronal cells. Whether HMGN1 
and HMGN2 affect the expression of these genes by directly binding to them 
or through other indirect mechanisms remained to be studied. One mechanism 
that could be used to explain how HMGN1-2 are affecting the expression of 
GOIs are through histone acetylation. In study conducted by Lim et al, HMGN1 
were previously shown to affect the expression of a subset of immediate early 
(IE)  genes  through  promoting  H3K14ac  and  inhibiting  phosphorylation  of 
histone 3 (H3S10) (Lim et al., 2005).  
In the undifferentiated cells, all the genes affected by the knockdowns were 
affected by both HMGN1 and HMGN2. In the day 3 cells, some genes were 
altered by knocking down either HMGN1 or HMGN2 (Zfp521, Nestin, Nse and 
GlyT2),  whereas  others  were  affected  only  by  the  specific  knockdown  of 
HMGN1 (NF-160 kDa) or HMGN2 (Nmdar2 and Rest). Thus, HMGN1 and HMGN2 
appear to have some redundant functions, particularly in the regulation of 
pluripotency-related genes, but they also have isoform-specific roles in the 
regulation of some neuronal lineage genes.  
It is interesting to note that the loss of HMGN1 and HMGN2 led to a reduction 
in GlyT1a expression in undifferentiated P19 EC cells, but not in the day 3 
cells.  Previously,  HMGN3  over-expression  was  shown  to  increase  GlyT1a 
transcription in Hepa cells by binding directly to the gene (West et al., 2004). 
It would have been interesting to examine the role of HMGN3 in regulating 
GlyT1a  expression  in  the  P19  EC  system,  but  this  knockdown  was  not 
performed due to the unexpected cytoplasmic localisation of HMGN3 in these 
cells.    It  is  clear  that  the  GlyT1a  gene  is  responsive  to  HMGN  levels,  and 
further studies are required to investigate the roles that the three different 
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5.13.4 Cell-type specific effects of HMGN1 and HMGN2  
HMGN1  and/or  HMGN2  knockdowns  altered  the  expression  of  many  of  the 
neural  lineage  genes  in  day  3  of  neural  differentiation  but  not  in 
undifferentiated  cells.  Similarly,  knockdown  of  HMGN2  reduced  Rest 
expression in day 3 cells but not in undifferentiated cells. In contrast, Glyt1a 
expression was altered by HMGN1/2 knockdown in undifferentiated cells but 
not  in  day  3  cells.  Some  of  these  apparent  discrepancies  could  be  due  to 
detection limits of the qPCR technology, meaning that it is not possible to 
accurately measure small changes in expression of a gene that is expressed at 
a very low level in the first place.  However, this cannot explain the Rest and 
Glyt1a data, and so it seems HMGN1 and HMGN2 may have a different set of 
target genes in undifferentiated compared to neuronal differentiated cells in 
the P19 EC system.  Therefore, the role of HMGN1 and HMGN2 in regulating 
the expression of specific genes appears to be linked to the differentiation 
status of the cells.  
5.14 Summary 
The results of this chapter show that HMGN1 and HMGN2 may play specific 
roles  in  pluripotency  and  neural  differentiation  of  P19  cells.  HMGN1  and 
HMGN2  specifically  affect  the  expression  of  key  pluripotency  and  neural-
related genes. Further experiments to validate the changes in GOIs seen here 
must be carried out before any conclusion can be derived from these results.  
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Chapter 6 
Summary and Future work 
6.1 Summary  
Investigating  the  mechanisms  of  ES/EC  cell  pluripotency  and  neuronal 
differentiation  are  critical  to  understanding  the  early  differentiation 
processes that occur in vivo. The role of HMGN proteins in ES/EC cells and 
neuronal  differentiation  remains  largely  unknown.  This  thesis  presents  the 
characterisation of HMGN1, HMGN2 and HMGN3 expression in undifferentiated 
and  neural  differentiating  P19  EC  cells.  RNA  interference  was  used  to 
knockdown HMGN1 and HMGN2 in order to investigate the roles that they play 
in this system. 
6.1.1 Characterisation of RA-induced neuronal differentiation of 
P19 cells (Chapter 3) 
P19  EC  cells  are  a  commonly  used  system  for  studying  the  mechanisms 
underlying stem cell-derived neuronal differentiation. In this study, a retinoic 
acid protocol was used to promote neuronal differentiation from P19 EC cells. 
Studies in chapter 3 characterised the neuronal differentiation system based 
on the expression of specific molecular markers. Two main steps in the RA 
protocol  were  shown  to  be  crucial  in  inducing  neural  differentiation:  the 
concentration  of  retinoic  acid  used,  and  the  density  of  EB-derived 
neuroectodermal cells plated out for further differentiation. Specifically, an 
RA  concentration of 1.0  µM  and  1.5  µM  showed higher capacity  for  neural 
induction compared to 0.5 µM, and a density of 3.5 X 10
6 cells per 10 cm dish 
were shown to be optimal for subsequent neuronal differentiation.  
Using  the  optimised  protocol,  P19-derived  neuronal  differentiation  was 
characterised using specific molecular markers. The differentiating cultures 
showed the expression of neuron and glia specific markers. In addition, core 
pluripotent markers were lost upon neural induction. The expression of these Chapter 6    168 
specific  markers  demonstrates  that  P19  EC  cells  can  be  used to  study  the 
early events involved in neuronal differentiation.  
6.1.2 HMGN expression during neuronal differentiation (chapter 
4) 
Chapter 4 presents the characterisation of HMGN1-3 expression and cellular 
localisation in undifferentiated and neural differentiating P19 cells. The major 
finding of this chapter is that the expression of HMGN2 and HMGN3 is up-
regulated  upon  neural  differentiation  (while  HMGN1  remained  unchanged), 
contrary to other findings in differentiation models where HMGNs were shown 
to be down-regulated (Furusawa et al., 2006; Crippa et al., 1991; Begum et 
al., 1990).  
The other finding from this chapter is that HMGN3 is predominantly localised 
to  the  cytoplasm  of  undifferentiated  and  neural  differentiating  P19  cells, 
whereas  all  previous  studies  show  HMGN  proteins  to  be  localised  in  the 
nucleus. It is possible that the HMGN3 gene in P19 cells has a mutation in the 
nuclear  localisation  signal,  or  that  a  component  of  the  nuclear  import 
apparatus is mutated, thus preventing the import of HMGN3 into the nucleus. 
To  address  this  question,  HMGN3  from  P19  cells  could  be  cloned  and 
sequenced to identify any possible mutations in the gene, and a GFP-tagged 
version  of  HMGN3  could  transfected  into  P19  cells  to  study  whether  it  is 
localised to the nucleus or the cytoplasm.  It would also be informative to 
investigate the localisation of HMGN3 in mouse ES cells. If the cytoplasmic 
localisation of HMGN3 in P19 cells does not appear to result from a mutation, 
it may be that the nuclear import of HMGN3 is regulated differently to that of 
HMGN1 and HMGN2, with the implication that HMGN3 plays a specific role in 
P19 EC cells that is different to those of HMGN1 and HMGN2. 
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6.1.3 HMGN1 and HMGN2 knockdowns in undifferentiated and 
neural differentiating P19 cells 
Chapter  5  initially  describes  the  establishment  of  HMGN1  and  HMGN2 
knockdowns  using  siRNA  in  undifferentiated  P19  EC  cells.  Four  siRNAs  (2 
specific to each HMGN family member) generated knockdown of HMGN1 or 
HMGN2  proteins  by  approximately  90%.  Using  these  knockdown  cells,  the 
expression of key genes were studied. HMGN1 and HMGN2 knockdown cells 
dramatically  down-regulated  key  pluripotency  regulators  Oct4,  Nanog  and 
Sox2. GlyT1a was also down-regulated by HMGN1 and HMGN2 knockdowns, but 
other  neural  lineage  genes  were  unaffected.  These  results  indicate  that 
HMGN1 and HMGN2 may play roles in regulating the pluripotency state and the 
consequent  differentiation  process  from  P19  EC  cells.  In  day  3  neural 
differentiating cells, the expression of neuron-specific genes were affected 
following  HMGN1  and  HMGN2  knockdown.  Expression  of  key  genes  like 
Nmdar2, Nestin, Zfp521, NF-160 kDa, GlyT2, Nse and Rest were differentially 
expressed  following  HMGN1  and/or  HMGN2  knockdowns.  However  it  is  not 
known whether the HMGN proteins directly or indirectly affect the expression 
of  these  genes.  It  can  be  speculated  that  HMGN1/2  bind  these  genes  and 
trigger  changes  in  histone  modifications  that  lead  to  either  transcriptional 
activation or repression. However the role, HMGN1 and HMGN2 in neuronal 
differentiation of P19 EC cells needs to be further investigated. 
6.2 Future work 
Results from this work showed that HMGN proteins may play an important role 
in stem cells and neuronal differentiation. One of the major accomplishments 
of this project is that it opened up several new aspects for further research, 
particularly in elucidating the role of HMGN proteins in stem cells and cellular 
differentiation. Some of the ongoing and future directions are briefly outlined 
below. 
The changes in GOIs expression following HMGN1/2 knockdown in this project 
were  shown  using  a transient  system.  Ongoing  work  is  being  performed  to 
establish  an  inducible  knockdown  system  for  HMGN1  and  HMGN2  using  the Chapter 6    170 
miRNA  lentiviral  platform  described  by  Shin  et  al  (Shin  et  al.,  2006).  This 
lentiviral system can be used to stably knockdown HMGN1/2 and study the 
relevant  GOIs.  This  is  an  important  experiment  as  it  should  validate  the 
results shown in this project.  
Following  the  establishment  of  the  stable  knockdown  system,  several 
questions could be addressed. The first is to study whether HMGN knockdowns 
affect the expression of other pluripotency genes, and/or those associated 
with  lineage  commitment,  by  conducting  genome-wide  gene  expression 
analyses.  Changes  in  gene  expression  could  be  validated  using  western 
blotting analysis.  
The next question that could be addressed is whether HMGN proteins directly 
bind the GOIs that show changes in expression. This could be performed using 
Chromatin  Immunoprecipitation  (ChIP)  studies.  Futher  analysis  could  be 
conducted to study whether the binding profiles of HMGNs overlap with those 
of  any  specific  histone  modifications.  The  HMGN  binding  profile  could  be 
compared with histone modifications such as the H3K4me3 active mark or the 
H3K27me3 repressive mark, particularly on bivalent genes. It would then be 
interesting  to  investigate  whether  these  marks  change  following  HMGN 
knockdown. This study could elucidate a mechanism for the role of HMGNs in 
regulating  specific  genes  in  undifferentiated  EC  cells  and  neural 
differentiating cells.  
The results from the studies outlined above could be validated using ES cells. 
Cells like mouse E14 ES cells could be used to study whether the roles of 
HMGNs are specific to EC cells or they have a global function in all embryonic-
like  stem  cells.  For  the  neural  differentiation,  other  protocols  besides  RA 
could be employed.  
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6.3 Concluding remarks 
The findings presented in this thesis have revealed a possible role for HMGN1 
and HMGN2 in undifferentiated and neural differentiating P19 EC cells. The 
expression  of  HMGN2  and  HMGN3  was  shown  to  be  up-regulated  in  early 
differentiating  neurons  derived  from  P19  EC  cells.  HMGN3  proteins  were 
shown to be exclusively localised in the cytoplasm of this cells. HMGN1 and 
HMGN2  knockdowns  affected  the  expression  of  key  pluripotency  regulator 
genes  in  undifferentiated  cells  and  neuron-specific  genes  in  neural 
differentiating cells.  
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Appendix  
 
 
Figure A.1: Cell images showing RA-induced neuronal differentiation from P19 
EC cells at day 2 from different EB plating densities.  
(a) A seeding density of 7.5 X 10
6. (b)  A seeding density of 5.5 X 10
6. (c) & (d) 
A seeding density of 3.5 X 10
6. Images were taken under 20 X objective using 
Olympus (IX51) microscope.  
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